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     This thesis was submitted as part of the Doctorate in Clinical Psychology at the School of 
Psychology, University of Birmingham. It consists of two volumes, the first being the 
research component which includes a review of the literature and an empirical study, and the 
second being the clinical component which includes five clinical practice reports.  
Volume I: Research component  
     The literature review examines the existing research on written emotional expression 
interventions for people surviving cancer. There is anecdotal and empirical evidence that 
written emotional expression tasks are beneficial to psychological wellbeing. The review 
examines randomised controlled studies which investigate the feasibility, efficacy and 
moderators of written emotional expression interventions. It was concluded that the studies 
showed promising results in reducing physical symptoms, reducing pain and enhancing 
sleep quality and duration, but that in the majority of studies, psychological outcomes were 
not affected by the interventions. Future research is needed to explore differences between 
written and verbal expression (therapy) to decipher whether expressive writing interventions 
are as efficacious as verbal emotional expression. Randomisation of participants to cancer 
specific and non cancer specific writing groups is also required so that comparisons can be 
made between cancer specific and non-cancer specific writing groups. Finally, future studies 
could benefit from further examining moderators of the effects of expressive writing on 
psychological health outcomes. This paper has been prepared for submission to Psycho-
Oncology. 
     The empirical paper presents a quantitative study that investigates the relationship 
between attitude towards emotional expression, resilience and psychological wellbeing in 
cancer survivors.  It was hypothesised that those with lower resilience and a more negative 
attitude towards emotional expression would have poorer quality of life and more 
psychological symptoms. Participants completed measures of attitude towards emotional 
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expression, resilience, and psychological wellbeing. Results replicate previous findings that 
psychological resilience is a ‘buffer’ against poor psychological wellbeing. Findings also 
suggest that the belief that expressing emotions will lead to social rejection predicts poorer 
resilience and psychological wellbeing in cancer survivors. In addition, interventions which 
include an aspect of resilience training and address a negative attitude towards emotional 
expression may be of benefit. Further longitudinal studies are needed to ascertain the links 
between attitude towards emotional expression, resilience and psychological wellbeing in 
this population. This paper has been prepared for submission to Psycho-Oncology. 
 
Volume II: Clinical component  
    The second volume of the thesis consists of five clinical practice reports. Firstly, a case 
formulation from a cognitive behavioural and a psychodynamic perspective are presented for 
a 36 year-old woman with bipolar disorder referred to a community mental health team. 
Secondly, a case study is presented from a compassion focused perspective of a woman 
with depression and anxiety who had had several bereavements close together. Thirdly, a 
service evaluation was carried out to assess how a healthy lives group for people with 
learning disabilities was being received by service users and staff members, and whether it 
was meeting the guidelines set out by the Walsall Partnership Board. In the fourth report a 
single case experimental design was used to evaluate the effectiveness of a systematic 
desensitisation intervention with a young lady suffering from a phobia of frogs. Lastly an 
abstract is presented for a clinical practice report presentation of a case study of an 18 year 
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Objective: This review aims to systematically evaluate empirical literature relating to the 
efficacy of emotional expression interventions in those with cancer.  
Method: A systematic review of the published literature was conducted. Databases 
searched included Web of Science, PubMed, PsycInfo, and Embase. Only randomised 
controlled trials examining expressive writing interventions in cancer patients were included. 
A total of 17 studies consisting of a total of 1755 heterogenous cancer patients were 
included in this review.  
Results: The majority of included studies in this review suggest that expressive writing 
interventions hold no psychological benefits for people with cancer. Physical health benefits 
were found however and these included lower pain ratings, fewer cancer-related doctor’s 
visits and better sleep quality. Results suggest that expressive writing interventions may not 
be feasible to conduct with palliative care patients. Despite the absence of evidence that 
expressive writing interventions reduced psychological distress for people with cancer, the 
authors of these trials continue to argue that expressive writing interventions are ‘feasible’ 
and well received by participants. 
Discussion: There are several possible reasons that could account for these null findings: 
1.) insufficient power, 2.) low rates of depression and anxiety, and high levels of quality of life 
in study participants, 3.) insufficient differences between expressive writing and neutral 
writing interventions, 4.) asking participants to write about cancer-related trauma only.  








     It is estimated that there are over two million people living with or beyond cancer in the 
UK, and it has been further predicted that this could rise by more than 3% a year (Maddams 
et al., 2008). These estimates are higher than previous predictions, as both cancer incidence 
and survival rates continue to rise (Cancer Research UK, 2013). Due to the ageing 
population, earlier detection of cancer and improvements in treatment, the number of people 
surviving cancer is expected to continue to rise.  
 
 
     Studies indicate that cancer can have a significant psychological impact, and can lead to 
or exacerbate difficulties with mental health difficulties such as depression (Lloyd-Williams, 
2000; Reich, 2008, Somerset, Stout, Miller & Musselman, 2004), anxiety (Mehnert, 
Lehmann, Schulte & Koch, 2007; Stark et al. 2002; Welch-McCaffrey, 1985), post-traumatic 
stress disorder (Hodgkinson et al., 2007; Mehnert & Koch, 2006) and insomnia (Escalante, 
2003; Savard et al., 2001). In addition to increasing the risk of meeting the criteria for a 
mental health difficulty, there are a number of other negative psychosocial outcomes of 
cancer. Those with cancer are more likely to experience less happiness and optimism 
(Peled, Carmil, Siboni-Somocha & Shoham-Vardi, 2008). Relationships with significant 
others can also be adversely affected (Pitceathly & Maguire, 2003), with couples reporting a 
wide range of constraints such as denial, avoidance and conflict within the relationship (Badr 




     Given the wide range of psychological difficulties documented in cancer survivors, it is 
accepted that there is a need for psychosocial interventions aimed at improving quality of life 
in this population (Carlson et al., 2004; Zabora et al., 1997). Results of meta-analyses 
support the usefulness of psychosocial interventions for improving quality of life in cancer 
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survivors (Rehse & Pukrop, 2003). The expression of emotions has been studied for several 
years and has formed the basis of many therapeutic interventions, both for those with 
physical illnesses and those without. Emotional expression has been defined as ‘how one 
conveys emotional experience through both verbal and nonverbal behavior’ (Gross, 1998, 
1999). Gross argued that emotional expression is an important part of emotion regulation 
and can affect health outcomes (Gross, 1999).  There are two theoretical approaches which 
have attempted to identify links between emotional expression and health that emerge in the 
research literature. The ‘non-expression’ approach argues that inhibiting emotion is harmful 
to psychological wellbeing and that emotions that are linked to previous traumatic events 
that have not been expressed can interfere with the individual’s ability to cope with future 
events, and leave them more prone to physical disease (Baikie, 2008; Freud, 1977; Gross & 
Levenson, 1997; Manning, 2010; Scheff, 1979). The suppression of anger has been related 
to hypertension and coronary heart disease and an inhibitory style to the development of 
cancer (Redford and Barefoot, 1988; Temoshok, 1985; Temoshok et al., 1985; Weidner et 
al., 1989).  The ‘expression approach’, which has been focused on in more recent years, has 
explored the advantages of emotional expression and found that disclosure of previously 
unexpressed emotions enhances physical health and emotional wellbeing (Greenberg et al., 
1996; Pennebaker, 1993; Pyszcynski et al., 1993). 
 
 
     One such intervention that has been developed to test the theory behind the ‘expression 
approach’ is the expressive writing paradigm. Expressive writing interventions (EWI) instruct 
participants to write down their deepest thoughts and feelings about a life event that is 
considered stressful (Pennebaker & Beall, 1986). Since James Pennebaker began studying 
expressive writing in college students in the 1980’s, over 200 studies have been conducted 
in this area. Many randomized controlled trials have been conducted with a range of groups, 
from people coping with everyday stressors (Barclay & Skarlicki, 2009; Harvey & Farrell, 
2003; Mackenzie, Wiprzycka, Hasher & Goldstein, 2007) to events such as natural disasters 
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(Smyth & Helm, 2003). Findings from such studies mostly found that the experimental group, 
who wrote about their experiences had a reduction in either physical or psychological 
symptoms. The first meta-analysis of EWI including healthy participants found a medium 
overall effect size, with mean weighted effect size across all studies including both physical 
and psychological outcomes being d = 0.47 (r = .23) (Smyth, 1998). In samples with physical 
and psychiatric disorders, more modest effects have been found (d = 0.19) (Frisina, Berod & 
Lepore, 2004). The results of Frisina et al (2004) also illustrated that expressive writing was 
more effective on physical outcomes (d = .21; p = .01) than on psychological outcomes (d = 
.07; p = .17)  (Qb > 10.83; p = .001).  
 
 
     There are several theories as to why there appears to be both physical and psychological 
benefits to expressive writing. Craft et al (2013) argue that when a person who has a life-
altering experience uses expressive writing, the individual is given the opportunity to reflect 
on and perhaps see their experiences in a new light (Mezirow, 1987, Pennebaker et al., 
1997), and they are also being consciously caring towards themselves (Watson, 2002). This 
integration leads to ‘transformative actions’ that can result in a decrease in physical and 
emotional distress. Through reflection on life-altering experiences, meaning is reconstructed 
and actions that assist with coping are more likely to occur (Craft et al., 2013). According to 
Frankl (1984), this kind of meaning making is fundamental for critical life events to be 
resolved positively. Pennebaker and Graybeal (2001) assert that expressive writing gives the 
individual opportunities to practice social behaviours that can result in a greater feeling of 
connectedness. The available evidence has both supported and contradicted the above 
theories, leading researchers to suggest that the mechanism behind expressive writing is 
probably complex and not accounted for by any particular theory. 
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     There have been several meta-analyses in the last decade that have analysed data from 
randomised controlled trials of written emotional expression in non-cancer populations 
(Frisina et al., 2004; Frattaroli, 2006; Harris, 2006; Mogk et al., 2006). While effect sizes 
were small (0.07-0.21), expressive writing was associated with improvements in physical 
and psychological health. Results however did not always match the hypotheses made by 
researchers and there still remains several unanswered questions regarding how exactly 
written emotional expression is beneficial, who it is most likely to be beneficial for, the most 
appropriate amount of writing, and how long the benefits are sustained for (Chung & 
Pennebaker, 2008; Craft et al., 2013; Sexton & Pennebaker, 2009; Sloan, Feinstein & Marx, 
2009; Stickney, 2010). This area has been studied extensively however there have been no 
literature reviews of the studies specific to cancer.  
 
 
     Tamagawa, Garland, Vaska & Carlson (2012) conducted a systematic review of 
psychological moderators of psychosocial treatment outcomes in cancer patients. They 
argued that while the moderating roles of baseline depression and anxiety have been 
explored previously (Naaman et al., 2009; Ross et al., 2002; Schenider et al., 2010; Sheard 
& Maguire, 1999), none of the literature has explored the role of other psychosocial 
characteristics as moderators of treatment outcome. According to Baron and Kenny (1986), 
a moderator is a variable that influences the relationship between independent and 
dependent variables. Tamagawa et al. (2012) concluded in their review that identifying 
moderators is one way to understand why there is such variance in the outcomes of 
psychosocial interventions, and to help researchers identify who is most likely to benefit from 
such interventions.  
 
This systematic review therefore has two main aims. These are: 
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1.) To summarise and critique the findings of studies which examine the effectiveness of 
expressive writing interventions for those with cancer, to determine whether written 
emotional expression is beneficial in this population, and if so, which outcomes does it 
affect. 
2.) To summarise the findings of these studies which examine moderator variables, in order 
to help determine who is most likely to benefit from such interventions. 
 
     Given the lack of research examining the role of potential moderating variables other than 
depression and anxiety, like the review by Tamagawa et al. (2012), this systematic review 
contributes to the increasing literature aimed at identifying which cancer patients will benefit 















2.1. Search strategy 
     Studies were identified by searching five electronic databases, including Web of Science 
(1900-2013), MEDLINE (1949-2013), PubMed (1946-2013), PsycINFO (1894-2013) and 
Embase (1973-2013) databases. The following keywords were used: Cancer, oncology, 
AND emotion* expression, emotion* inhibition, expressive disclosure, emotion* disclosure, 
repression, expression, writing, talking or sharing. Reference lists of the identified articles 
and relevant review papers were then explored to ensure that any articles missed by the 
database searches were identified and included in the review. This literature search was 
conducted in August and September 2013. 
 
2.2. Inclusion criteria 
     This review included studies if they explored the effects of an expressive writing 
intervention in cancer patients. Participants were adults aged over 18 years old, with a 
current or previous cancer diagnosis, and could be at any stage of the disease. All studies 
included in this review employed a randomised controlled trial design. Some studies also 
explored a moderating role of participants’ characteristics on the outcome of expressive 
writing interventions. These moderators are discussed where they have been investigated, 
however studies were not excluded if they did not investigate moderators. This review only 
included studies published in the English language. There were no restrictions regarding 
publication dates of the studies. 
 
2.3. Exclusion criteria 
     Studies which did not randomise participants were excluded. According to Sibbald and 
Roland (1998), while non-randomised controlled trials can detect associations between an 
intervention and an outcome, they cannot exclude the possibility that this association was 
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caused by an unidentified third factor which is linked both to the intervention and the 
outcome. Studies in which the intervention included an element of group work were excluded 
as it was not clear whether the EWI intervention alone would yield the same results. Studies 
were excluded if they only assessed biological outcomes such as pain. Systematic reviews, 
conference abstracts and dissertations were excluded from the review. 
 
2.4. Data extraction process 
     As part of the review process, a data extraction sheet was developed, which detailed the 
following data items extracted from each study included in the review: 1). Objectives of the 
study; 2). Inclusion and exclusion criteria; 3.) participant characteristics including gender, 
age, type and stage of cancer; 4.) a description of the expressive writing intervention and 
control conditions; 5). follow up time points, 6.) moderator variables, 7.) outcome variables, 
8.) conclusions, 9.) limitations, and 10.) ideas for future research. See Appendix A. 
 
2.5. Methodological evaluation 
2.5.1. The Downs and Black tool 
     Included studies were assessed with the Downs and Black Tool (Downs & Black, 1998) 
for methodological quality, and the Cochrane Collaboration’s tool for assessing risk of bias 
(Higgins et al., 2011, Higgins & Altman, 2008). The Downs and Black Tool (Downs and 
Black, 1998) (see Appendix B) consists of 27 questions in four categories: reporting (n=11), 
external validity and power (n=4), internal validity (bias) (n=7) and internal validity 
(confounding) (n=6). The last item in the Downs and Black tool, which asks about the power 
of the study, has been modified in previous systematic reviews because of the complexity in 
its scoring in the original version (Monteiro & Victora, 2005; Samoocha et al., 2010). These 
studies changed the item from a score out of five to a score out of one, and placed the item 
in the external validity category. A score of 1 was given if a power calculation was present 
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while a score of 0 was given if there was no power calculation or exploration of whether the 
number of participants was appropriate. Each study was then categorised as strong, 
moderate, limited, or poor quality depending on its total score out of 27.  
 
     Mean scores employing the Downs and Black Tool (Downs and Black, 1998) were 21.94 
(SD = 2.30, range = 18-26). Appendix C displays the analyses of items 1 through 27 of the 
tool, with separate tables for 1.) reporting analysis, 2.) external validity and power, 3.) 
internal validity (bias) and 4.) internal validity (confounding). Twelve studies were classed as 
being of strong methodological quality and five were classed as being of moderate 
methodological quality. When comparing the four categories from the Downs and Black tool, 
the category of internal validity (bias and confounding) scored the lowest, with a mean score 
of 5.41 (SD =.94, range = 4-7) out of a maximum of 7 for bias and a mean score of 4.94 (SD 
= .75, range = 4-6) out of a maximum of 6 for confounding. Reporting (/10) had a mean 
score of 7.94 (SD = .90, range = 6-9) and external validity and power analysis (/4) had a 
mean of  6.45 (SD = 3.60, range  = 3-4).  
 
     The drop-out rate in the included studies was relatively low apart from in studies which 
included metastatic and palliative patients some of whom died during the study (de Moor et 
al. 2002; Low et al. 2010; Rosenburg et al. 2002). It was also suggested by de Moor et al 
(2008) that drop out is likely in those patients who are about to have surgery, as they had a 
62% completion rate in their study. Craft et al. (2013) also reported a 42% drop out rate, 
however they used an intention-to-treat analysis in order to take this into account. 
      
     The Down and Black tool has been argued to be both valid and reliable for evaluating 
experimental and nonexperimental studies (Altman & Burton, 1999; Olivo et al., 2008; 
Saunders, Soomro, Buckingham, Jamtvedt & Raina, 2003) and has been rated as one of the 
top six quality assessment tools (Deeks et al., 2003; Saunders, Soomro, Buckingham, 
Jamtvedt, & Raina, 2003). Several previously published reviews in the field of health 
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psychology have employed the Downs and Black tool to critically evaluate included studies 
(e.g. Rosenbloom, Khan, McCartney & Katz, 2013; Samoocha, Bruinvels, Elbers, Anema & 
van der Beek, 2010).  
 
2.5.2. The Risk of Bias tool 
     Higgins et al (2011) however, argue that it is not appropriate to critique clinical trials using 
quality scales and their resulting scores, as such quality scales combine assessments of 
both the quality of reporting of the trial and also the trials conduct, often assigning different 
weights to each aspect. The Cochrane Collaboration’s tool for assessing risk of bias (Higgins 
et al., 2011, Higgins & Altman, 2008) was first designed in 2005 and adapted in 2011. The 
authors argue that including the details of trial conduct, on which the review author’s 
judgments of the risk of bias are based, means there is improved transparency with this 
approach, as it allows readers to decide whether they agree with the judgments that have 
been made. The risk of bias tool (Higgins et al., 2011) argues that randomised controlled 
trials should 1.) generate a random allocation sequence; 2.) conceal allocation; 3.) blind 
participants and healthcare providers; 4.) report incomplete outcome data and 5.) report all 
data rather than selective data. To establish the validity of the randomised controlled trials, 
each study was evaluated on the basis of these five components, and was rated either ‘-’ low 
risk for bias, ‘+’ high risk for bias, or ‘U’ unreported.  
      
     Appendix D displays the assessment of risk of bias of each study included in this review. 
Each aspect was rated as either ‘-‘ (low risk for bias), ‘+’ (high risk for bias) or ‘U’ 
(unreported). Only 3 out of 15 studies provided adequate information for all five aspects 
(Arden-Close et al. 2013; Cepeda et al. 2008; Stanton et al. 2002), and therefore were 
categorised as low risk for potential biases. While Creswell et al. (2007) and Low et al. 
(2006) reanalysed results from a previous study (Stanton et al., 2002) these studies were 
rated for methodological quality based on their reporting of the study and not what was 
known to be reported by Stanton et al. (2002). Over half of the studies included in this review 
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did not report generation of random allocation sequence (10 studies, 58.8%), allocation 
concealment (12 studies, 70.5%), and blinding of participants and researchers (12 studies, 
70.5%). For statements supporting the author’s judgement regarding each bias, see 
Appendix D.  
 
     This review therefore employs both the Downs and Black tool and the Risk of Bias tool in 
order to allow the reader to compare each study using both tools. Each study was evaluated 
using these scoring systems by two researchers who discussed the scores of each study 
throughout. 
 
2.5.3. Comparisons between Downs and Black and risk of bias ratings 
 
     It is evident from the Downs and Black tool (1998) that all the studies in this review were 
categorised as of either strong or moderate methodological quality. However, when using 
The Cochrane Collaboration’s tool for assessing risk of bias (Higgins et al., 2011, Higgins & 
Altman, 2008), the majority of studies did not provide adequate information for its five 
aspects to be assessed, and therefore would be considered to be of poor quality by this tool. 
This demonstrates the variability of different criteria for assessing methodological quality that 
are currently used within the field. Arguably, as The Cochrane Collaboration’s tool was 
designed to assess the quality of randomised controlled trials, it could be concluded that this 
tool is more suitable for use in this review, and therefore that the majority of the included 
studies are of poor methodological quality. It is clear that authors of future RCTs need to be 
clearer in their reporting of the randomisation, allocation concealment, blinding and selective 










3.1. Selection of studies 
 
     A summary of the study selection process is shown in Figure 1. After applying the search 
limit to studies published in the English language and to those with human participants a 
total of 173 potentially relevant articles were identified through an initial search using 
PsycINFO, Web of Science, MEDLINE, Embase and PubMed. Of these 173 articles, 87 
were identified as relevant by title and abstract. Manual reference searches did not identify 
any further randomised controlled trials. These studies were then examined fully for inclusion 
based on inclusion and exclusion criteria. Seventy-one studies did not meet the inclusion 
criteria due to either having non randomised designs, no control group, or interventions that 
were not solely expressive writing. A total of 17 studies were thus identified as eligible for 
























































Figure 1. Flow diagram of study selection process 
 
 
3.2. Study and participant characteristics 
 
     All 17 studies were randomised controlled trials which were available in the English 
language and were conducted in a developed country. Sixteen studies were carried out in 
the USA and one in the United Kingdom.  All trials recruited participants from hospitals or 
university cancer centres. One study included spouses, while the rest included only the 
individual with cancer. Two of the studies were studies that re-examined data from a 
previously published study (Stanton et al, 2002). These studies were included because they 
added to the research literature by examining moderators, which can help us understand 
Literature search of databases: 
PSYCLIT, Web of Science, MEDLINE, 
PubMed, Embase and PsycINFO 




Articles screened for relevance 
on basis of title and abstract 
87 articles 
Full manuscript review and 
application of inclusion and 
exclusion criteria 
 
Seventy-one studies were excluded 
due to:  
 Non RCT design 
 Non written intervention 
 
17 studies included 
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 why there is such variance in the outcomes of psychosocial interventions (Tamagawa et al., 
2012). 
 
    The characteristics of the participants from the 17 studies varied. Of the 17 studies, 10 
(58.8%) included female participants with breast cancer (Creswell et al., 2007; Gellaitry et 
al., 2010; Low et al., 2010; de Moor et al., 2008; Low et al., 2006; Stanton et al., 2002; 
Walker, Nail & Croyle, 1999). Five studies (33%) included male participants with either 
prostate cancer (Rosenburg et al., 2002, Zakowski et al., 2004) renal cell carcinoma (de 
Moor et al. 2002), stage IV cancer of several different types (Cepeda et al., 2008) and 
patients receiving palliative care for several different cancer types (Bruera et al., 2008). The 
majority of studies (71%) included participants with stage I and II cancer while 29% included 
participants with stage III and IV cancer (Bruera et al., 2008; Cepeda et al., 2008; deMoor et 
al., 2002; Low et al., 2010; Mosher et al., 2012). The included studies involved a total of 
1,775 participants. Two of the studies did not contribute original data to the research 
literature, instead further examining existing research for moderators and mediators 
(Creswell et al., 2007; Low et al., 2006). It was decided that these studies would be included 
in this review as one of the aims of the review was to examine which moderating variables 
are important in the outcome of expressive writing interventions. 
 
     The number of participants in each study ranged from 24 to 507. The sample sizes of the 
studies varied with five having total samples of over 100 participants, seven having 50-100 
participants and five with less than 50 participants. Only two studies had a sample size of 
over 100 participants per group, two studies had 50 – 100 participants per group and the 
remaining 13 studies had fewer than 50 participants per group.  
 
3.3. Experimental conditions 
     Table 1 shows the experimental and control conditions for each trial. Twelve studies had 
a two-arm design and five studies had a three-arm design, having more than two 
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experimental conditions. All trials had an expressive writing condition where thoughts and 
feelings about cancer were explored. The expressive writing interventions in the included 
studies were based on the writing paradigm used in previously published studies which 
asked participants to write about their deepest thoughts and feelings, for between three and 
five sessions, usually over consecutive days for 15-20 minutes per writing session 
(Pennebaker, 1994, 1997a, 1997b; Smyth & Pennebaker, 1999).  While the original studies 
were conducted in the laboratory, more recently the writing sessions have been conducted 
at home, including in the studies included in this review, apart from de Moor et al. (2002). 
See Appendix 1 for Pennebaker’s original expressive writing protocol (Pennebaker, 1994). 
Typical writing instructions are as follows: 
 
     ‘For the next 4 days, I would like you to write your very deepest thoughts and feelings 
about the most traumatic experience of your entire life or an extremely important emotional 
issue that has affected you and your life. In your writing, I’d like you to really let go and 
explore your deepest emotions and thoughts. You might tie your topic to your relationships 
with others, including parents, lovers, friends or relatives; to your past, your present or your 
future; or to who you have been, who you would like to be or who you are now. You may 
write about the same general issues or experiences on all days of writing or about different 
topics each day. All of your writing will be completely confidential. Don’t worry about spelling, 
grammar or sentence structure. The only rule is that once you begin writing, you continue 
until the time is up.’ (Baikie & Wilhelm (2005).  
 
     The studies in this review stated that they based their intervention on this writing prompt, 
adapting it to ask participants about their experience of cancer. Two studies (Arden-Close et 
al., 2013; Gellaitry et al., 2010) used a Guided Disclosure Protocol (GDP) where participants 
were guided to write different aspects of their experience on each day. On day one they 
were asked to write about their deepest thoughts and feelings regarding their cancer. On day 
two they were asked to write about what having breast cancer means to them. On day three 
they were asked to write about the positive aspects of their cancer experience, and on day 
four they were asked to write about their thoughts regarding the future. 
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     Only three studies presented the exact prompt that participants were given (Arden-Close 
et al., 2013; Rosenburg et al., 2002, Stanton et al., 2002), while the remainder stated that 
the full details could be requested from the authors. All participants completed the 
intervention at home, apart in the trial by de Moor et al. (2002) where sessions were 
conducted in clinic waiting areas.  
 
3.4. Other experimental conditions 
     One study had a condition where participants could write about any self-selected trauma  
(Craft et al., 2013), and three studies had a condition where they were asked to write about 
the positive aspects of their cancer experience (Creswell et al., 2007; Low et al., 2006; 
Stanton et al., 2002). Gellaitry et al. (2010) asked participants to write about positive aspects 
in one of four writing sessions, but did not look at positive aspect writing as a separate 
condition. 
 
3.5. Control conditions 
     Five of the studies had a control condition that consisted of usual care (Craft et al., 2013; 
Gellaitry et al., 2010; Cepeda et al., 2008; Rosenburg et al., 2002; Walker, Nail & Croyle, 
1999), while 12 of these studies had an active control condition, which consisted of either  
writing factual material about their previous day (Arden-Close et al., 2013; Mosher et al., 
2012; Jensen-Johansen et al., 2012; Stanton et al., 2002; Zakowski et al., 2011; Zakowski et 
al., 2004) or factual material regarding their cancer diagnosis and treatment (Creswell et al., 
2007; Low et al., 2010). One study had both a neutral writing and no writing condition (Craft 
et al., 2013). One study had an attentional control group, who completed a questionnaire 
(Cepeda et al., 2008), and one study compared a condition where participants wrote on 
three occasions and a condition where participants only wrote on one occasion. . 
 
 
EMOTIONAL EXPRESSION IN CANCER SURVIVORS 
18 
 
Table 1. Participants and interventions 
Authors 
(year) 










et al (2013) 
UK 102 couples where one 
partner had ovarian cancer. 
EWI group 53 yrs, control 
group 57 yrs 
Members of a charity for 
those with ovarian cancer 
who consented to be 
contacted by third 
parties.  
1. EWI (n = 53 
couples) 





disclosure about the 
patient’s diagnosis and 
treatment.  
Fact writing. Wrote 
about what the 




days, 15 mins. 
26 
Craft et al 
(2013) 
USA 120 women with stage I, II, 
and III breast cancer. 56 
yrs 
Recruited from a cancer 
center 
1. EWI (n = 26). 
2. Any self selected 
trauma (n = 19). 
3. Fact writing control 
(n = 22). 
4. Usual care control 
(n = 44) 
Deepest thoughts and 
feelings re: cancer 
experience.  
1. Fact writing. Facts 
about breast cancer 
diagnosis and 
treatment. 
2. Usual care. 
Four consecutive 
days, 20 mins. 
21 
Mosher et al 
(2012) 
USA 87 women with metastatic 
breast cancer and 
significant distress. 57 yrs 
Recruited from a cancer 
center in New York 
between March 2008 and 
November 2009. 
1. EWI (n = 44). 
2. Control (n = 42). 
Deepest thoughts and 
feelings re: cancer 
experience.  
Fact writing. Wrote 
about activities of 
the previous day. 
Four writing 
sessions over 4-7 





Denmark 507 women treated for 
stage I and II breast 
cancer, treated with surgery 
within 3 weeks of 
diagnosis. 53 yrs 
Recruited from a cancer 
center between March 
and September 2006. 
1. EWI (n = 253).  
2. Control (n = 254). 
Wrote about a 
traumatic experience 
and deepest thoughts 
and feelings re: cancer 
experience.  
Fact writing. Wrote 







USA 88 women with 
gynaecological cancer at all 
stages of disease. 57 yrs 
 
Recruited through clinics 
in the metropolitan areas 
of Milwaukee, Wisconsin 
and Reno, Nevada 
between 1998 and 2003 
1. EWI (n = 43).  
2. Control (n = 45). 
Deepest thoughts and 
feelings re: cancer 
experience.  
Fact writing. Wrote 
about daily activities. 
Three 
consecutive 





USA 93 women with stage I and 
II breast cancer 
Recruited from a cancer 
center, during their final 
week of treatment. 
1. EWI (n = 45) 
2. Control (n = 48) 
Day 1: Exploring 
deepest thoughts and 
feelings re: experience 
Usual care. Four consecutive 
days, 20 mins. 
21 
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of breast cancer. Day 
2: What does having 
breast cancer mean to 
you? Day 3: Benefit 
finding. Day 4: Looking 
to the future. 
Low et al 
(2010) 
 
USA 62 women with stage IV 
breast cancer. 53 years 
Recruited from a cancer 
center. 
1. EWI (n = 31).  
2. Control (n = 31). 
Wrote about cancer- 
related emotions. 
Fact writing. Facts 
about breast cancer 
diagnosis and 
treatment. 
Four 20 min 
sessions within 3 
weeks. 
24 
Cepeda et al 
(2008) 
USA 234 patients with different 
cancer types. 49 years. 
64% female 
Recruited from oncology, 
radiotherapy, and pain 
clinic of the Javeriana 
University Oncology 
Centre and the 
Colombian National 
Institute of Cancer. 
1. EWI (n = 79).  
2. Attentional control 
(n = 77). 
3. Usual care control 
(n = 78). 
Wrote a story about 
how cancer affected 










de Moor et 
al (2008) 
USA 49 patients with breast 
cancer. EWI group 56 
years, control 50 years 
Recruited from a cancer 
center at the end of 
neoadjuvant 
chemotherapy 
1. EWI (n = 24).  
2. Control (n = 25). 
Deepest thoughts and 
feelings re: breast 
cancer 




use and sleep habits 
Four sessions in 
a week, 20 mins. 
21 
Bruera et al 
(2008) 
USA 24 patients receiving 
palliative care. 54 years, 
66% female 
Recruited from a cancer 
center 
1. EWI (n = 12).  
2. Control (n = 12) 
Deepest thoughts and 
feelings re: breast 
cancer experience. 




use and sleep 
habits. 
Four sessions in 







63 patients with stage I and 
II breast cancer. 49 yrs 
(Further examined Stanton 
et al 2002) 
Used sample from 
Stanton et al (2002) 
1. EWI (n not 
reported). 
2. Positive writing (n 
not reported). 
3. Control (n not 
reported). 
1. Deepest thoughts 
and feelings re: breast 
cancer experience.  
2. Positive thoughts 
and feelings regarding 
their experience with 
breast cancer. 
Fact writing. Facts 
about breast cancer 
diagnosis and 
treatment. 
Four sessions in 
3 week period, 
20 mins. 
23 
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Low et al 
(2006) 
USA 63 patients with stage I and 
II breast cancer. 49 yrs 
(Further examined Stanton 
et al 2002) 
Used sample from 
Stanton et al (2002) 
 
1. EWI (n = 20).  
2. Positive writing (n = 
19).  
3. Control (n = 16).  
Wrote about their 
deepest thoughts and 
feelings re: breast 
cancer experience. 
Fact writing. Facts 
about breast cancer 
diagnosis and 
treatment. 
Four sessions in 





USA 104 prostate and 
gynaecological cancer 
patients. 59 years. 
51.9% female 
Recruited through clinics 
in the Chicago and 
Milwaukee metropolitan 
areas for an on-going 
longitudinal study 
1. EWI (n = 62).  
2. Control (n = 42). 
Deepest thoughts and 
feelings re: cancer 
experience. 
Fact writing. Wrote 
about daily activities. 
Three 
consecutive 
days, 20 mins. 
20 
Rosenburg 
et al (2002) 
USA 30 prostate cancer patients 
receiving outpatient care. 
70 years 
 
Recruited through an 
outpatient clinic at a 
cancer center. 
1. EWI (n = 16).  
2. Control (n = 14). 
Wrote about 
experience of prostate 
cancer and treatment. 
Also allowed to write 
about other traumatic 
experiences.   








USA 42 patients with metastatic 
renal cell carcinoma. 56.4 
years, 85.7% male  
Recruited through a 
Phase II clinical trial of 
vaccine therapy 
1. EWI (n = 21) 
2. Control (n = 21) 
 
Wrote about deepest 
thoughts and feelings 
re: cancer. 









Stanton et al 
(2002) 
USA 63 patients with stage I and 
II female breast cancer 
patients. 49 years 
Recruited through an 
outpatient clinic at a 
cancer center. 
1. EWI (n = 20).  
2. Positive writing (n = 
19).  
3. Control (n = 16). 
1. Wrote about their 
deepest thoughts and 
feelings re: breast 
cancer experience. 
2. Wrote about positive 
thoughts and feelings 
re: breast cancer. 
Fact writing. Facts 
about breast cancer 
diagnosis and 
treatment. 
Four sessions in 







USA 44 women completing 
radiotherapy for stage I or II 
breast cancer 
Recruited through an 
outpatient clinic at a 
cancer center. 
1. EWI single dose (n 
= 11)  
2. EWI three doses (n 
= 14). 
3. Control (n = 14). 
Wrote about deepest 
thoughts and feelings 
re: cancer experience. 
Usual care. 1. One session at 
the clinic lasting 
30 mins. 
2. Three 
sessions in 3 
days, 30 mins. 
21 
 




     All studies reported a follow up, with seven studies reporting one follow up only (Mosher 
et al., 2012; Low et al., 2010; Creswell et al., 2007; Low et al., 2004; Stanton et al., 2002; 
Zakowski et al., 2011; Zakowski et al., 2004), six studies with two follow up assessments 
(Arden-Close et al., 2013; Craft et al., 2013; Jensen-Johansen et al., 2012; de Moor et al., 
2008; Rosenburg et al., 2002; Stanton et al., 2002), and four studies reporting three or more 
follow up assessments (Gellaitry et al., 2010; Cepeda et al., 2008; de Moor et al., 2002; 
Walker, Nail & Croyle, 1999). Follow ups ranged from between one and nine months. See 




















EMOTIONAL EXPRESSION IN CANCER SURVIVORS 
22 
 























No main effects for any outcomes. 
However, in patients, QoL improved if 
illness-related couple communication 
improved and buffered the effect of 
intrusive thoughts on perceived stress. The 
interaction explained 2.3% of the variance 
in QoL at 3-month followup (B=1.17, 






Change in illness-related 
communication 
moderated the effect of 
group on QoL in patients 
(B=1.17, SE=0.52, 
b=0.20; F(1, 85) = 5.16, 
p=0.03). 















EWI group had better quality of life at 1 
month follow up (F(3,93) = 4.22, P = 0.008, 
partial n
2
 = 0.120). Fact writing group also 
reported better quality of life at 1 month 
follow up (mean = 119.62 SD 13.52) 
compared to usual care controls (mean = 



















No main effects. EWI group reported 
greater use of mental health services during 
study than controls (odds ratio = 3.40, 95% 









IES, BDI, POMS, 




3 and 9 
months 
No main effects.  Alexithymia TAS-20 EOT scores 
moderated the effect of 
EWI on IES total scores at 
3 months (β= .26, p = 
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Neo Five Factor 
Inventory, 
BSI, POMS, IES 
Baseline, 
6 months  
No main effects. Neuroticism, 
extraversion 
Neuroticism but not 
extraversion moderated 
effects of emotional 
disclosure on distress 
















No main effects of mood, QoL, healthcare 
utilisation. Those in the EWI group were 
more satisfied with the emotional support 
they received (F(1,77) = 54.20, p<0.05). 
  










No main effects. Social 
constraints 
Those with high levels of 
perceived social 
constraints reported lower 
distress (F(1, 99) = 1.45, 
p < .04) and fewer 
avoidant thoughts (F(1, 




Anxiety Rated their pain on a 
0-10 scale and their 
well-being on a seven-
point Likert scale 
weekly for 8 weeks. 
Daily, 
throughou
t the 8 
week 
study. 














No main effects. Social 
constraints 
Those with high levels of 
social constraints had 
lower daily pain after 
surgery (t(1, 31) = 2.10, p 
= .05). 


















POMS, FACT-T,  




EWI group (β = 1.37, t(54) = -2.99, p = 
.004) and positive writing group (β -.23, 
t(54) = -1.92, p = .060) had fewer physical 
symptoms at 3 month follow up. Self-




Baseline life satisfaction 
or mood did not moderate 
the outcomes of 
expressive writing. 






POMS, FACT-T,  















measure, POMS, IES, 
BSI. 
Baseline,  
6 months  
No main effects. Social 
constraints 
Those with high levels of 
social constraints reported 
lower distress (F(1, 99) = 
1.45, p < .04) and fewer 
avoidant thoughts (F(1, 
99) = 6.25, p < 0.2) 
following EWI. 
Rosenbur







BPI, FACT-P,  SCL-90 
POMS-B, WOC-C 
Baseline, 
3 and 6 
months 
No main effects for psychological variables. 
Those in the EWI group showed greater 
improvements in pain severity (F = 3.98, df 
= 2.0, p = .03), frequency of health care 
contacts (F = 2.65, df = 2.0, p = .09) and 
lower utilisation of medicines (F = 2.73, df = 
2.0, p = .08). 
  













IES, POMS, PSS, 
PSQI 
Baseline, 
4, 6, 8, 10 
weeks 
No main effects found for distress, impact 
of events, perceived stress, mood 
disturbance, except for Vigor subscale of 
POMS (ES = 0.82, p = .03). Patients in EW 
group had less sleep disturbance, better 
sleep quality (ES = -.99, p = .01), sleep 
duration (ES = -.87, p = .04), and less 








POMS, FACT,  





No difference in depression or quality of life 
scores. EWI group had fewer physical 
symptoms and cancer related Dr’s visits 











PANAS, IES, Side 
Effect Severity Scale 
(SEC) 
1, 4-6, 16, 
and 28 
weeks  
No main effects.   
* This study aimed primarily to investigate moderators of the relationship between EWI and psychological outcomes 
Key: BDI = Beck Depression Inventory; BPI = Brief Pain Inventory; BSI = Brief Symptoms Inventory; CES-D = The Center for Epidemiologic Studies– Depression Scale; FACT = 
Functional Assessment of Cancer Therapy; FACT-F = Functional Assessment of Chronic Illness Therapy - Fatigue; FACT – P = Functional Assessment of Cancer 
Therapy Scale – Prostate; IES = Impact of Events Scale; MOS-SF12 = Medical Outcomes Study – Short Form; PANAS = Positive and Negative Affect Scale; POMS = Profile of 
Mood States; POMS – B = The Brief Profile of Mood States; PSQI = Pittsburgh Sleep Quality Index; PSS = Perceived Stress Scale; SCL – 90 = The Symptom Checklist 90 
Revised; STAI = State Trait Anxiety Inventory; WOC-C = The Ways of Coping – Cancer Version. 
 
 
        All the measures used in the included studies were validated tools.
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3.7. Effects of interventions 
 
 
     Comparisons between expressive writing interventions, usual care and neutral writing 
conditions are shown in Table 2 and explored in more detail below. The impact of EWI were 
examined regarding depressive symptoms and mood, general psychiatric symptoms, 
perceived stress, psychosocial functioning, the impact of events, ways of coping, 
perceptions of emotional support and pain and other physical outcomes. Expressive writing 
interventions did not appear to be related to improvements in depressive symptoms, quality 
of life or other psychological variables. Expressive writing interventions do appear to be 
effective in reducing pain and other physical health outcomes however. In some cases 
results are reported where there are three or fewer studies from which the conclusions were 
gathered. This applied particularly to comparisons between EWI and an attentional control 
group, EWI and a positive writing group, different doses of EWI, and also to data on 
moderator variables which were only studied in 6 trials. Data comparing conditions are 
described in turn below. Table 3 summarises which studies found significant and non-
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Significant findings Non-significant findings 






None Gelliatry et al. (2010); Rosenburg et al. 
(2002); Walker, Nail and Croyle (1999) 
 General psychiatric 
symptoms 
None Cepeda et al. (2008); Rosenburg et al. 
(2002) 
 Quality of life Craft et al. (2013) Gellaitry et al. (2010); Rosenburg et al. 
(2002);  
 Impact of events  Walker, Nail & Croyle., (1999) 
 Ways of coping  Rosenburg et al. (2002) 
 Emotional support Gellaitry et al. (2010) None 
 Pain and other 
physical  
Rosenburg et al. (2002) Gellaitry et al. (2010); Cepeda et al. 
(2008) 
2.) EWI vs. NW Depressive 
symptoms and 
mood 
de Moor et al. (2002) Mosher et al. (2012); Jensen-Johansen 
et al. (2012); Zakowski et al. (2011); 
Low et al. (2010); de Moor et al. (2008) 
Bruera et al. (2008); Creswell et al. 
(2007); Low et al. (2006); Zakowski et 
al. (2004); Stanton et al. (2002) 
 General psychiatric 
symptoms 
None Mosher et al. (2012); Zakowski et al. 
(2011); de Moor et al. (2008); Bruera et 
al. (2008); Zakowski et al. (2004) 
 Quality of life Craft et al. (2013) Arden-Close et al. (2013); Creswell et 
al. (2007); Low et al. (2006); Stanton et 
al. (2002);  
 Perceived stress  Arden-Close et al. (2013); de Moor et 
al. (2008); de Moor et al. (2002) 
 Use of mental 
health services 
Mosher et al. (2012) None 
 Psychosocial 
functioning 
Zakowski et al. (2004) None 
 Impact of events None Jensen-Johansen et al. (2012); 
Zakowski et al. (2011); Low et al. 
(2010); Zakowski et al. (2004); 
de Moor et al. (2002) 
 Pain and other 
physical  
Creswell et al. (2007) 
Stanton et al. (2002) 
None 
 Sleep de Moor et al. (2002) Craft et al. (2013); de Moor et al (2008) 
3.) EWI vs. 
attentional control 
Sense of wellbeing None Cepeda et al (2008) 
 Pain intensity None Cepeda et al (2008) 
4.) EWI vs. any 
trauma 
 Craft et al. (2013)  
5.) EWI vs. positive  None Stanton et al. (2002) 
6.) One dose vs. 
three doses 
 None Walker, Nail & Croyle (1999) 
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3.7.1. Comparison 1: Expressive writing versus no intervention/usual care  
 
Depressive symptoms and mood 
     No differences in mood between experimental and usual care control groups were found 
by Gelliatry et al. (2010), Rosenburg et al. (2002) and Walker, Nail and Croyle (1999).  
 
General psychiatric symptoms 
 
     Cepeda et al. (2008) found that sense of wellbeing was similar in all conditions before 
and after treatment. Rosenburg et al. (2002) found no group differences in SCL-90 scores. 
 
Quality of life 
 
     Craft et al. (2013) found that expressive writing about breast cancer and breast cancer 
trauma significantly improved participants quality of life at one and six month follow ups 
(t(25) = 5.88, P < 0.001). There were significant group differences between those who wrote 
about breast cancer trauma and those who did not write at all at one month follow up 
(F(3,93) = 4.22, P = 0.008, partial n2 = 0.120) but not at six month follow up. Gellaitry et al. 
(2010) and Rosenburg et al. (2002) found no group differences in quality of life. 
 
Impact of events 
 
     Walker, Nail & Croyle (1999) found that EWI did not decrease cognitive intrusion or 
avoidance. 
 
Ways of coping 
 
     Rosenburg et al. (2002) reported no group differences in ways of coping. 
 
 
Perceptions of emotional support 
 
     Gellaitry et al. (2010) found that those in the EWI group reported that they were more 
satisfied with the emotional support that they received from a range of key individuals than 
those in the usual care group (F(1,77) = 54.20, p<0.05). Those in the EWI group reported a 
decrease in discrepancy between ideal and actual levels of emotional support while emotional 
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support discrepancy increased in the control group, which suggests that writing helped women to 
maintain levels of emotional support which satisfied them. 
 
 
Pain and other physical health symptoms 
 
     Cepeda et al. (2008) found that pain intensity was similar in all conditions before and after 
treatment. Rosenburg et al. (2002) reported that those in the expressive disclosure condition 
showed greater improvements in physical health outcomes including pain severity (F = 3.98, 
df = 2.0, p = .03), frequency of health care contacts (F = 2.65, df = 2.0, p = .09) and lower 
utilisation of medicines (F = 2.73, df = 2.0, p = .08) in comparison to controls. Gellaitry et al. 
(2010) however found there were no group differences in health care utilisation. 
 
 
3.7.2. Comparison 2: Expressive writing versus neutral writing  
 
Depressive symptoms and mood 
 
     There were no differences in depression scores or mood scores between expressive 
writing and neutral writing groups (Mosher et al., 2012; Jensen-Johansen et al., 2012; 
Zakowski et al., 2011; Low et al., 2010; de Moor et al., 2008; Bruera et al., 2008; Creswell et 
al., 2007; Low et al., 2006, Zakowski et al., 2004, Stanton et al., 2002), apart from on the 
Vigor subscale of the POMS in the study by de Moor et al. (2002) (ES = 0.82, p = .03). 
 
General psychiatric symptoms 
 
     No differences between experimental and neutral writing participants were found on the 
General Severity Index (Zakowski et al., 2004). No group differences found in spiritual 
wellbeing, distress or sleep quality were found by Mosher et al. (2012). Zakowski et al. 
(2011), Zakowski et al. (2004) and de Moor et al. (2008) found no group differences on the 
Brief Symptoms Inventory. Bruera et al. (2008) found no main effects for anxiety using the 
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Quality of life 
      
     Craft et al. (2013) found that there was significant group differences between those who 
wrote about breast cancer trauma and those who wrote about facts regarding breast cancer 
at one month follow up (F(3,93) = 4.22, P = 0.008, partial n2 = 0.120). However, while they 
hypothesised that the fact writing group would not experience quality of life benefits, this 
group did still produce statistically significant results at one month follow up (mean = 119.62, 
SD = 13.52) compared to the no writing group (mean = 104.38, SD = 21.31). Arden-Close et 
al. (2013), Stanton et al. (2002) and two papers which further analysed these findings 
(Creswell et al., 2007; Low et al., 2006) found no group differences in quality of life. Arden-
Close et al. (2013) reported that quality of life did improve however if illness-related couple 
communication improved and buffered the effect of intrusive thoughts on perceived stress. 
The interaction explained 2.3% of the variance in quality of life at 3-month follow up (B=1.17, 





     No significant group differences were found using the Perceived Stress Scale (PSS) 
(Arden-Close et al., 2013; de Moor et al., 2008; de Moor et al., 2002).  
 
Use of mental health services 
 
     Mosher et al. (2012) found that the expressive writing group reported greater use of 
mental health services than the neutral writing group during the study (odds ratio = 3.40, 




     Zakowski et al (2004) found that written expression buffered the effects of social 
constraints on distress (GSI score) at a six month follow-up (β = -.507, t(4.45) = 1. 99, p < 
0.04.) 
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Impact of events 
 
     No differences were found between expressive and neutral writing groups in the Impact 
of Events Scale scores (Jensen-Johansen et al., 2012; Zakowski et al., 2011; Zakowski et 
al., 2004; de Moor et al., 2002). Low et al. (2010) found no group differences in the 
Intrusions subscale of the IES. 
 
 
Pain and other physical outcomes 
 
     Creswell et al. (2007) found that those who wrote about their deepest thoughts and 
feelings regarding cancer (β = 1.37, t(54) = -2.99, p = .004) and those who wrote about 
positive thoughts and feelings about their experience (β -.23, t(54) = -1.92, p = .060) had 
fewer physical symptoms at three month follow up. Emotional expression (β = -.48, t(57) = -
.36, p = .001) and benefit finding (β  = –.35), t(57) = –2.46, p = .017) also predicted less 
cancer-related doctor visits for three months following the intervention. Stanton et al. (2002) 
found that compared to fact writing controls, those participants who engaged in emotionally 
expressive writing and benefit finding participants had fewer physical symptoms and cancer-




     de Moor et al. (2002) found that patients in the EWI group had less sleep disturbance, 
better sleep quality (ES = -.99, p = .01), sleep duration (ES = -.87, p = .04), and less daytime 
dysfunction (ES = 1.03, p = .04) compared to neutral writing controls. However de Moor’s 
later study (de Moor et al. 2008) found no main effects for sleep, and neither did Craft et al 
(2013). 
 
3.7.3. Comparison 3: Expressive writing versus attentional control 
 
     Only one study examined differences between an EWI group and an attentional control 
group, who completed the McGill Pain Questionnaire (Cepeda et al., 2008). They found that 
pain intensity and sense of well-being were similar in the EWI and attentional control group 
before and after treatment.  
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3.7.4. Comparison 4: Expressive writing versus any self-selected trauma  
     Only Craft et al. (2013) included a condition where participants wrote about any self-
selected trauma. It was found that those participants who wrote about the trauma of their 
breast cancer had higher scores at one month follow up than those who wrote about any 
self-selected traumatic event (F(3,93) = 4.22, P = 0.008, partial n2 = 0.120). 
 
3.7.5. Comparison 5: Expressive writing versus positive thoughts and feelings about cancer 
     Three studies examined differences between EWI and writing about positive thoughts 
and feelings about cancer. However all three studies originated from the same original data 
(Stanton et al., 2002). This study found that no group differences in psychological outcomes 
between experimental and control groups. They did find however that avoidance was 
significantly related to distress at one month in the EWI condition (F(1, 17) = 14.28, p = 
.0015), and that EWI resulted in a decrease in distress for women who were low on 
avoidance. 
 
3.7.6. Comparison 6: One dose versus three dose writing sessions 
     Only one study varied the number of writing sessions between experimental groups, with 
one group completing one writing session and one group completing three writing sessions 
(Walker, Nail & Croyle, 1999). They reported that neither of these interventions were 




     The studies in this review examined the role of 8 moderator variables. These are 
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Personality traits    
 
     Two studies examined the moderating effects of personality variables. These were 
alexithymia (Jensen-Johansen et al., 2012), neuroticism (Zakowski et al., 2011), and 
extraversion (Zakowski et al., 2011). Alexithymia is defined as an inability to identify and 
describe emotions in the self according to Sifneos (1973). Jensen-Johansen et al. (2012) 
found that scores on the External Oriented Thinking subscale of The Toronto Alexithymia 
Scale (TAS-20) moderated the effect of EWI on Impact of Events scores at three month 
follow up (β= .26, p = .021). Those who had greater difficulties with describing feelings were 
more likely to have an increase in positive mood (PPMS) from baseline to three month follow 
up in the control group (β = -.24, p = .049) but not in the EWI group. Neuroticism has been 
defined as ‘a dispositional tendency to experience negative emotions’ (Watson & Clark, 
1984). Zakowski et al. (2011) reported that women with low levels of neuroticism had lower 
distress levels and cancer related avoidance compared to women with high levels of 
neuroticism in the EWI group (F(1,83) = 8.47, p < .01). Extraversion, which has been defined 
by Costa and McCrae (1980) as ‘being active, energetic and outgoing’ was not found to be a 
moderator in the same study.    
 
Psychological wellbeing  
 
     Creswell et al. (2007) studied life satisfaction and mood as moderators. Neither of these 
psychological variables were found to moderate the effects of emotional writing on distress. 
Those who had a poorer quality of life and lower mood reported that their wellbeing 




     Four studies examined social support variables as moderators. These were social 
constraints (Jensen-Johansen et al., 2012; de Moor et al., 2008; Zakowski et al., 2004), and 
emotional support (Low et al., 2010). Social constraints has been defined as perceived 
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inadequacy in social support, which can lead to an increase in reluctance to express one’s 
thoughts and emotions (Lepore & Hegeson, 1998). Zakowski et al. (2004) found that those 
with high levels of perceived social constraints reported lower distress (F(1, 99) = 1.45, p < 
.04) and fewer avoidant thoughts (F(1, 99) = 6.25, p < 0.2) following EWI, while those with 
high levels of social constraints in the control condition reported greater distress and more 
avoidant thoughts. Furthermore, de Moor et al (2008) found average daily pain was lower 
following EWI in those with high levels of social constraints (t(1, 31) = 2.10, p = .05). Jensen-
Johansen et al. (2012) found no statistically significant moderation effects of social 
constraints in any of the analyses however. Low et al. (2010) found that patients with low 
levels of social support had fewer intrusive thoughts following expressive writing. Arden-
Close et al. (2013) found that change in illness-related communication between couples 
during the expressive writing intervention moderated the effect of group on quality of life in 
patients (B=1.17, SE=0.52, b=0.20; F(1, 85) = 5.16, p=0.03). In summary, it appears that 
expressive writing interventions were more helpful for patients who had poor social support 
prior to these interventions. 
 





     Those psychological variables examined in the EWI studies appeared to be largely 
unchanged following the intervention. Despite this however, results indicate that expressive 
writing is linked to changes in physical symptoms and decreased medical use for patients. 
This has also been found to be the case in studies of other long term health conditions such 
as asthma, arthritis (Smyth, Stone, Hurewitz & Kaell, 1999) and HIV (Petrie, Fontanilla, 
Thomas, Booth & Pennebaker, 2004). Expressive writing also appears to improve sleep 
quality and duration in cancer patients, as well as in those with other chronic health 
conditions (e.g. Gillis, 2002). Expressive writing does not appear to be feasible in palliative 
care populations. In addition, positive writing, or ‘benefit finding’ was also found not to have 
any psychological benefits, and no differences were found between a one dose and three 
dose writing intervention.   
 
 
     It has been argued for many decades that inhibiting emotions is damaging to our mental 
health and that negative emotions that have not been expressed can interfere with our ability 
to deal with new events (Baikie, 2008; Baker, 2009; Manning, 2010). The largely 
nonsignificant findings of the trials included in this review therefore warrants exploration. 
There are several possible reasons that could account for these null findings: 1.) insufficient 
power, 2.) low rates of depression and anxiety, and high levels of quality of life in study 
participants, 3.) insufficient differences between expressive writing and neutral writing 
interventions, 4.) asking participants to write about cancer-related trauma only. These are 
explored in turn below. 
 
4.1. Methodological issues this review highlights 
     One reason for the mixed results of EWI trials could be insufficient statistical power due 
to moderate sample sizes (mean n = 104). At present, it is not possible to draw comparisons 
EMOTIONAL EXPRESSION IN CANCER SURVIVORS 
36 
 
between results of therapy trials and EWI trials, as effect sizes of many verbal interventions 
are much larger than what has been reported in EWI studies. According to Pennebaker 
(2004), while it may be tempting to compare CBT and expressive writing, such comparisons 
are ‘premature’.    
 
     Another possible explanation for null findings in the included studies is the finding that 
most participants were well adjusted psychologically, with low rates of depression and 
anxiety, and high levels of quality of life. However, while trials conducted in non-metastatic 
populations have recruited participants with low levels of psychological distress, this has not 
been the case in those trials that involved metastatic or palliative care populations, and so 
there remains an alternative explanation for null findings. Bruera et al. (2008) conclude that 
expressive writing interventions are not feasible in palliative care settings, as although they 
found that patients were willing to participate, most became too ill to complete the study. 
They argued that those in the palliative care population may even experience negative 
effects of writing as has previously been found in those with posttraumatic stress disorder 
(Gidron et al., 1996), as coping skills training may be needed before expressive writing can 
be beneficial. Mosher et al. (2012) assert that whilst participants in most expressive writing 
trials have been able to reflect on past stressors, metastatic and palliative care patients are 
writing about an ongoing and life threatening stressor. Previous research has argued that 
decreasing physiological arousal towards traumatic memories is crucial in experiencing 
benefits from expressive writing (Low et al. 2006), which suggests that writing about a 
current, life threatening stressor may have limited psychological benefit. 
 
     It could be the case that expressive writing groups and neutral writing groups did not write 
significantly differently in order for effects to be found. For example, Bruera et al. (2008) 
reported that while participants in the expressive writing group were instructed to write about 
their deepest thoughts and feelings about cancer, little of what was written included words 
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that are considered emotional by Pennebaker et al. (1996). It could also be argued that 
writing about facts regarding one’s cancer diagnosis cannot be emotionally neutral. Craft et 
al. (2013) argue that focusing on the total experience of cancer that includes physical 
responses such as sleep and fatigue may be as helpful as focusing on emotional responses 
to with cancer. This does not explain why few main effects were found compared to usual 
care control groups however. 
 
     The non-significant results of expressive writing on psychological wellbeing in these 
studies suggests that it is possible that dealing with cancer may not be the most traumatic 
experience that patients feel needs to be explored and expressed. Only one study (Craft et 
al., 2013) included a condition where participants were able to choose a traumatic event to 
write about. It could be the case that being made to express cancer-related emotions when 
this may not be needed at the time may not be as helpful as expressing feelings related to 
another previous trauma. Suppressing previous trauma had been found to negatively impact 
upon the ability to deal with a current traumatic situation (Manning, 2010). Contrary to this 
idea, Craft et al. (2013) did not find writing about any self-selected trauma to be effective in 
cancer patients, and this group had the highest drop-out rate, even though most of them 
wrote about their cancer experience. Craft et al. (2013) argue that being given a writing topic 
is helpful, and having to make a choice about writing topic might somehow affect the benefit 
of expressive writing. 
 
 
     In summary, it remains unclear why trials continue to find few psychological benefits of 
expressive writing in those with cancer. How expressive writing can benefit pain and other 
physical symptoms if it does not benefit patients psychologically remains a mystery. 
 
 




     The findings of the studies included in this review clearly indicate that emotional 
expression is not beneficial for everyone at all times, an idea that had been put forward by 
previous research literature (Stroebe et al., 2002). Tamagawa et al. (2012) concluded in their 
review that identifying moderators is one way to understand why there is such variance in 
the outcomes of psychosocial interventions, and to help researchers identify who is most 
likely to benefit from such interventions (Tamagawa et al., 2012). Several studies included in 
this review included moderating variables. Factors encompassing general psychological 
wellbeing were not significant moderators. It appears that those who have a poorer quality of 
life and lower mood improved equally following the EWI to those who had a better mood and 
quality of life. This finding contrasts with previous research which has suggested that 
psychological intervention in cancer patients is usually more beneficial for people with poorer 
psychological health and quality of life (Naaman et al., 2009; Ross et al., 2002; Schneider et 
al., 2010; Sheard & Maguire, 1999; Tamagawa et al., 2012).  
 
     In terms of personality factors, those with higher levels of neuroticism were found to have 
higher distress levels at follow up than those with lower levels of neuroticism (Zakowski et 
al., 2011). Previous literature has also suggested that people who lack the ability to reflect 
upon and process their emotional experiences benefit less from expressive writing 
(Pennebaker, 1997). Jensen-Johansen et al. (2012) found that those who had greater 
difficulties with describing feelings were more likely to have an increase in positive mood 
(PPMS) from baseline to three month follow up in the control group but not in the EWI group. 
Results from non-cancer samples are also ambiguous, with some studies indicating that 
expressive writing is more beneficial for alexithymic individuals (e.g. Baikie, 2008), and 
others finding it to be ineffective (e.g. Lumley, Tojek & Macklem, 2002). 
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     Social factors appear to play a moderating role on the main effects of the included 
studies. Zakowski et al. (2004) found that those with high levels of perceived social 
constraints reported lower distress and fewer avoidant thoughts following EWI, and de Moor 
et al. (2008) also found average daily pain was lower in those with high levels of social 
constraints. Jensen-Johansen et al. (2012) found no statistically significant moderation 
effects of social constraints in any of the analyses however. Perceived social support also 
appears to play a moderating role, with Low et al. (2010) finding that patients with low levels 
of perceived social support had fewer intrusive thoughts following expressive writing. Arden-
Close et al. (2013) found that change in illness-related communication between couples 
during the expressive writing intervention moderated the effect of group on quality of life in 
patients. Lepore (2001) proposed a social-cognitive processing theory which suggests that 
when people perceive there to be social constraints on their expression of negative thoughts 
and emotions, this may impact upon their psychological adjustment to life stressors (Lepore, 
Silver, Wartman & Wayment, 1996). Expressive writing interventions may provide an 
opportunity for people with high social constraints to compensate for their perceived poor 
social support, allowing them to tell their story and reflect on the role of cancer in their life, 
and therefore acting as a buffer against their poor social support. 
 
4.3. Gaps in the literature 
     At present, it remains unclear how the effects of written emotional disclosure compare to 
those of therapy. No studies have investigated differences between expressive writing 
interventions and individual therapy to the author’s knowledge. Secondly, according to 
Mosher et al. (2012) it remains unclear whether expressive writing is more or less beneficial 
for patients during acute phases of the stressor such as after diagnosis or after receiving test 
results that indicate metastases. Thirdly, only one study so far has explored whether it is 
unhelpful to assume that cancer is the most important trauma for an individual to disclose 
during expressive writing interventions. In terms of moderating variables, it appears that 
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perceived social constraints and social support could play a moderating role on the main 
effects of the included studies, but results are inconsistent and require further exploration. 
Finally, it is unknown whether written emotional expression is as effective in cancer 
populations than in other samples with physical and psychological difficulties, and the 
reasons for any differences found remain unclear. 
 
4.4. Future research 
     There are several avenues for further research to explore. Firstly, studies exploring 
differences between written and verbal expression (therapy) are needed to decipher whether 
expressive writing interventions are as efficacious as verbal emotional expression. As written 
emotional disclosure would be more cost effective than therapy, this would be important to 
know. Studies which compare the effects of EWI at different key time points such as after 
diagnosis or after test results indicating metastases are needed in order to help establish 
whether expressive writing is more or less beneficial for patients during  acute phases of the 
stressor. More trials which include a self selected trauma topic are required, to examine 
whether it is unhelpful to assume that cancer is the most important trauma for an individual 
to express. Randomisation of participants to cancer specific and non cancer specific writing 
groups is required so comparisons can be made between cancer specific and non-cancer 
specific writing groups. Finally, future studies could benefit from further examining 
moderators of the effects of expressive writing on physical and psychological health 
outcomes, as there is still a need to further examine factors which determine who is more 
and less likely to benefit from EWI (Jensen-Johansen et al., 2012). It appears that perceived 
social constraints and social support could play a moderating role, but further studies which 
replicate and extend these findings are required. Finally, studies that explore differences in 
results found in cancer and non-cancer populations would be beneficial in exploring why 
expressive writing may not be as effective in cancer populations. 
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4.5. Limitations of this review 
     This review has several limitations. The quality of reported data and methodology varied 
considerably. The use of both the Downs and Black tool (1998) and the Risk of Bias tool 
(Higgins et al., 2011, Higgins & Altman, 2008) also highlights the differences in 
methodological ratings according to the tool utilised. All the studies in this review were 
categorised as of either strong methodological quality or moderate methodological quality 
according to the Downs and Black tool. However, when using Risk of Bias tool, the majority 
of studies did not provide adequate information for its five aspects to be assessed, and 
therefore would be considered to be of poor quality. Both tools were utilised in this review as 
the author began appraising the studies using the Downs and Black tool, and after deciding 
to only include RCTs in the review, it was decided that the Risk of Bias tool may be more 
appropriate. The data from the Downs and Black tool is still presented here for interest. The 
samples included in this review were predominantly Caucasian, and therefore results may 
not be generalisable to different cultures. This could be particularly relevant as emotional 
expression can vary widely between cultures. According to Niedenthal et al. (2006), 
moderation of emotional expression is evident in more collectivist cultures more than in 
individualistic cultures, as strong emotions could be seen as disrupting intra-group 
relationships and social functioning. Furthermore, only 29% of studies included a total of 100 
or more participants, and therefore power to detect group differences is relatively low in this 
review. According to Bartolucci and Hillegass (2010), conducting a meta-analysis in this area 
would enables us to detect a small but clinically relevant effect of the interventions included. 
A meta-analysis was not conducted here due to the heterogenous nature of the outcomes 
measured, as meta-analysis assumes that evaluation techniques are consistent across 








     As suggested by Craft et al. (2013) results of EWI trials are varied and several questions 
still remain. Despite the absence of evidence that expressive writing interventions reduce 
psychological suffering for people with cancer, the authors of these trials continue to argue 
that expressive writing interventions are ‘feasible’ and well received by participants. On the 
whole, drop-out rates were low, apart from studies focusing on those with metastases or 
those receiving palliative care, which suggests that the interventions were tolerated well by 
participants. However, while expressive writing interventions have been considered ‘feasible’ 
and have been found to benefit participants’ physical health, the majority of evidence 
suggests that such interventions on the whole are not beneficial psychologically at follow up.  
 
     Considering the small number of studies that have examined moderators in this 
participant group, it is not possible to state decisively for whom expressive writing 
interventions are most effective. Only if future research can replicate the moderating roles of 
social constraints and neuroticism and exclude other moderators can we start to identify 
specific psychosocial variables which may make EWI more or less beneficial. There appears 
to be a long way to go before clinicians can make recommendations to patients that they 
should ‘write their wrongs’ (Bolton, 2006, p. 98). 
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Objective: This study aimed to investigate the relationship between attitude towards 
emotional expression, resilience and psychological wellbeing in cancer survivors.  It was 
hypothesised that those with lower resilience and a more negative attitude towards 
emotional expression would have poorer quality of life and more psychological 
symptoms. 
Method: Participants were 251 individuals (139 male, 112 female) with a non-metastatic 
cancer diagnosis, having received cancer treatment in the previous eight months. 
Participants completed measures of attitude towards emotional expression, resilience, 
quality of life and psychological symptoms.  
Results: Age explained 4.3% of the variance in psychosymptomatology. Resilience 
explained 9.2% of the variance in quality of life, and increased the explained variance in 
psychosymptomatology to 15%. The addition of attitude towards emotional expression 
increased the explained variance to 14.1% for quality of life, and 24% for 
psychosymptomatology. The belief that expressing emotions will lead to social rejection 
predicts poorer resilience and psychological wellbeing in cancer survivors. 
Discussion: Results replicate previous findings that psychological resilience is a 
‘buffer’ against poor psychological wellbeing. Patients may benefit from resilience 
training to enhance their coping skills. In addition, interventions which address a 
negative attitude towards emotional expression may also be of benefit.  
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     The latest figures from Cancer Research UK indicate that over two million people in the 
UK are living with or beyond cancer (Cancer Research UK, 2013). With 320,467 new cases 
of cancer being diagnosed in the UK in 2009 alone, incidence rates are rising. Survival 
rates have also increased significantly in recent decades (Cancer Research UK, 2013; 
Coleman et al., 2011; Peto, Boreham, Clarke, Davies & Beral, 2000; Ries et al., 2003). As 
a result of the ageing population, and earlier detection of cancer and improvements in 
treatment, it has been further estimated that the number of people living with cancer could 
rise by more than 3% per year (Maddams et al., 2008).  
     
      Although the treatments currently available for cancer can prolong life and potentially 
treat the disease, both the disease and the treatments themselves can cause substantial 
suffering, impairments in quality of life (Carlson et al., 2004; Zabora et al., 1997) and 
psychosocial functioning (Pitceathly & Maguire, 2003; Badr & Taylor, 2005; Garos, Kluck, & 
Aranoff, 2007). Macmillan Cancer Support (2011) defines a cancer survivor as someone 
who has received cancer treatment and has no current disease, or is living with progressive 
disease and may be receiving treatment but is not in the terminal phase of illness. The NHS 
Cancer Reform Strategy (Department of Health, 2007) stresses the importance of cancer 
survivors being given psychological and social assistance in order to help them have ‘as 
normal a life as they can’.  
 
     However, not everyone struggles in the face of adversity. Although many cancer 
patients suffer from emotional distress and poorer quality of life, the psychosocial factors 
which contribute towards distress vulnerability in cancer patients remains poorly 
understood (Min et al., 2013). ‘Resilience’ has become an increasingly popular area of 
study in the social and medical sciences. Stewart and Yuen (2011) state that ‘resilience is 
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the capacity of individuals to maintain, or regain their mental health in the face of significant 
adversity, including physical illness.’ 
 
     In the past two decades, there has been a move away from illness models that focus on 
‘deficits’, and towards models that focus on ‘strengths’, in order to further an understanding 
of how many people are able to develop psychologically healthily despite being at risk of 
psychological difficulty (Windle, 2011). This way of coping can result in the individual 
‘bouncing back’ to their previous state of functioning, or not displaying any adverse effects 
(Masten, 2009). A more controversial idea of resilience has come from the suggestion that 
people sometimes experience ‘posttraumatic growth’ whereby the adversity results in better 
functioning than was experienced previously (Linley & Joseph, 2004; Tedeshi & Calhoun, 
2004). The concept of resilience is a dynamic and interactive one, which considers 
protective factors and positive adaptation to adversity, rather than focusing on risk factors 
(Hjemdal, 2007). As this field has only become popular in the last decade, there is no 
generally accepted theoretical model of resilience available at present. 
 
     Early resilience research focused on young people who were considered to be at risk 
due to absent or poor parenting, poor living conditions, or violence. These studies were 
found to report several common characteristics in resilient individuals, including self-
esteem, optimism, mastery, hope, spirituality, determination, effective coping strategies, 
and good social support (Garmezy, Masten, & Tellegen, 1984; Masten et al., 1988; Werner 
& Smith, 1982). A recent systematic review (Stewart & Yuen, 2011) of resilience in the 
chronically physically ill found similar characteristics in resilient individuals, and concluded 
that while working definitions of resilience differed across studies, it was consistently 
associated with several psychological factors across different diseases. These were self-
efficacy, self-esteem, internal locus of control, optimism and mastery.  
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    Studies which focus on psychological resilience in cancer survivors have reported that 
there are common psychological responses to cancer diagnosis and treatment, with 
resilience being the most common (e.g. Deshields, Tibbs, Fan & Taylor, 2006). According 
to Greve and Staudiner (2006), while people may experience a lower level of psychological 
functioning during difficult life circumstances such as chronic illnesses than they would 
without the illness, this should still be considered resilience. Resilience has been found to 
predict greater fatigue in the early stages of radiotherapy (Strauss et al., 2007) and has 
been found to be an important psychological predictor of psychological wellbeing and 
quality of life in cancer patients (Strauss et al., 2007). It was decided that this research 
study would focus on psychological resilience as opposed to other models of coping due to 
the lack of existing research in this new area of study and the grant funding given to one of 
the research supervisors to study resilience. 
 
     The way in which individuals with chronic disease process and express their emotions 
has been previously linked to their psychological adjustment to the disease. It has been 
argued that emotional regulation, defined as ‘the individuals' efforts to control which 
emotions they have, when they have them, and how they express them’ (Gross, 2002), 
may influence how patients adapt both physically and psychologically to their chronic 
disease (Porter, Keith, Lipkus and Hurwitz, 2005). Research suggests that this may be 
particularly relevant for patients facing a life-threatening diagnosis such as cancer, which 
may be associated with many physical and psychological symptoms for both patients and 
caregivers (Bernhard and Hurny, 1998; Northouse et al., 2000). The majority of existing 
research indicates that those who express their negative emotions are more likely to 
experience less distress than those that suppress them (e.g. Iwamitsu et al., 2005; 
Iwamitsu et al., 2003; Stanton et al., 2002). The results of several studies suggest that 
emotional expression is linked to psychological wellbeing in cancer survivors. Porter, Keith, 
Lipkus and Hurwitz (2005) found that patients who had high levels of ambivalence towards 
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emotional expression engaged in more catastrophising and reported higher levels of pain 
behaviours and poorer quality of life. Patients whose caregivers were high in ambivalence 
towards emotional expression also experienced more catastrophising, pain and lower 
emotional well-being. Servaes et al. (1999) examined differences in emotional expression 
between a breast cancer and healthy group. The patient group showed more ambivalence 
over emotional expression and more restraint than healthy controls, although there were no 
group differences in alexithymia or the expression of emotions in general. The expressive 
writing paradigm has been studied extensively and has been suggested to be helpful in 
cancer populations, although results from randomised controlled trials are mixed (Craft, 
Davis & Paulson, 2013).  
 
     There have not been any studies to date which have explored whether attitude towards 
emotional expression is linked to psychological resilience in cancer survivors. This study 
therefore aims to investigate whether there is a relationship between attitude towards 
emotional expression, psychological resilience and wellbeing in cancer survivors. It was 
hypothesised that psychological symptomatology and poor quality of life would be positively 
related to a negative attitude towards emotional expression. Secondly, it was hypothesised 
that a positive attitude towards emotional expression would be related to psychological 
resilience. Thirdly, it was hypothesised that attitude towards emotional expression and 
resilience would significantly predict psychological symptomatology and quality of life.  
 
     According to Deshields et al (2006), research in this area could be helpful to clinicians in 
helping identify patient characteristics that are associated with distress and furthermore 
could help establish which clinical interventions promote resilience in survivors. This 
research could therefore have significant clinical implications; firstly, in terms of helping 
identify cancer survivors who may be more vulnerable to psychological distress and 
secondly by considering whether interventions that target cancer patients’ resilience 
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2.1. Ethical considerations 
     This study was reviewed and approved by Solihull Research Ethics Committee 
(Reference number 13/WM/0079) and the Research and Development Office at University 
Hospital Birmingham (see Appendix F for approval letter). Individual cancer consultants 
were told about the aims and procedures of the study and were aware that their patients 
may be taking part. Lists of potential participants were given to the West Midlands Cancer 
Intelligence Unit (WMCIU), where participants were checked to be alive and their details 
correct before questionnaires were posted. Data collection and storage complied with the 
Data Protection Act (1998) and the Caldicott Principles (Department of Health, 1997). 
Questionnaires were given a unique identifier. A password protected document was then 
kept on an NHS computer linking identifiers to patient names and demographic details. 
Solihull Research Ethics Committee did not require a consent form to be completed by 
participants, as they considered the return of the questionnaire as consent. Participants 
were made aware that their care would not be affected in any way should they choose not 
to take part, and that they could withdraw their data from the study at any time. A fellow 
trainee who was working on a joint project was the main contact point for participants 
regarding questions around study participation. 
2.2. Participants and recruitment method 
     Participants were individuals who had been given a cancer diagnosis and had 
completed treatment in the previous eight months. Participants were recruited as 
outpatients at the Cancer Centre at University Hospital Birmingham. This study was 
combined with a study conducted by a fellow clinical psychologist in training, who was 
recruiting from the same participant group but investigating the role of illness beliefs. It was 
decided that combining the two information sheets and questionnaire packs would reduce 
the burden on participants compared to taking part in two separate studies. Potential 
participants were identified through a clinical database which holds all patient details. In 
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order to identify patients who might meet the inclusion criteria, lists of patients who had 
recently finished treatment were accessed through nurses who delivered chemotherapy 
and radiotherapy at the cancer centre.  
2.3. Inclusion/exclusion criteria 
     Inclusion criteria were as follows: over 18 years of age; a previous diagnosis of cancer, 
of any type and stage; had finished cancer treatment in the previous 2 weeks to 8 months; 
non metastatic cancer/curative treatment; able to speak, read and write in English. 
Exclusion criteria were as follows: medical status precluding participation (which included 
visual loss, current hospitalisation, seizures, unable to write, confusion); those who were 
currently or had previously been seen by a clinical psychologist at the Cancer Centre for 
psychological difficulties. Potential participants’ medical notes were accessed to establish 
whether they met the inclusion criteria. 
2.4. Procedure 
     Those individuals who met the inclusion criteria were then contacted via post with an 
invitation letter, the study information sheet and the questionnaires enclosed. Participants 
who did not wish to complete the questionnaires were asked to return them uncompleted in 
the pre-paid envelope provided to ensure their desire not to participate was recorded. 
Those individuals who did not return the questionnaires within two weeks of receiving them 
were sent a reminder letter. Two-hundred and fifty-six participants chose to take part in the 
study out of a total of 557 who were invited, resulting in a 45.9% response rate. Five 
potential participants stated that they felt too physically unwell to participate in the study. 
Forty-nine sent the questionnaire back in the post to record their wish not to participate, 
however they did not record a reason. The remaining non-responders did not return the 
questionnaire. Responders and non-responders were compared on several demographic 
characteristics. They did not significantly differ on gender, age, time since treatment, 
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     A demographic questionnaire asked participants for their gender, date of birth, ethnicity, 
religion, marital status, education, occupation, and hours worked before and after cancer 
diagnosis. Information regarding participants’ cancer diagnoses, stage and treatment were 
accessed through their medical notes, with participants’ permission. 
 
The Attitude Towards Emotional Expression Scale (AEE; Joseph, Willians, Irwing & 
Cammock, 1994) 
     The AEE is a 20 item measure of the individual’s attitudes towards emotional 
expression.  Items are rated on a five point Likert scale from one (strongly disagree) to five 
(strongly agree) and higher scores represent a more negative attitude towards emotional 
expression. The AEE has four subscales in total, and mean scores are calculated for the 
items in each subscale, with possible ranges of four to twenty. Three of these subscales 
measure the extent to which the person believes that: expression of emotions is a sign of 
weakness (weakness); emotions should be kept under control (control); and other people 
will reject expressed emotions (social). The fourth subscale measures the behavioural 
tendency to keep emotions to oneself (non-expression). The AEE is considered to be valid, 
and the internal reliabilities of the subscales are considered satisfactory (Cronbach’s alphas 
= .90, .90, .83, and .77) (Laghai & Joseph, 2000; Joseph et al., 1994). 
 
The Connor-Davidson Resilience Scale (CD-RISC; Connor & Davidson, 2003) 
     The CD-RISC is a 25 item self-rated questionnaire used to quantify resilience, 
encapsulating the concepts of control, challenge (hardiness), goal-orientation, adaptability, 
commitment, self-esteem, humour, social skills, and pain endurance. Each item is 
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answered based on the respondents feelings in the past month, and is rated on a five point 
Likert scale from 0 (not at all true) to 4 (true nearly all the time). The scale gives a score 
between 0 and 100, with higher scores representing greater resilience. When the scale was 
described initially, mean scores for individuals in the general population were 80.4 (Connor 
& Davidson, 2003). The CD-RISC has solid psychometric properties and is able to 
distinguish between various degrees of illness severity according to Connor and Davidson 




The Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1977; 1994) 
     The Symptom Checklist-90-Revised (SCL-90-R) is a self-report inventory which asks 
respondents to rate how distressed they have felt over the past seven days on a list of 90 
psychological symptom items. Answers are rated on a five point Likert scale ranging from 1 
(not at all) to 5 (extremely). The SCL-90-R measures symptoms that correspond with nine 
primary symptom dimensions and three global scores. The primary symptom dimensions 
are: Somatization (SOM), Obsessive-Compulsive (OBS), Interpersonal Sensitivity (INT), 
Depression (DEP), Anxiety (ANX), Hostility (HOS), Phobic Anxiety (PHOB), Paranoid 
Ideation (PAR), and Psychoticism (PSY). The global scales are the Global Severity Index 
(GSI), the Positive Symptom Distress Index (PSDI), and the Positive Symptom Total (PST). 
Of these three summary scales, the global symptom index (GSI) is considered the most 
reliable indicator of overall distress. The SCL-90 is appropriate for use with individuals from 
the community, as well as those with psychological or medical difficulties. Previous studies 
have indicated that the SCL-90-R is appropriate for assessing adjustment in chronic illness 
(Green, Gleser, Stone, & Seifert, 1975; Merpert & Recklitis, 2012; Mitchell, 1985; Schmitz, 
Kruse, Heckrath, Alberti, & Tress, 1999; Thompson et al., 1994), and had been used widely 
in cancer survivors (Elkin, Phipps, Mulhern, & Fairclough, 1997; Lerman, Jarski, Rea, 
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Gellish, & Vicini, 2011; Recklitis, O’Leary, & Diller, 2003; Tas et al., 2007; Tross et al., 
1996; Wijnberg-Williams, Kamps, Klip, & Hoekstra-Weebers, 2006). 
 
European Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC QLQ-C30; Aaronson et al., 1993) 
     The EORTC QLQ-C30 is a measure that was developed by the European Organization 
for Research and Treatment of Cancer (EORTC) Study Group on Quality of Life to assess 
topics relevant to cancer patients. The EORTC Quality of Life Questionnaire (QLQ-C30) 
consists of 30 items covering physical, role, emotional, cognitive and social function, as 
well as global health status. In addition, there are symptom scales which measure fatigue, 
nausea and vomiting, pain and six single-item scales (diarrhoea, constipation, appetite 
loss, insomnia, dyspnoea, and financial difficulties). A higher score on functioning scales 
represents a higher (‘better’) level of functioning while higher scores on symptom scales 
indicate higher (‘worse’) level of symptoms. Item scores are linearly transformed to a range 
from 0 to 100. Previous studies have found the measure to be a valid and reliable in 
assessing quality of life aspects relevant to cancer patient populations (Aaronson et al., 
1993; Bjordal & Kassa, 1992). 
 
2.6. Data analysis 
     All data analysis was carried out using IBM SPSS version 19.0 (Statistical Package for 
the Social Sciences). Firstly, data were checked for data entry errors by checking the 
minimum and maximum values for each subscale. Where maximum or minimum values fell 
outside the possible range, the respondent’s questionnaire was checked again for the 
correct score. Missing data were substituted with the mean score on the subscale, where 
only one item score was missing. Where two or more item scores were missing on one 
subscale, the participant was excluded from the analysis. Scores on the AEE and SCL-90 
were not normally distributed, therefore nonparametric analyses were performed where 
possible. All tests were one-tailed, in keeping with the directional hypotheses. Spearman’s 
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rank correlations were used to explore the first and second hypotheses, i.e. the 
relationships between AEE, CD-RISC, SCL-90R and EORTC QLQ-C30 subscale scores. 
Regression analyses were then employed to establish whether resilience and attitude 
towards emotional expression predicted quality of life and psychological symptoms. There 
is no nonparametric equivalent for regression that currently exists. Allison (1999) states that 
in regression, normal distribution is the least important assumption of regression, and 
emphasises assumptions such as linearity and homoscedasticity of residuals, alongside 
absence of multicollinearity, extreme outliers, and leverage of residuals. These 
assumptions were met by the data in the present study, and as a result regression analysis 
was considered appropriate. Hierarchical regression was employed as it can be useful for 
evaluating contributions of predictors over and above the previously entered predictors as a 
means for examining incremental validity (Field, 2013). Resilience was entered first as 
psychological resilience has been shown to predict psychological wellbeing in several 
previous studies (Mi Ryu & Yi, 2013; Min et al., 2013; Sharpley, Bitsika, Wootten & Christic, 
2014; Strauss et al., 2007). The author wanted to examine the additional effect of attitude 
towards emotional expression over and above any effect of resilience, therefore resilience 
was entered first and attitude towards emotional expression second. Kerlinger (1986) 
stated that there is no “correct” method for choosing the order of variable entry in 
hierarchical regression; ‘the theory behind the problem should determine the order of entry 
of variables in multiple regression analysis’ (p. 545). In order to test for the presence of 
significant differences in resilience and psychological wellbeing in patients who exhibited 
‘strong’ versus ‘weak’ belief that emotional expression will lead to social rejection, t-tests of 
scores were conducted using the median split for AEE social rejection score to form ‘strong’ 








3.1. Participant characteristics 
     Data from 251 participants (139 male, 112 female) were used in the data analysis. 
Ninety two were individuals with prostate cancer (36.6%), 91 with breast cancer (36.2%), 
22 with colorectal cancer (8.8%) and 46 in an ‘other’ cancer group (18.3%). This ‘other 
cancer’ group consisted of those with gynaecological cancer (n = 7), skin cancer (n = 11), 
lung cancer (n = 3), head and neck (n = 15), blood cancer (n = 4), bone cancer (n = 1), 
bladder cancer (n = 4), and testicular cancer (n = 1). Sociodemographic and clinical 
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Table 1. Sociodemographic and clinical factors 




(n = 91) 
Prostate  
(n = 92) 
Colorectal  
(n = 22) 
    Other  
   (n = 46) 
Gender     
Female 95.6% 0% 54.5% 46.2% 
Male 4.4% 100% 31.8% 53.8% 
Mean age 61.2 (12.5) 67.51 (7.67) 64.18 (10.33) 64.72 (11.07) 
Ethnicity     
White 92.3% 90.1% 86.4% 86.0% 
Black Caribbean 1.1% 4.4% 0% 0% 
Black African 1.1% 1.1% 0% 0% 
Asian 4.4% 1.1% 13.6% 11.6% 
Religion     
Athiest 9.9% 13.2% 13.6% 14.0% 
Christian 74.7% 74.7% 59.1% 67.4% 
Sikh 1.1% 0% 0% 11.6% 
Hindu 1.1% 0% 0% 0% 
Muslim 3.3% 1.1% 13.6% 0% 
Jehovas witness 0% 1.1% 0% 0% 
Spiritualist 0% 1.1% 0% 0% 
Marital status     
Married 72.5% 73.6% 72.7% 76.7% 
Not married/divorced/ 
widowed 
27.5% 26.4% 27.3% 23.3% 
Academic attainment     
No qualifications 29.7% 37.4% 57.1% 38.1% 
GCSE equivalent 33% 26.4% 14.3% 59.5% 
A level equivalent 15.4% 16.5% 0% 7.1% 
Degree or higher 18.7% 17.6% 28.6% 26.2% 
Work status     
Full time 18.7% 18.7% 13.6% 4.7% 
Part time 31.9% 20.9% 27.3% 14.0% 
Retired 42.9% 54.9% 50.0% 69.8% 
Homemaker 2.2% 3.3% 4.5% 2.3% 
Student 0% 0% 4.5% 0% 
Sick leave 1% 2.2% 0% 7.0% 
Clinical factors     
Treatment type     
Radiotherapy (r/therapy) 90.1% 53.8% 36.4% 95.2% 
Chemotherapy (c/therapy) 30.8% 2.2% 9.1% 33.3% 
Surgery  63.7% 50.5% 90.9% 19.0% 
Treatment combinations     
Radiotherapy only 24.2% 47.3% 0% 48.8% 
Chemotherapy only 3.3% 0% 9.1% 4.7% 
Surgery only 1.1% 46.2% 54.5% 0% 
Surgery and c/therapy 2.2% 0% 31.8% 0% 
Surgery and r/therapy 40.7% 0% 4.5% 16.3% 
Surgery and c/therapy and 
r/therapy 
23.1% 0% 0% 2.3% 
C/therapy and r/therapy 3.3% 2.2% 0% 18.6% 
One or more comorbidities 47.3% 47.3% 40.9% 37.2% 
Time since treatment (months) 4.81 (1.50) 4.8 (1.94) 5.59 (1.94) 4.89 (1.72) 
Time since diagnosis (months) 11/67 (5.41) 17.31 (16.74) 9.16 (5.21) 13.86 (12.29) 
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3.2. Post hoc power calculations 
     It is important to consider whether the present study is sufficiently powered to support 
the conclusions made by the author. The main identified risk would be that the correlations 
displayed in Table 3 would contain Type 2 errors (the possibility that some correlations may 
not have achieved significance due to the number of participants). Power analysis was 
therefore carried out using G-power (version 3.1.9) to establish the sample size that would 
have been needed to allow the strongest nonsignificant correlation and linear regression to 
achieve a level of significance, assuming a two tailed p<0.05. It should be noted however 
that this calculation is based on parametric analysis and the correlations presented here 
are nonparametric. Adopting a power of 0.90, the sample size needed for the strongest 
nonsignificant correlation to reach significance would be 92 cancer survivors. The sample 
size needed for the multiple regression to achieve significance would be 209 cancer 
survivors. The sample size was therefore sufficiently large to find key effects, whilst 
minimising type I and type II errors. 
 
3.3. Descriptive statistics for measures obtained 
     Table 2 presents the sample characteristics for the measures obtained. According to 
Verdonck-de Leeuw et al. (2010) a difference in EORTC QLQ-C30 scores of between 10 
and 20 represents a moderate subjective difference. Employing this system, the EORTC 
QLQ-C30 scores for men on physical functioning, role functioning and emotional 
functioning are higher than normative data (Scott et al., 2008). Women also scored higher 
on physical functioning, role functioning, emotional functioning and social functioning. In 
general, subscale scores do not differ greatly between the cancer types on any of the 
measures. Those in the ‘other’ cancer category however had lower physical functioning, 
role functioning and social functioning scores. Scores did not differ significantly between 
men and women on any measure.  
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Table 2. Descriptive statistics for the measures obtained (by cancer type) 
 Mean(SD) 
Measure Breast 
(n = 91) 
Prostate 
(n = 92) 
Colorectal 
(n = 22) 
Other 
(n = 46) 
AEE     
Weakness 2.0 (0.91) 1.9 (0.74) 2.1 (0.93) 2.2 (0.82) 
Behaviour 2.9 (0.88) 3.1 (0.84) 3.1 (0.87) 3.1 (0.73) 
Control 2.5 (0.81) 2.7 (0.82) 2.7 (0.75) 2.8 (0.83) 
Rejection 2.3 (0.76) 2.5 (0.62) 2.5 (0.69) 2.7 (0.73) 
CD-RISC 68.8 (13.98) 71.6 (15.65) 66.8 (12.71) 66.4 (15.78) 
EORTC QLQ-
C30 
    
Physical 
functioning 
83.7 (15.75) 86.0 (18.17) 79.1 (16.75) 73.2 (24.48)
†
 





79.9 (22.01) 83.5 (17.73) 78.0 (23.22)  72.4 (25.87) 
Emotional 
functioning 
78.6 (21.91) 81.8 (19.49) 66.3 (28.58)   69.4 (29.45) 
Social functioning 81.1 (22.39) 75.4 (24.77) 73.5 (26.56) 68.8 (30.34)
 †
 
GHS 66.8 (20.73) 70.9 (23.47) 64.0 (18.96) 61.4 (19.51) 
Fatigue 26.5 (20.54) 19.1 (19.09) 31.3 (22.38) 35.8 (29.15) 
Nausea 11.9 (16.90) 9.2 (16.27) 15.2 (17.74) 15.6 (18.39) 
Pain 15.8 (24.01) 12.7 (22.56) 19.7 (31.97) 23.9 (30.36) 
Dyspnoea 15.8 (24.01) 12.7 (22.56)  19.7 (31.97)   23.7 (30.66) 
Insomnia 9.9 (21.94) 4.7 (13.60) 7.6 (20.39) 30.4 (35.71) 
Appetite loss 1.1 (5.98) 1.1 (5.95) 3.03 (9.80) 10.9 (28.16) 
Constipation 34.4 (33.86) 29.3 (30.79) 30.3 (28.92)   34.1 (32.58) 
Diarrhoea 26.4 (30.43) 19.2 (25.79) 31.8 (33.29)   36.9 (30.81) 
Financial 
difficulties 
16.8 (27.83) 18.5 (28.96) 33.3 (30.86)   23.2 (35.04) 
SCL90-R     
Somatization 0.6 (0.65) 0.6 (0.72) 0.7 (0.66) 0.9 (0.97) 
Obsessive 
compulsive 
0.6 (0.59) 0.6 (0.65) 0.5 (0.68) 1.0 (0.98) 
Interpersonal 
sensitivity 
0.4 (0.63) 0.4 (0.58) 0.5 (0.72) 0.8 (0.91) 
Depression 0.6 (0.67) 0.6 (0.63) 0.6 (0.72) 1.0 (0.93) 
Anxiety 0.4 (0.52) 0.3 (0.49) 0.3 (0.52) 0.7 (0.94) 
Hostility 0.2 (0.43) 0.4 (0.59) 0.4 (0.55) 0.6 (0.83) 
Phobic anxiety 0.2 (0.50) 0.2 (0.42) 0.1 (0.18) 0.6 (0.86) 
Paranoia 0.2 (0.43) 0.3 (0.52) 0.2 (0.54) 0.6 (0.88) 
Psychoticism 0.2 (0.31) 0.7 (0.71) 0.2 (0.39) 0.5 (0.62) 
Cognitive deficit 0.7 (0.71) 0.7 (0.71) 0.6 (0.63) 1.0 (1.01) 
GSI 0.4 (0.51) 0.4 (0.51) 0.5 (0.52) 0.8 (0.81) 
† 
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 Result significantly higher than normative data 
 
      Mean scores on the measure subscales by treatment type and number of treatments 
are shown in Table 4. Mean scores on the EORTC QLQ-C30, SCL90-R, AEE and CD-
RISC did not differ significantly between treatment types or number of treatments.  
 Mean (SD) 
Measure Male (n = 139) Female (n = 112) 
AEE   
Weakness 2.0 (0.79)           2.0 (0.89) 
Behaviour 3.1 (0.80)           2.9 (0.89) 
Control 2.7 (0.79)           2.6 (0.83) 
Rejection 2.5 (0.65)           2.4 (0.77) 
CD-RISC 70.9 (14.78) 67.3 (14.87) 
EORTC QLQ-C30   
Physical functioning 82.3 (21.19)† 82.1 (16.08)† 
Role functioning 76.1 (25.85)† 80.5 (22.80)† 
Cognitive functioning 81.9 (20.51) 76.9 (22.84) 
Emotional functioning 77.9 (22.93)† 75.9 (24.87)† 
Social functioning 73.5 (26.60) 79.3 (23.70)† 
Fatigue 23.1 (22.31) 29.4 (22.91) 
Nausea 11.5 (17.24) 12.4 (17.00) 
Pain 16.3 (26.72) 16.7 (24.50) 
Dyspnoea 16.2 (26.79) 13.4 (26.26) 
Insomnia 10.1 (22.58) 3.9 (17.18) 
Appetite loss 2.4 (10.34) 3.9 (17.18) 
Constipation 28.8 (29.81) 36.3 (34.23) 
Diarrhoea 24.5 (29.09) 28.3 (30.41) 
Financial difficulties 19.7 (29.98) 20.5 (30.43) 
Global health status 68.3 (22.92) 65.6 (19.80) 
SCL90-R   
Somatization 0.6 (0.78) 0.7 (0.72) 
Obsessive compulsive 0.7 (0.72) 0.7 (0.73) 
Interpersonal sensitivity 0.4 (0.62) 0.5 (0.78) 
Depression 0.6 (0.67) 0.6 (0.80) 
Anxiety 0.4 (0.58) 0.4 (0.67) 
Hostility 0.4 (0.61) 0.3 (0.59) 
Phobic anxiety 0.2 (0.47) 0.3 (0.66) 
Paranoid ideation 0.3 (0.56) 0.3 (0.62) 
Psychoticism 0.3 (0.48) 0.3 (0.47) 
Cognitive deficit 0.7 (0.76) 0.8 (0.80) 
GSI 0.5 (0.55) 0.6 (0.60) 
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Table 4. Descriptive statistics for the measures obtained (by treatment type) 
 Mean(SD) 




(n = 134) 
Chemotherapy 
(n = 46) 
Radiotherapy  
(n = 179) 
1  
(n = 153) 
2 
(n = 69) 
3 
(n = 22) 
AEE      
Weakness 1.9 (0.86)         2.1 (1.01) 2.1 (0.87) 2.1 (0.82) 1.9 (0.76) 2.3 (1.21) 
Behaviour 3.0 (0.844)       3.0 (0.91) 3.1 (0.85) 3.1 (0.87) 2.9 (0.73) 3.1 (1.05) 
Control 2.6 (0.76)         2.7 (0.86) 2.7 (0.84) 2.7 (0.83) 2.6 (0.77) 2.7 (0.88) 
Rejection 2.4 (0.68)         2.5 (0.72)    2.5 (0.74) 2.5 (0.71) 2.5 (0.67) 2.5 (0.82) 
CD-RISC 68.9 (14.65)     66.5 (16.54) 69.4 (15.27) 69.9 (14.89) 68.1 (15.10) 67.6 (16.02) 
EORTC QLQ-C30      
Physical functioning 85.3 (15.74)     82.9 (14.92) 80.2 (19.77) 82.4 (19.99) 83.2 (16.75) 81.8 (14.71) 
Role functioning 80.1 (22.43)     78.6 (25.26) 78.9 (25.01) 75.9 (24.83) 82.1 (23.27) 83.3 (21.82) 
Cognitive 
functioning 
82.3 (18.93)     77.2 (22.86) 78.1 (22.22) 79.9 (20.99) 79.9 (21.69) 79.5 (21.16) 
Emotional 
functioning 
78.1 (23.04)     75.4 (23.86) 77.2 (23.59) 75.9 (24.82) 80.3 (21.09) 75.4 (23.91) 
Social functioning 77.7 (24.09)     73.9 (26.91) 76.6 (25.38) 75.1 (25.87) 79.7 (23.02) 76.5 (26.55) 
GHS 68.8 (20.83)     65.2 (16.61) 65.7 (21.79) 67.4 (22.82) 68.1 (20.46) 63.3 (16.99) 
Fatigue 22.8 (20.72)     31.9 (19.54) 27.9 (23.24) 24.3 (22.76) 26.1 (23.24) 31.3 (16.67) 
Nausea 11.1 (16.34)     13.4 (19.76) 12.9 (17.97) 11.1 (16.33) 10.4 (14.32) 18.2 (24.07) 
Pain 12.9 (22.73)     15.2 (20.73) 18.6 (16.21) 15.9 (26.78) 17.4 (23.98) 13.6 (19.67) 
Dyspnoea 12.9 (22.73)     15.2 (20.73) 18.5 (26.27) 15.8 (26.83) 17.4 (23.99) 13.6 (19.67) 
Insomnia 8.2 (12.41)       15.9 (26.97) 12.6 (25.01) 10.2 (22.38) 13.1 (27.54) 9.1 (18.34) 
Appetite loss 1.9 (11.39)        2.9 (15.43) 4.1 (16.06) 2.6 (11.80) 5.3 (19.49) 0.0 (0.00) 
Constipation 28.1 (30.27)      39.1 (33.19) 33.9 (33.23) 31.6 (32.39) 30.4 (31.17) 36.4 (33.97) 
Diarrhoea 21.6 (26.57)      36.2 (33.57) 29.2 (30.12) 24.8 (29.50) 23.7 (27.47) 39.4 (31.93) 
Financial  19.9 (30.07)      21.0 (31.71) 20.3 (31.07) 20.5 (29.89) 16.9 (29.49) 25.8 (35.53) 
SCL90-R      
Somatization 0.5 (0.62)          0.7 (0.64) 0.8 (0.81) 0.6 (0.78) 0.7 (0.72) 0.7 (0.63) 
OCD 0.6 (0.68)          0.8 (0.80) 0.7 (0.77) 0.7 (0.66) 0.7 (0.82) 0.6 (0.80) 
Interpersonal 
sensitivity 
0.4 (0.71)          0.6 (0.85) 0.5 (0.73) 0.4 (0.61) 0.6 (0.79) 0.5 (0.88) 
Depression 0.6 (0.71)          0.8 (0.83) 0.8 (0.77) 0.6 (0.70) 0.7 (0.79) 0.7 (0.83) 
Anxiety 0.4 (0.61)          0.5 (0.67) 0.5 (0.65) 0.4 (0.59) 0.5 (0.69) 0.5 (0.65) 
Hostility 0.4 (0.63)          0.3 (0.65) 0.4 (0.63) 0.4 (0.55) 0.4 (0.69) 0.4 (0.72) 
Phobic anxiety 0.2 (0.56)          0.4 (0.79) 0.3 (0.63) 0.2 (0.46) 0.4 (0.70) 0.3 (0.80) 
Paranoia 0.3 (0.53)          0.4 (0.73) 0.4 (0.62) 0.3 (0.57) 0.3 (0.63) 0.4 (0.64) 
Psychoticism 0.3 (0.46)          0.3 (0.38) 0.3 (0.48) 0.3 (0.49) 0.3 (0.49) 0.3 (0.35) 
Cognitive deficit 0.7 (0.74)          0.8 (0.87) 0.8 (0.82) 0.7 (0.72) 0.8 (0.84) 0.8 (0.91) 
GSI 0.4 (0.55)          0.6 (0.63) 0.6 (0.61) 0.5 (0.55) 0.6 (0.63) 0.6 (0.64) 
 
3.4. Correlation analysis 
     Table 5 shows the results of the correlations between the AEE, CD-RISC, SCL-90R and 
EORTC QLQ-C30 subscales. In keeping with the first hypotheses, there were significant, 
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negative associations between the AEE weakness subscale and physical functioning (r = -
.193, p = 0.02), cognitive functioning (r = -.149, p = 0.018), emotional functioning (r = -.179, 
p = 0.04) and global health status (-.170, p = 0.007). AEE weakness was positively 
associated with nausea (r = .153, p = 0.015), pain (r = .155, p = 0.014), dyspnoea (r = .152, 
p = 0.016), appetite loss (r = .163, p = 0.010) and diarrhoea (r = .153, p = 0.016) on the 
EORTC QLQ-C30. The behaviour subscale was significantly negatively correlated with 
physical functioning (r = -.165, p = 0.009), role functioning (r = -.145, p = 0.022), emotional 
functioning (r = -.287, p = 0.000) and cognitive functioning (r = -.239, p = 0.000). The 
behaviour subscale was positively associated with fatigue (r = .183, p = 0.004), nausea (r = 
.212, p = 0.001), pain (r = .215, p = 0.001), dyspnoea (r = .215, p = 0.001), constipation (r = 
.218, p = 0.001), and diarrhoea (r = .233, p = 0.000). The control subscale was negatively 
associated with physical functioning (r = -.155, p = 0.014), role functioning (r = -.149, p = 
0.018), cognitive functioning (r = -.141, p = 0.001), and emotional functioning (r = -.136, p = 
0.031), and positively associated with nausea (r = .125, p = 0.048), pain (.157, p = 0.013), 
dyspnoea (r = .152, p = 0.016), and diarrhoea (r = .130, p = 0.04). The social rejection 
subscale was negatively associated with physical functioning (r = -.251, p = 0.000), role 
functioning (r = -.290, p = 0.000), cognitive functioning (r = -.206, p = 0.001), emotional 
functioning (r = -.269, p = 0.000), social functioning (r = -.264, p = 0.000) and global health 
status (r = -.306, p = 0.000), and positively associated with fatigue (r = .234, p = 0.000), 
nausea (r = .160, p = 0.011), appetite loss (r = .201, p = 0.001), constipation (r = .153, p = 
0.015), diarrhoea (r = .254, p = 0.000), and financial difficulties (r = .173, p = 0.006). There 
were significant, positive associations between all AEE subscales and SCL90-R subscales. 
In keeping with the second hypothesis, CD-RISC scores were significantly, negatively 
correlated with the weakness (r = -.191, p = 0.002), behaviour (r = -.186, p = 0.003) and 
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Table 5. Spearmans Rho correlations between AEE, CD-RISC, EORTC QLQ-C30 and 
SCL90-R subscales 
 
  AEE subscale 
Measure Subscale Weakness Behaviour Control Social 
rejection 
CD-RISC Total -.191** -.186** -.097 -.211** 
EORTC Physical 
functioning 
-.193** -.165** -.155** -.251** 
 Role 
functioning 
-.123 -.145* -.149* -.290** 
 Cognitive 
functioning 
-.149* -.239** -.141* -.206** 
 Emotional 
functioning 
-.179** -.287** -.136* -.269** 
 Social 
functioning 
-.072 -.066 -.047 -.264** 
 Fatigue .090 .183** .095 .234** 
 Nausea .153* .212** .125* .160* 
 Pain .155* .215** .157* .121 
 Dyspnoea .152* .215** .152* .116 
 Insomnia .065 .053 -.050 .061 
 Appetite loss .163** .107 .016 .201** 
 Constipation .053 .218** .119 .153* 
 Diarrhoea .153* .233** .130* .254* 
 Financial 
difficulties 
.039 .046 .042 .173** 
 Global health 
status 
-.170** -.106 -.119 -.306** 
SCL90-R Somatization .171** .261** .191** .279** 
 Obsessive 
compulsive 
.187** .285** .191** .382** 
 Interpersonal 
sensitivity 
.145* .295** .139* .337* 
 Depression .172** .339** .192** .396** 
 Anxiety .214** .307** .155* .330** 
 Hostility .184* .269** .170** .301** 
 Phobic 
anxiety 
.241** .278** .185** .353** 
 Paranoid 
ideation 
.222** .244** .243** .386** 
 Psychoticism .188** .281** .179** .362** 
 Cognitive 
deficit 
.134* .251** 163** .301** 
 GSI .191** .340** .193** .368** 
*p < 0.05 **p <0.01 
 
 
EMOTIONAL EXPRESSION IN CANCER SURVIVORS 
69 
 
3.5. Regression analysis 
     Univariate regression analyses were carried out between age and the dependent 
variables, time since treatment and the dependent variables, and time since diagnosis and 
the dependent variables. Age was found to be a significant predictor of the Global 
Symptom Index on the SCL90-R (F(1, 244) = 11.85, p < 0.001), but was not a significant 
predictor of EORTC QLQ-C30 scores, CD-RISC scores or the AEE subscale scores. Time 
since treatment and time since diagnosis were not significant predictors of any of the 
dependent variables. 
 
     Hierarchical multiple-regression analysis was performed to examine whether attitude 
towards emotional expression and psychological resilience predicted quality of life and 
psychosymptomatology. As shown in Tables 6 and 7, age explained 4.3% of the variance 
in psychosymptomatology. The addition of resilience explained 9.2% of the variance in 
quality of life, and 15% of the variance in psychosymptomatology. The addition of attitude 
towards emotional expression increased the explained variance to 14.1% for quality of life, 
and 24% for psychosymptomatology. Only the social rejection subscale of the AEE was a 
significant contributor to the model. The social rejection subscale of the AEE significantly 
predicted CD-RISC score (R2 = .73, F(1, 247) = 11.95, p < .001), but the remaining AEE 
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Table 6. Hierarchical multiple regression analysis for the predictors of quality of life (Global 
Health Status) in cancer patients 
Step/predictor R2 Adjusted R2 R2 
change 
B SE β t 
   Step 1 .096 .092**      
Resilience    .449 .088 .310** 5.13 
   Step 2 .375 .141**      
Resilience 
AEE 
   .387 .090 .267** 4.32 
        Weakness    -1.37 2.01 -.053 -.684 
        Behaviour    1.89 1.91 .074 .998 
        Control    1.77 2.21 .067 .425 
        Social rejection    -7.32 2.38 -.239* -3.07 
* p < 0.01 ** p < 0.001 
Table 7. Hierarchical multiple regression analysis for predictors of psychosymtomatology 
(Global Symptom Index) in cancer patients 




B SE β t 
Step 1 
  Age 









  Age 
  Resilience 












Step 3 .27 .24** 0.09**     
  Age 
  Resilience 
  AEE 








      Weakness    .048 .051 .069 .945 
      Behaviour    .079 .048 .115 1.63 
      Control    .020 .056 .028 .353 
      Social rejection    .165 .060 .199 2.74* 
* p < 0.01 ** p < 0.001 
     Table 8 displays the results of t-tests conducted using the median split for AEE social 
rejection score to form ‘strong’ versus ‘weak belief subgroups. Those with a strong belief 
that emotional expression (EE) will lead to social rejection had lower psychological 
resilience (t = 0.22, p = .009), physical functioning (t = 2.61, p = 0.01), cognitive functioning 
(t = 2.57, p = 0.011), role functioning (t = 4.03, p = 0.000), emotional functioning (t = 3.55, p 
= 0.000) and social functioning (t = 3.97, p = 0.000). They also had significantly higher 
levels of fatigue (t = -2.53, p = 0.012), pain (t = -1.65, p = 0.011) appetite loss (t = -2.51, p = 
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0.013), diarrhoea (t= -3.46, p = 0.001), financial difficulties (t = -2.27, p = 0.024), and all of 
the SCL90-R subscales were significantly higher in this group. 
 
Table 8. Resilience, quality of life and psychological symptoms according to AEE social 
rejection belief  (t-test results) 
Dependent 
variable 
 Weak belief that EE 
will lead to social 
rejection (n = 121) 
Strong belief that EE 
will lead to social 
rejection (n = 129) 
  
  Mean (SD) Mean (SD) t p 
CD-RISC Total 71.81 (14.24) 66.88 (15.21) 0.22 0.009 
EORTC 
QLC-30 
Physical functioning 85.34 (19.14) 79.12 (18.54) 2.61 0.010 
 Role functioning 84.29 (20.78) 72.09 (26.45) 4.03 0.000 
 Cognitive functioning 83.33 (19.84) 76.37 (22.89) 2.57 0.011 
 Emotional functioning 82.44 (21.38) 71.96 (24.95) 3.55 0.000 











 Nausea 10.19 (16.29) 13.56 (17.77) 
 
-1.56 0.120 
 Pain 13.77 (23.44) 19.12 (27.57) 
 
-1.65 0.011 
 Dyspnoea 13.77 (23.44) 19.01 (27.65) -1.61 0.109 



























































































4.1. Summary of findings 
     The current study aimed to examine the relationship between attitude towards emotional 
expression, psychological resilience and psychological wellbeing in a group of cancer 
survivors. Firstly, results replicate previous findings that resilience predicts quality of life 
and psychological symptoms both in those with cancer (Sharpley, Bitsika, Wootten & 
Christic, 2014; Mi Ryu & Yi, 2013; Min et al., 2013), other chronic conditions (Sturgeon & 
Zautra, 2010; Yi et al., 2010) and in healthy individuals (Bonnanno, 2005; Tugade, 
Fredericksen & Barrett, 2004). According to Sharpley et al. (2014) resilience may act as a 
‘buffer’ against distress, depression in particular. There are several other potential ‘buffers’ 
reported in previous cancer research, such as hope (Ho, Ho, Bonanno, Chu & Chan, 2010), 
social support (Alferi et al., 2001; Kornblith et al., 2001; Kroenke, Kubzansky, 
Schernhammer, Holmes & Kawachi, 2006; Sammarco, 2001), and spirituality (Breitbart, 
2001; Jenkins & Pargament, 2008; Stefanek, McDonald & Hess, 2004; Laubmeier, 
Zakowski & Bair, 2004). The present study supports previous literature that suggests that 
psychological resilience measured by the CD-RISC may also play a role in helping to 




     Secondly, the present study found that having the belief that expressing your emotions 
will lead to social rejection is associated with lower resilience, lower quality of life (including 
physical pain) and more psychological symptoms. Research indicates that one of the most 
common concerns raised by those affected by cancer is fear of social rejection and stigma 
(Fallowfield, 1997; Gray, Doan & Church, 1991). Those with cancer have reported non-
disclosure of their cancer due to a sense of wanting to protect other people from 
embarrassment (Frank, 1995; Waskul & van der Riet, 2002). Existing research literature 
focusing on fear of negative evaluation from others suggests that shame is a predictor of 
greater psychological distress (Gilbert, 1992, 1998a, b). Those who experience feelings of 
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shame have been found to adopt non-assertive and submissive behaviours, and therefore 
may find it difficult to express their emotions to others as a problem solving strategy 
(Arrindell et al., 1990; Gilbert et al., 1994; Allan and Gilbert, 1997; Gilbert and McGuire, 
1998). The findings of the current study therefore support previous research findings that 
fear of social rejection is related to psychological distress.  
 
4.2. Strengths and limitations 
     This study is the first study to explore the link between attitude towards emotional 
expression and psychological resilience in cancer survivors. Results support the notion that 
the belief that emotional expression will lead to social rejection predicts psychological 
resilience in this population. These findings add to the growing literature on emotional 
expression and support the hypothesis that conflict over expressing one’s emotions is an 
important factor in emotional psychological wellbeing and physical health. Post hoc power 
calculations indicated that the sample size was sufficiently large to find key effects, whilst 
minimising type I and type II errors. 
 
     This study had several limitations. Non-responders were not asked to clarify why they 
did not wish to take part, which may have shed some light on the differences between 
responders and non-responders and how this could have affected the results. Secondly, 
this study mainly included participants who had prostate and breast cancer. Generalising 
the results to those with other types of cancer would therefore be problematic. Similarly, 
this study focused on individuals who had received treatment for cancer, with no recurrent 
disease or metastases. Psychological outcomes are likely to differ during times of acute 
stress such as after initial diagnosis, during treatment, after treatment and after recurrence. 
The results of the present study cannot be generalised to other time points during the 
cancer journey. Those with metastatic disease could possibly have lower levels of 
resilience (Min et al., 2013) and may differ in terms of their attitude towards emotional 
expression. The EORTC QLQ-C30 scores for men on physical functioning, role functioning 
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and emotional functioning are higher than normative data (Scott et al., 2008). Women also 
scored higher on physical functioning, role functioning, emotional functioning and social 
functioning. Mean SCL90-R scores in those with breast cancer are lower in this study than 
found in previous research (Fafouti et al., 2010; Pan et al., 2013). Resilience scores 
however are significantly lower than those found in a previous prostate cancer study 
(Sharpley, Bitsika, Wootten & Christie, 2014). The present sample therefore appears to be 
higher functioning than previous samples, apart from on psychological resilience. Several 
individuals (n = 4) contacted the researchers and stated that they were either too physically 
or mentally unwell to participate.  
 
     The participants in this study had mostly undergone radiotherapy, alone or alongside 
other cancer treatments (71%). This was due to the assistance of a nurse who delivered 
radiotherapy in identifying patients through their lists of participants who had recently 
received radiotherapy. Although this method of convenience sampling limits the 
generalisability of its findings to those who receive chemotherapy or surgery alone, steps 
were taken to ensure that the participants selected were appropriate for the study aims. 
There was no significant difference in resilience, quality of life or psychological symptoms 
between treatment types and number of treatments in the present study. Although physical 
pain was measured using the EORTC QLQ-C30, pain ratings were not controlled for in the 
analysis, meaning that it remains unclear whether physical pain influences attitude towards 
emotional expression, resilience or psychological wellbeing. The present study was cross 
sectional and therefore did not assess directional factors. It remains unclear whether 
resilience is a determinant of or a response to stress, as assessment of directional factors 
was not possible in this study.  
 
     There are several variables which may have confounded the results of the present 
study.  Social support was also not assessed. Lack of social support has been linked to 
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poor psychological wellbeing in cancer survivors (Alferi et al., 2001; Kornblith et al., 2001; 
Kroenke, Kubzansky, Schernhammer, Holmes & Kawachi, 2006; Sammarco, 2001) and 
social barriers are thought to have adverse effects on emotional expression (Zakowski et 
al., 2004; Zakowski et al., 2003). An individual may have a healthy attitude towards 
emotional expression but they may not have adequate social support to facilitate the 
expression of their emotions.  
4.3. Clinical implications 
     If the findings of the present study prove to be replicable in similar populations, they 
have a number of clinical implications. Firstly, the results indicate that screening for levels 
of resilience soon after diagnosis could be beneficial in identifying which patients may 
benefit from an intervention to help develop their resilience skills and strategies. This 
conclusion was also made by Sharpley et al. (2014).  Interventions which focus on 
improving individual’s resilience could be of benefit in making them less vulnerable to 
psychological distress. A cognitive behavioural approach to resilience training, which 
assists participants in how to cope with stressors, has been employed successfully in 
chronic pain (Karoly & Reuhlman, 2006) and depression (Padesky & Mooney, 2012) and 
could be applied in cancer populations. An RCT in breast cancer survivors found that two 
90 minute group sessions of stress management and resilience training (SMART) 
significantly improved resilience and reduced perceived stress and anxiety (Loprinzi, 
Prasad, Scrhroeder, & Sood, 2011). This intervention focused on cultivating mindfulness 
skills and skills such as gratitude, compassion, acceptance, forgiveness, and higher 
meaning.       
 
     Secondly, interventions focusing on attitude towards emotional expression could also be 
helpful for symptom management. The majority of existing research indicates that those 
who express their negative emotions are more likely to experience less distress than those 
who suppress them (e.g. Iwamitsu et al., 2002; Iwamitsu et al., 2003; Stanton et al., 2002). 
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Porter, Keith, Lipkus and Hurwitz (2005) found that patients who had high levels of 
ambivalence towards emotional expression engaged in more catastrophising and reported 
higher levels of pain behaviours and poorer quality of life. Psychological interventions may 
therefore benefit from considering factors such as how the patient communicates their  
physical and emotional pain to others according to Porter et al. (2005). NICE guidelines 
(2004) state that around the time of a cancer diagnosis, around half of all patients 
experience severe levels of depression and anxiety, and in the year after diagnosis, around 
one in ten. Patients’ psychological symptoms are often not detected and therefore they are 
often not offered access to needed services (MORI, 1992). Cancer survivors who have low 
levels of psychological resilience and a more negative attitude towards emotional 
expression may particularly benefit from psychological support, in order to help buffer 
against psychological distress.  
 
4.4. Future research 
     The present study highlights several areas for future research to explore. Further 
research is needed to establish whether findings would be similar in other cancer types, as 
well as in those with metastases or those receiving palliative care. Similarly, as all 
participants had finished treatment, future research could consider whether the 
relationships found between attitude towards emotional expression, resilience and 
psychological wellbeing would be replicated after diagnosis or during treatment. Previous 
research has suggested that there are four trajectories that emerge in the first year after 
traumatic life events: a resilient trajectory whereby normative psychological functioning is 
maintained; chronic distress characterised by high levels of distress; delayed distress 
characterised by normative functioning followed by high levels of distress and recovery, 
where initial high levels of distress reduce to normative levels (Bonanno et al., 2002; 
Bonanno, Wortman & Nesse, 2004; Bonanno, Galea, Bucciarelli & Vlahov, 2006; 2007; 
Norris, Tracy & Galea, 2009). Cancer studies have found that these four adaptation 
trajectories apply to psychological adjustment in cancer populations (Helgeson et al., 2004; 
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Hou, Law, Yin & Fu, 2010). Ideally, longitudinal research is needed in which measures are 
completed at several time points throughout the illness trajectory. This would facilitate a 
better understanding of how attitude towards emotional expression relates to resilience and 
psychological outcome. A prospective study would inform researchers whether resilience 
predates cancer diagnosis and treatment, protects against psychological difficulties post-
cancer, and whether resilience can develop further following cancer. 
 
     Tusaie and Dyer (2004) assert that while previous research has explored several 
common characteristics in individuals who are resilient, further research needs to explore 
the dynamic interactions of these factors. Sharpley et al. (2014) used factor analysis to 
establish which aspects of resilience might be more powerful than others in helping 
prostate cancer patients cope with diagnosis and treatment. They concluded that ‘staying 
focused when under pressure’, ‘knowing where to turn for help during a crisis’, and 
‘maintaining a humorous outlook in the face of problems’ were the most protective aspects 
of resilience in buffering against depression. Future research would benefit from examining 
these aspects further to establish whether these findings are robust.  
 
 
     At present, it is unclear how attitude towards emotional expression develops. Research 
has suggested that children who receive confusing messages about emotions from their 
carers can develop ambivalence towards emotional expression, as the child learns that 
negative emotional states are not acceptable (King, 1998). It is also largely unclear why a 
negative attitude towards emotional expression is linked to higher levels of psychological 
difficulty, further research is needed to support the two hypothesised pathways of reduced 
coping (Tucker et al., 1999) and social support (King, 1998).  
 
     Given the finding that the belief that expressing one’s emotions can lead to social 
rejection was related to greater distress, further research in this area could benefit from 
measuring fear of negative evaluation in this population. Further research could also benefit 
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from exploring the relationship between attitude towards emotional expression and social 
support in this population. Although an individual may have a healthy attitude towards 
emotional expression, they may not have people around them that they feel they can 
confide in. Sharpley et al. (2014) found that it is not only the emotional expression of the 
patient that is important in physical and psychological wellbeing but also the emotional 
expression of those close to them. 
 
4.4. Conclusions 
     In conclusion, the results of the present study supports previous findings that 
psychological resilience ‘buffers’ against distress in cancer survivors. Furthermore, the 
belief that emotional expression will lead to social rejection predicts resilience and 
psychosymptomatology in the present sample. These findings suggest that addressing 
psychological resilience and the belief that expressing one’s emotions will lead to social 
rejection could be of psychological benefit to cancer survivors. The relative contribution of 
different aspects of psychological resilience requires further exploration. Further research is 
also needed to establish whether findings would be similar in those with metastases or 
those receiving palliative care, and after diagnosis or during treatment. 
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     Although the treatments currently available for cancer can prolong life and potentially 
treat the disease, both the disease and the treatments themselves can cause substantial 
suffering, impairments in quality of life (Carlson et al., 2004; Zabora et al., 1997) and 
psychosocial functioning (Pitceathly & Maguire, 2003; Badr & Taylor, 2005; Garos, Kluck, & 
Aranoff, 2007). Although many cancer patients suffer from emotional distress and poorer 
quality of life, the psychosocial factors which contribute towards distress vulnerability in 
cancer patients remains poorly understood (Min et al., 2013). The way in which individuals 
with chronic disease process and express their emotions has been previously linked to their 
psychological adjustment to the disease. It has been argued that emotional regulation, 
defined as ‘the individuals' efforts to control which emotions they have, when they have 
them, and how they express them’ (Gross, 2002), may influence how patients adapt both 
physically and psychologically to their chronic disease (Porter, Keith, Lipkus and Hurwitz, 
2005). ‘Resilience’ has become an increasingly popular area of study in the social and 
medical sciences. Stewart and Yuen (2011) state that ‘resilience is the capacity of 
individuals to maintain, or regain their mental health in the face of significant adversity, 
including physical illness.’ 
 
 
2. LITERATURE REVIEW 
 
 
     Since James Pennebaker began studying expressive writing in college students in the 
1980’s, over 200 studies have been conducted in this area. Expressive writing interventions 
(EWI) instruct participants to write down their deepest thoughts and feelings about a life 
event that is considered stressful (Pennebaker & Beall, 1986). Craft et al (2013) argue that 
when a person who has a life-altering experience uses expressive writing, the individual is 
given the opportunity to reflect on and perhaps see their experiences in a new light 
(Mezirow, 1987, Pennebaker et al., 1997), and they are also being consciously caring 
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towards themselves (Watson, 2002). Findings of 17 research studies published in the last 15 
years suggests that use of expressive writing does not appear to influence the majority of 
psychological variables that were assessed in the studies included in this review. Despite 
this however, results indicate that expressive writing is linked to changes in physical 
symptoms and decreased medical use for patients. Individual differences in general 
psychological wellbeing factors did not significantly influence the outcome of the EWI 
interventions. It appears that those who have a poorer quality of life and lower mood 
improved equally following the EWI to those who had a better mood and quality of life. This 
finding is in contrast with previous research which has suggested that psychological 
intervention in cancer patients is usually more beneficial for people with poorer psychological 
health and quality of life (Naaman et al., 2009; Ross et al., 2002; Schneider et al., 2010; 




3. EMPIRICAL PAPER 
 
 
     The way in which individuals with chronic disease process and express their emotions has 
been previously linked to their psychological adjustment to the disease. There have not been 
any studies to date which have explored whether attitude towards emotional expression is 
linked to psychological resilience in cancer survivors. This study aimed to investigate the 
relationship between attitude towards emotional expression, resilience and psychological 
wellbeing in cancer survivors.  It was hypothesised that those with lower resilience and a more 







     Participants were 251 individuals (139 male, 112 female) with a cancer diagnosis, having 
received cancer treatment in the previous eight months. None of the participants had been 
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diagnosed with metastases. Cancer types included prostate cancer (36.6%), breast cancer 
(36.2%), colorectal cancer (8.8%), and those in an ‘other’ cancer group (18.3%). Subscale 




     Participants completed psychological measures at one time point; of attitude towards 
emotional expression, psychological resilience, quality of life and psychological symptoms. 
These were: 
 A demographic questionnaire 
 The Attitude Towards Emotional Expression Scale (AEE; Joseph, Willians, Irwing & 
Cammock, 1994) 
 The Connor-Davidson Resilience Scale (CD-RISC; Connor & Davidson, 2003) 
 The Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1977; 1994) 
 European Organisation for Research and Treatment of Cancer Quality of Life 





 Age explained 4.3% of the variance in psychosymptomatology. The addition of 
resilience explained 9.2% of the variance in quality of life, and 15% of the variance in 
psychological symptoms. The addition of attitude towards emotional expression 
increased the explained variance to 14.1% for quality of life, and 24% for psychological 
symptoms. Only the social rejection subscale of the AEE was a significant contributor 
to the models. 
 Those with a strong belief that emotional expression will lead to social rejection had 
lower psychological resilience, physical functioning, cognitive functioning, role 
functioning, emotional functioning and social functioning. They also had significantly 
higher levels of fatigue, pain, appetite loss, diarrhoea, financial difficulties, and all of 
the SCL90-R subscales were significantly higher in this group. 
 
 





     Results replicate previous findings that resilience predicts quality of life and psychological 
symptoms in those with cancer (Sharpley, Bitsika, Wootten & Christic, 2014; Mi Ryu & Yi, 
2013; Min et al., 2013). Secondly, the present study found that having the belief that 
expressing your emotions will lead to social rejection is associated with lower resilience, 
lower quality of life (including physical pain) and more psychological symptoms. Screening 
for levels of resilience soon after diagnosis could be beneficial in identifying which patients 
may benefit from an intervention to help develop their resilience skills and strategies. 
Secondly, interventions focusing on attitude towards emotional expression could also be 
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Pennebaker’s expressive writing protocol (Pennebaker, 1994) 
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Title Written emotional disclosure for women with ovarian cancer and their partners: 
randomised controlled trial 
Authors Arden-Close, E., Gidron, Y., Bayne, L. and Moss-Morris, R. 
Year 2013 
Journal Psycho-Oncology 
Country of origin UK 
Aims Investigate the effectiveness of guided writing in cancer patients and their partners. Also 
tested two theories that may account for beneficial effects of written emotional 
disclosure, the cognitive processing hypothesis and the social interaction hypothesis. 
Design ‘Patients and their partners (N= 102 couples) were randomised to write at home for 15 
min a day over 3 days about the patient’s diagnosis and treatment using the GDP or 
what the patient did the previous day (control).’ 
Sample (patient 
group) 
A group of 102 couples where one partner had ovarian cancer. ‘Participants were 
members of a UK charity for patients with ovarian cancer who had consented to be 
contacted by third parties, and their spouses/partners.’ 
Sample size 102 couples where one partner had ovarian cancer. 53 couples in the experimental 




Ethnicity Not reported. 
Age range ‘Writing group mean age 53.02 (10.30) comparison group 57.39 (8.09). ‘GDP 
participants were significantly younger than controls, and more time had passed since 
their diagnosis. Therefore, patient age and time since diagnosis were added as 
covariates.’ 
Treatment type Mixed 
Stage of cancer Mixed. Mostly stage 3. 
EWI description ‘The GDP protocol was as follows: Day 1: Describe the diagnosis and treatment 
chronologically and what led to what, without mentioning emotions. Day 2: Part 1: 
Describe how you felt and what you thought at the time of the diagnosis. Part 2: What 
impact has your diagnosis and treatment had on your life, and has it caused you to 
change priorities? Day 3: How do you currently feel and think about the diagnosis and 
treatment? Are your current thoughts and feelings the same as at diagnosis? Would you 
be able to cope with similar situations better because you have experienced it? Spouses 
received similar instructions regarding their partner’s cancer and their own 
responses/reflections.’ 
Follow-up period Baseline, three months, 6 months 
Measures The Functional Assessment of Cancer Therapy—General The Perceived Stress Scale 
(PSS) 
Data analysis ‘To determine equivalence between groups on demographic and biomedical 
characteristics, independent samples t-tests were used for continuous data and w2 
analysis for categorical data. To test the research questions, 2x3 mixed-design repeated 
measures analyses of covariances were performed, with group (GDP, control) as the 




‘Contrary to expectations, despite including partners, there was no effect of the GDP on 
the primary outcomes.’ 





‘Guided Disclosure Protocol participants used more positive and negative emotion and 
insight words on days 2 and 3 than controls. They also rated their essays as more 
personal and revealing of emotions across all 3 days (all p values <0.01).’ 
Conclusions ‘This study aimed to determine the effect of the GDP on perceived stress and QoL in 
ovarian cancer couples. However, contrary to expectations, despite including partners, 
there was no effect of the GDP on the primary outcomes. Approximately half of the 
participants experienced a recurrence during the study. Written disclosure may be 
ineffective for dealing with recurrent stressors, as it does not teach strategies for dealing 
with possible recurrences. Similarly, the cognitive processing hypothesis was not 
supported. Intrusive thoughts even increased in partners in the GDP group. Similarly, 
the social interaction hypothesis was not supported. There was no effect of the GDP on 
communication. Distressed couples are less likely to agree to participate in such studies 
[48], and Couples’ Illness Communication Scale scores at baseline were high, 
suggesting that communication was close to ceiling level.’ 
Moderators ‘Change in illness-related communication moderated the effect of group on QoL in 
patients. The interaction explained 2.3% of the variance in QoL at 3-month followup 
(B=1.17, SE=0.52, b=0.20; F(1, 85) = 5.16, p=0.03).’ 
Identified 
limitations 
‘Approximately half of the participants experienced a recurrence during the study. 
Written disclosure may be ineffective for dealing with recurrent stressors, as it does not 
teach strategies for dealing with possible recurrences. First, for ethical reasons, no 
demographic information was collected about non-responders, preventing comparisons 
with responders. Second, the power analysis was based on an anticipated large effect 
size. Basing it on effects of written disclosure in cancer from previous studies (with 
smaller effects) might have been more appropriate. Third, medical data were self-
reported. Although the high correlation between patient- and consultant-reported CA 125 
levels suggested it was accurate, medical information would ideally have been validated 
against records. Fourth, the participants were members of a support charity, thus 
possibly more motivated to engage in the study than the general population with ovarian 
cancer because of the use of more active coping strategies [51]. Finally, the PSS may 
not have captured cancer-related distress sufficiently. The full IES might have been a 
more appropriate measure of cancer related distress. Avoidant coping as measured by 




‘Several issues need to be addressed in future research. Fifteen minutes was often 
insufficient for participants to describe their diagnosis and treatment. On day 1, 
participants should be invited to write until they feel they have completed all necessary 
details or be provided with, for example, 30 min. Also, the results were based on a 
cancer that affects only women. The effects of structured writing about cancer/other 




Title Expressive writing in early breast cancer survivors.  
 
Authors Craft, M. A., Davis, G. C., & Paulson, R. M. 
Year 2013 
Journal Journal of Advanced Nursing, 69(2), 305-315. 
Country of origin USA 
Aims Investigate whether or not expressive writing improves the quality-of-life of early breast 
cancer survivors. And whether or not the type of writing prompt makes a difference in 
results.  
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Design Randomised controlled trial. Participants were randomized into one of four groups: a control 
group (no writing) or one of three expressive writing groups: breast cancer trauma, any self-
selected trauma and facts related to breast cancer.  
Sample (patient 
group) 
The final analysis included 30 in the control group and between 19–26 in each of the writing 
groups. 
Sample size Breast cancer trauma condition (n=26), self-selected trauma condition (n=19), facts only 
condition (n=22), control (n=30).  
Inclusion/exclusi
on criteria 
Inclusion criteria: diagnosis of breast cancer, either invasive or non-invasive, definitive 
treatment (surgery, chemotherapy and/or radiation therapy) completed, time from diagnosis 
less than 2 years, able to speak and write English and physically able to write either by 
hand or with a word processor for 20-minute periods. Exclusion criteria: Recurrent or 
metastatic breast cancer, their mental status precluded participation, or if they had ever 
been diagnosed and/or treated for clinical depression. 
Ethnicity 92% Caucasian 
Age range 32–78 years with a mean of 56 years (SD = 10.51).  
Treatment type Surgery, chemotherapy and/or radiation therapy 
Stage of cancer Most were at early stages (0, I or II) of breast cancer, whereas 4.1% were at Stage III. 
Recurrent or metastatic breast cancer excluded 
EWI description ‘Participants wrote 20 minutes a day for 4 consecutive days. The writing intervention 
followed the paradigm established by Pennebaker et al. (1989) and used by most 
researchers in expressive writing. The three writing groups were instructed to write with 
individualized assignments on (a) deepest thoughts and feelings about breast cancer, (b) 
deepest thoughts and feelings about a self-selected worst trauma, or (c) facts of treatment 
only – day 1, diet, day 2, exercise regimen, day 3, sleep pattern and day 4, medications.’ 
Follow-up period 1 month and 6 months 
Measures used QOL. ‘FACT-B’. ‘This 37-item self-report instrument, contains 27 general 
items plus 10 breast cancer-specific items (Brady et al. 1997). Subscales include physical 
well-being, social/family well-being, emotional well-being and functional well-being, the 10 
additional items address physical and psychological concerns related to breast cancer.’ 
Timing of 
measures 
Measured at baseline, 1 and 6 month follow ups. 
Data analysis ‘Initially, analysis of variance (ANOVA) tested the four study groups for important 
differences. Multivariate analysis of variance (MANOVA) analysed the combined effect of 
time and group assignment on the outcome variable. Changes in QOL over the three time 
periods were analysed using paired t-tests. Multiple regression was used to answer the 
question of whether or not expressive writing contributed to QOL. In addition, intention-to-
treat (ITT) analysis was used to test the hypotheses due to the high dropout rate between 
the T1 and T3 assessment periods’ 
Findings ‘The results revealed a main effect of time, F(1,93) = 13.80, P < 0.001, partial n2 = 0.129. 
Additional analyses revealed that there were no important differences between groups at 
Time 1, F(3,93) = 0.20, P = 0.898, partial n2 = 0.006. There were, however, important 
differences between groups at Time 2, F(3,93) = 4.22, P = 0.008, partial n2 = 0.120. 
According to post-hoc tests, participants who wrote about facts regarding their breast 
cancer (group 4) had significantly higher QOL scores at Time 2 (mean = 119.62 SD 13.52) 
than those who did not write at all at Time 2 (mean = 104.38 SD 21.31). There was also a 
substantial time · group interaction, F(3,93) = 7.14, P < 0.001, partial n2 = 0.187 (See Table 
1 for actual scores).  Testing of Hypothesis 2 (H2) with a paired sample t-test revealed that 
participants who wrote about the trauma of their breast cancer experience had significantly 
higher QOL scores at Time 2 (mean = 114.83 SD 10.48) than at Time 1 (mean = 107.95 SD 
9.26) t(25) = _5.88, P < 0.001. Furthermore, a paired sample t-test revealed that 
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participants who wrote about the facts of their breast cancer experience had significantly 
higher QOL scores at Time 2 (mean = 119.62 SD.A separate repeated measures MANOVA 
was conducted to further examine the effect of time and group on the FACT-B, or QOL 
scores, at Time 1 and Time 3 (H2) (Figure 3). The results revealed an important time x 
group interaction, F(3,93) = 3.68, P = 0.015, partial n2 = 0.106. A paired sample t-test 
revealed that participants who wrote about the trauma of their breast cancer experience had 
significantly higher QOL scores at Time 3 (mean = 112.60 SD 9.12) than at Time 1 (mean = 
107.95  D 9.26) t(25) = _2.77, P = 0.011. There was, however, no main effect of time, 
F(1,93) = 0.53, P = 0.470, partial n2 = 0.006, nor was there a main effect of group, F(3,93) 





Conclusion ‘Those who wrote about the trauma of their breast cancer had higher scores at T2 than 
those who did not write or those who wrote about any traumatic event. Those who wrote 
about the trauma of their breast cancer or facts about breast cancer had higher scores than 
those who did not write or those who wrote about any traumatic event. Those who wrote 
about facts of breast cancer and breast cancer trauma had higher change scores than the 
control group of no writing from T1–T2. No important change occurred for any of the groups 
from T2–T3. Those who wrote about breast cancer trauma and facts of breast cancer 
showed a greater positive change than did the other groups from T1–T3. The writing groups 
significantly contributed to QOL, with the exception of the group writing about any trauma at 
Time 3. Although the group who wrote about the facts only of their breast cancer was 
originally designed to control for researcher attention, it produced statistically significant 
results similar to the group instructed to write about thoughts and feelings related to the 
trauma of breast cancer. Beneficial outcomes may be gained through use of this  technique. 
Even though the statistical gains were slight, the overall improvement of early cancer 
survivors using expressive writing to write about their breast cancer or the facts related to it 
show promise for this writing intervention as a treatment for improving QOL.’ 
Identified 
limitations 
‘Although the convenience sample used in this study limits the generalizability of its 
findings, steps were taken to assure that the participants selected were appropriate for the 
study aims. Because the study results might have been affected by the participant drop-out 
rate, ITT analysis was conducted to address possible bias of the study outcomes. Using the 
added analysis, the results were essentially the same when the non-completer’s last score 
was used. Other methodological limitations include varying previous exposure to journaling 
and variance in attrition in the different groups which may indicate a preference for one way 







‘In actuality, one might argue that writing about the physical aspects of breast cancer is not 
a neutral topic at all and may allow individuals to tap into some feelings they 
have been suppressing, perhaps in a very non-threatening way. For this reason, future 
research might benefit from structuring the cancer facts arm (or neutral topics arm) as a 
true intervention arm with the instructions including ‘tell the story of your breast cancer by 
talking about diet, exercise, sleep and medications’. 
 
 
Title Randomized Trial of Expressive Writing for Distressed Metastatic Breast Cancer 
Patients 
Authors Catherine E. Mosher, Katherine N. DuHamel, Joanne Lam, Maura Dickler, Yuelin Li, 
Mary Jane Massie, and Larry Norton 
Year 2012 
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Journal Psychological Health 27(1): 88–100. doi:10.1080/08870446.2010.551212 
Country of 
origin 
New York, USA 
Aims ‘This study examines the health effects of expressive writing in an advanced breast cancer 
patient sample and extends prior work in several respects. First, only patients with clinically 
elevated distress participated in this trial. In previous expressive writing studies, cancer 
patients were typically in the post-treatment phase and reported good baseline quality of 
life, which left little room for positive changes during the intervention period (e.g., Rosenberg 
et al. 2002; Zakowski et al. 2004). Second, this study examined indices of existential 
wellbeing (i.e., a sense of meaning and peace and demoralization), which are theoretically 
linked to emotional processing and expression and particularly relevant for patients with life 
limiting illness (Schwartz & David, 2002).’ 
Design Randomised controlled trial. Computerized random assignment to the expressive writing or 





87 women with metastatic breast cancer and significant psychological distress. Women with 
Stage IV breast cancer were recruited from a comprehensive cancer center in New York 
City from March 2008 to November 2009. 
Sample size 87 (44 in expressive writing group, 42 in neutral writing group. 
Inclusion/exclus
ion criteria 
‘Inclusion requirements were (1) English fluency, (2) at least 18 years of age, and (3) 
significant distress as indicated by scores exceeding the cutoff (≥ 4) on the Distress 
Thermometer (Jacobsen et al. 2005). Patients were excluded from study participation if 
they: (1) had severe cognitive impairment assessed with the Short Portable Mental Status 
Questionnaire (Pfeiffer, 1975), or (2) engaged in expressive writing on a daily basis.’ 
Ethnicity ‘Patients were stratified by ethnicity (Caucasian vs. African American vs. other ethnicity) and 
age (<55 vs. 55–65 vs. >65 years). In the expressive writing group 81.8% were Caucasian, 
4.5% African American, 4.5% Hispanic, 9.1% other. In the neutral writing group 81% were 
Caucasian, 9.5% African American, 7.1% Hispanic, 2.4% other.’ 
Age range Expressive writing group – 57.4 mean, 12.5 SD. Neutral writing – 58.5 mean, 11.7 SD. 
Stage of cancer Stage IV breast cancer 
Type of cancer 
treatment 
Not reported 
EWI description ‘Patients completed four writing sessions over 4–7 weeks. For Session 1, a post-doctoral 
psychology research fellow called the patient and provided a brief introduction to the writing 
task. Patients were asked to go to a quiet area of their house where they would not be 
interrupted. Expressive writing participants were instructed to write their deepest thoughts 
and feelings about their cancer, whereas neutral writing participants described yesterday's 
activities in a factual manner.’ 
Follow-up 
period 
‘Patients completed a follow-up phone interview approximately 8 weeks after the final 
writing session. Interviewers were blinded to participants' group assignment.’ 
Measures used 
 
The Meaning/Peace subscale of the Functional Assessment of Chronic Illness Therapy—
Spiritual Well-Being scale.  The Distress Thermometer (DT; Roth et al. 1998)  Center for 
Epidemiologic Studies—Depression scale (CES-D; Radloff, 1977) Patients also completed 
the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A; Zigmond & 
Snaith, 1983). The Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, 
Berman, & Kupfer, 1989).The Functional Assessment of Chronic Illness Therapy Fatigue 
subscale (FACIT-F; Yellen, Cella, Webster, Blendowski, & Kaplan, 1997). Trained 
interviewers administered the Australia-modified Karnofsky Performance Status Scale 
(AKPS; Abernethy, Shelby-James, Fazekas, Woods, & Currow, 2005) to assess baseline 
functional impairment. 
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Data analysis ‘Multivariate analyses of covariance (MANCOVA) were used to examine the effects of group 
assignment on follow-up outcomes, controlling for baseline values of the dependent 
variables. The following conceptually-related groups of dependent variables were analyzed 
in three separate MANCOVAs: (1) existential well-being (meaning/peace and 
demoralization); (2) psychological well-being (general distress, depressive symptoms, and 
anxiety); and (3) physical well-being (sleep and fatigue). Additional MANCOVAs were 
conducted to examine whether the effects of group assignment on the three sets of 
dependent variables differed according to functional status, time since diagnosis, and level 
of education (0 = less than a college degree, 1 = college degree or higher). Each potential 
moderator was independently analyzed and baseline values of the dependent variables 
were included as covariates. Finally, a logistic regression analysis was conducted to 
examine the effect of group assignment on the use of mental health services during the 
study, controlling for baseline use.’ 
Findings ‘Three MANCOVA analyses revealed no effects of writing group on the following sets of 
dependent variables with baseline values as covariates: (1) existential well-being (meaning/ 
peace and demoralization); (2) psychological well-being (general distress, depressive 
symptoms, and anxiety); and (3) physical well-being (sleep and fatigue) (see Table 2). To 
further examine the effects of writing group, mean change scores were calculated (data not 
shown). These scores revealed little change in study outcomes from baseline to follow-up 
for both writing groups.’ 
Manipulation 
checks 
‘An independent rater unaware of writing group assignment read the transcribed essays in 
random order and judged the writing instructions for each essay. In addition, after each 
writing session, participants rated how personal their essays were and how much they 
revealed emotions in their essays on 7-point scales (1 = not at all; 7 = a great 
deal/extremely) (Stanton et al. 2002). The computerized text analysis program, Linguistic 
Inquiry and Word Count (LIWC; Pennebaker, Mayne, & Francis, 1997) provided the 
percentage of positive emotion words and negative emotion words in each essay, which 
served as a third manipulation check.’ 
Moderators None. 
Conclusions ‘First, the 100% retention rate across the four writing sessions supports the feasibility of 
home-based interventions for advanced cancer patients. Second, the findings provide a 
reliable estimate of health effects of expressive writing in this population due to the low 
attrition rate and rigorous methods (e.g., randomization, blind assessments, distress 
criterion for study entry). Third, results suggest that expressive writing may improve uptake 
of psychological support services among distressed patients without increasing symptom 
severity. Reducing personal barriers to psychological support seeking among those with 
clinically elevated distress is an important goal of health care.’ 
Identified 
limitations 
‘Limitations of this trial should be noted. First, patients who were younger and more 
proximal to diagnosis were more likely to participate; however, these response biases were 
relatively small in magnitude. Second, the generalizability of the findings to men and 
patients with diverse ethnic and socioeconomic backgrounds warrants examination. In 
addition, although the sample size was more than double that of most expressive writing 
trials with cancer patients, we had limited power to detect small effect sizes. Finally, this 
study relied on self-reported outcome measures that were administered at one follow-up 
assessment. Administering objective and self-reported health assessments over time would 
provide a more comprehensive evaluation of expressive writing's health effects. A longer 
follow-up period may have revealed benefits of expressive writing when combined with 
mental health interventions. An intervention that involves social support and greater 





‘Next steps include documenting further social outcomes of expressive writing and testing 
whether it is a useful adjunct to standardized psychosocial interventions.’ 
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Title Effects of an expressive writing intervention on cancer-related distress in Danish 
breast cancer survivors — results from a nationwide randomized clinical trial 
Authors M. B. Jensen-Johansen, S. Christensen, H. Valdimarsdottir, S. Zakowski6, A. B. Jensen, D. 






Aims ‘To examine the effects of an expressive writing intervention (EWI) on cancer-related 
distress, depressive symptoms, and mood in women treated for early stage breast cancer.’ 
Design The women were randomised to the EWI group (n = 253) or control group (n=254). 
Sample (patient 
group) 
507 women treated surgically within 3 weeks of their diagnosis for invasive breast cancer 
stage I and II between March and September 2006. 
Sample size 507 
Inclusion/exclus
ion criteria 
Eligible participants were female Danish residents, able to read and write Danish, aged 18-
70 years, and treated surgically within 3 weeks of their diagnosis for invasive breast cancer 
stage I and II between March and September 2006. 
Ethnicity Not stated. 
Age range 27-70. 
Treatment type Surgery 
Stage of cancer Breast cancer stage I and II 
EWI description Both groups were instructed to write for 20 min, once a week, over a 3 week period. The 
home based intervention followed previously used procedures (Zakowski et al. 2004). 
Following the procedure described by Pennebaker and Beall (1986), we asked EWI 
participants to write about a traumatic or distressing event and to explore their deepest 
feelings and emotions associated with this experience. They were free to write about their 




Baseline, 3 and 9 months post intervention. 
Measures used Impact of Events Scale (IES) 
Beck Depression Inventory (BDI) 
Profile of Mood States (POMS) 
A Passive Positive Mood Scale (PPMS) 
The Social Constraints Scale (SCS-C) 




‘Repeated-measures analyses of variance and covariance (RM ANOVAs, RM ANCOVAs) 
were used to compare mean distress scores at the three time points. Effects were 
calculated for time and for time_group interactions, the latter reflecting significant 
differences between EWI and CTRL over time. Variables were inspected for outliers and 
log-transformed (Ln) as needed [36]. Possible moderator effects suggested in the literature 
were explored as recommended [37] with linear regressions entering the interaction terms. 
The influence of writing topic was explored by repeating the aforementioned RM ANOVAs 
combined with planned comparisons (simple contrast) between the CTRL group and each 
of the two writing topic groups (own cancer and other topics). A nationwide cohort of 3343 
Danish women treated for primary breast cancer [25,34] was used as a non-writing 
reference group.’ 
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Findings ‘Most EWI participants (n = 108) reported to have written about their breast cancer in at 
least one of the three sessions. The remaining women (n = 85) wrote about other personal 
traumas in all three sessions. Women who had received mastectomy, had received  
chemotherapy, or had used pain medication and professional help were more likely to write 
about having breast cancer than other traumas (chi2 tests; p = 0.012–0.026). No other 
group 
differences were found at baseline (data not shown). Repeated-measures analyses of 
variance revealed statistically significant reductions in cancer-related distress (IES), 
depressive symptoms (BDI-SF), and negative mood (POMS) (F: 6.43–21.26; p<0.001). No 
effects of time were found for positive mood (PPMS, POMS Vigor). The effect sizes were 
medium to high with hp 2 rangingbetween 0.03 and 0.09 (_d between 0.36 and 0.64). 
When including age and baseline levels of BDI-SF as covariates, no effects of time reached 
statistical significance. No time_group interactions reached statistical significance in any of 
the analyses, with or without covariates entered into the model. Effect sizes for time_group 
interactions were small, with hp 2 ranging between 0.001 and 0.012 (d<0.20) (A complete 
table of RM ANOVA statistics, adjusted effect sizes (hp 2 ), and effect sizes based on 
unadjusted change scores can be obtained from the authors by request).’ 
Manipulation 
checks 
‘Compared with CTRL, the EWI group showed significant changes in the expected 
directions in negative [Wilks’ lambda (l) = 0.79, F(5, 442) = 24, p<0.001] and positive mood 
[l = 0.85, F(5, 442) = 15.7, p<0.001] immediately after the writing sessions (RM ANOVAs) 
(data not shown). The effect sizes were large [multivariate partial eta squared (hp 2 ): 0.15 
to 0.21_Cohen’s d: 0.84–1.04].’ 
Moderators ‘No statistically significant moderation effects of social constraints (SCS-C) were found in 
any of the analyses, with or without covariates in the model (data not shown). Scores on the 
TAS-20 EOT subscale moderated the effect of EWI on IES-total scores at three months 
(beta: 0.26, p = 0.021), with lower EOT scores in the EWI group (but not CTRL) being 
associated with greater reductions in IES scores from baseline to three months. TAS-DDF 
moderated changes in positive mood (PPMS) from baseline to three months (beta: _0.24, p 
= 0.049), with higher scores on TAS-DDF being associated with increase in PPMS in the 
CTRL group, but not in EWI group. No other moderation effects were found for TAS-20 total 
and subscale scores (data not shown).Repeated-measures analyses of variance with 
Writing Topic Group as the independent variable revealed a significant interaction 
(time_Topic-Group) for the IESavoidance subscale [effect size (hp 2 ): 0.05_Cohen’s d: 
0.46], suggesting greater reductions over time in IESavoidance when writing about other 
topics than about one’s own cancer. However, none of the contrast analyses revealed 
significant differences when comparing either of the two writing subgroups to controls 
(SPSS, K-matrix). No further interaction effects (time_Topic-Group) reached statistical 
significance, when including all three time points in the model.’ 
Conclusions ‘The results of this large, randomized controlled trial with a nationwide sample of women 
treated for breast cancer did not confirm our hypothesis that EWI participants would 
experience greater reductions in distress when compared with an active control group.’ 
Identified 
limitations 
‘While our randomized clinical trial has several strengths, including a large, population-
based sample providing the ability to adjust for a number of potential confounders, a 
number of limitations could have influenced the results. First, 44% of the eligible women 
actively refused or failed to respond to the invitation to participate. Another issue could be 
the slightly longer duration of telephone calls in the EWI group due to more spontaneous 
talk initiated by the participants during debriefing, and we cannot rule out this debriefing as a 
confounder. Finally, there are several issues concerning writing topic. One concern could be 
that we distinguished between women who wrote about their own cancer experience in any 
one of three sessions and women who wrote about another traumatic experience in all three 
sessions. The variation in writing dose, however, did not influence the results. Second, 
writing topic was categorized according to self-report, rather than an in-depth qualitative 
analysis of all essays. While the inter-rater reliability between an independent rater and self-
reported writing topics appeared acceptable for a subsample of essays, it is unknown 
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whether the writing topic effects would hold up, if writing topics had been determined 
independently. Third, we do not know the reasons for choosing not to write about cancer. 
The reason could be that for some women, the cancer was no longer stressful, while for 
others the cancer was experienced as too stressful to write about. Including a measure of 
perceived or observer-rated stressfulness of their cancer diagnosis and treatment could 
have been relevant. A fourth potential confounder could be the recency of the non-cancer 
trauma. While we assume to be comp aring cancer with non-cancer writings, we could in 
fact be comparing the recency of the trauma. Although self-selected writing topic may 
increase external validity, lack of randomization may limit the generalizability of differences 
found between writing topic groups. Finally, while we considered a three-arm trial with a 
third group randomized to a group restricted to write about their cancer, this was abandoned 
because due to statistical power considerations.’ 
Future research ‘These limitations should be considered in future EWI studies with cancer patients.’ 
 
 
Title Who benefits from emotional expression? An examination of personality differences 
among gynaecological cancer patients participating in a randomised controlled 
emotional disclosure intervention trial. 
Authors Zakowski 
Year 2011 




Aims Examined the role of neuroticism and extraversion in the effects of written emotional 
disclosure in patients diagnosed with gynaecological cancer. 
Design Participants were randomised to EWI (N = 43) or NW (n = 45). 
Sample (patient 
group) 
‘Women who had been diagnosed with gynaecological cancer were recruited through clinics 
in the metropolitan areas of Milwaukee, Wisconsin and Reno, Nevada between 1998 and 
2003 for a longitudinal study examining the psychosocial effects of emotional disclosure.’ 
Sample size Final sample consisted of 88 patients who completed all assessments necessary. 
Inclusion/exclus
ion criteria 
‘Eligibility requirements included a first time diagnoses if gynaecological cancer, completion 
of active cancer treatment, no evidence of psychiatric problems or any current life-
threatening disease other than cancer, and ability to fluently read and write in English.’ 
Ethnicity 97.70% were Caucasian, 70.5% currently married, 48.3% currently employed, and 33.3% 
had at least a college education. 
Age range Patients were between 24 and 84 years old (m = 57.92, SD = 12.85). 
Treatment type 98.9% had undergone surgery. 
Stage of cancer Types of cancer included uterine (25%), ovarian (48.9%), cerival (11.4%) and other (9%), 
and 5.7% had more than one type of cancer.Cancer staging information revealed that 
30.7% had Stage I, 12.5% stage II, 28.4% stage III, and 6.8% stage IV disease at diagnosis.  
EWI description ‘Details of the procedures are described elsewhere (Zakowski et al. 2004). Briefly, 
participants completed informed consent, a baseline assessment, 3 days of writing including 
brief questionnaires, a 1 week and 6 month follow up assessment.’ 
Follow-up 
period 
Baseline, 1 week and 6 months post intervention. 
Measures used NEO five factor inventory 
Brief Symptoms Inventory 
Impact of Events Scale 
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‘Hierarchical multiple regression analysis entering Baseline Distress, Neuroticism, 
Extraversion, 
Condition in step 1, and the Condition by Neuroticism and Condition by Extraversion cross 
products in step 2 showed a significant Condition×Neuroticism interaction F(1,83) = 8.47, p 
< .01 on distress at follow-up but no significant Condition by Extraversion interaction.’ 
Findings ‘As reported previously, there was no significant main effect of writing condition (Zakowski 
et al. 2004). There was also no significant main effect for Neuroticism but a trend towards 
significance for Extraversion suggesting a negative relation with distress at follow-up (see 
Table 4). Regression lines plotted in accordance with recommendations by Aiken and West 
(1991) revealed that experimental group participants low on N exhibited reduced distress 6 
months after writing about their cancer while participants high on N exhibited heightened 
levels of distress. Participants in the control condition reported medium distress levels 
irrespective of level of N (see Figure 1). This was confirmed when examining simple slopes 
(Aiken & West, 1991) 
which revealed a significant regression of distress on neuroticism in the experimental 
condition, t = 3.10, p = .004, _ = 0.32 but no significant effect in the controls, t = −1.69, p = 
.10, _ = −0.19.’ 
Manipulation 
checks 
‘A manipulation check was included in order to verify the effectiveness of and subjects’ 
compliance with the writing instructions. At the end of each writing session subjects rated 
how personal the essay was and to what extent they revealed their emotions in the essay. 
Total scores were examined collapsing across the three writing sessions revealing a 
significant condition effect on both sets of ratings, F(1,84) = 23.48, p < .001, and F(1,84) = 
33.42, p < .001, respectively, suggesting that the manipulation was effective. Zero-order 
correlations revealed a significant moderate correlation between N and E (r =−.45), 
significant negative correlations of GSI with E and positive correlations with N (see Table 
3).’ 
Moderators ‘Testing the hypothesis that high N individuals would report more negative mood after 
emotional disclosure, we conducted a multiple regression analysis with change in negative 
mood from pre- to post-writing across the three writing days as the dependent variable. In 
addition to a significant Condition main effect, F(2,84) = 5.10, p < .03 there was a significant 
N×Condition interaction, F(3,84) = 5.02, p < .03 (see Table 4). Table 4. Regression plot 
revealed that high N participants exhibited the greatest increases in negative mood after 
writing about their cancer experience (see Figure 2). Simple slope analysis, however, 
revealed non-significant relationships between Neuroticism and negative mood change for 
the experimental group, t = 1.63, p = .11, _ = 0.25 as well as the control group, t = −1.62, p 
= .11, _ = −0.25. Next, we conducted similar multiple regression analysis to examine 
whether high N individuals would use more avoidant coping during the week following 
emotional disclosure. Again there was a significant relationship between baseline avoidance 
and avoidance post-writing, F(1,86) = 30.25, p < .001 and a significant N×Condition 
interaction, F(4,87) = 11.42, p = .001 (see Table 4). Regression plot revealed that results 
were in the expected direction with participants high on N reporting the highest levels of 
avoidance of cancer-related reminders (see Figure 3). Simple slope analysis revealed a 
significant positive relation between N and avoidance in the experimental condition, t = 3.36, 
p = .002, _ = 0.39 and a non-significant effect in Controls, t =−.78, p = .544, _ = −0.10.’ 
Conclusions ‘Patients high in Neuroticism did not appear to benefit from the intervention and in fact 
exhibited higher levels of distress at 6-month follow-up compared to those lower in 
neuroticism who reported lower post-writing distress. Extraversion however did not 
moderate the effect. Several mechanisms were proposed for the moderating role of these 
personality traits. With respect to neuroticism, we surmised that those high on this trait 
would view emotional disclosure as distressing and thus have higher negative mood after 
each writing session. Further, as a result of being confronted with a trait-incongruent and 
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thus a potentially aversive experience, these patients were expected to respond with greater 
avoidance of cancer-related thoughts and stimuli 1 week after disclosure. Indeed, patients 
scoring higher on neuroticism reported a greater increase in negative moods in response to 
the expressive writing sessions (though simple slopes did not reveal this effect to be 
significant) as well as greater avoidance 1 week later, however, neither of these variables 
significantly accounted for the moderating effect of neuroticism.’ 
Identified 
limitations 
‘Due to the relatively low number of participants, we were not able to examine the three-way 
interaction of N by E by Condition. It is possible that the combination of varying levels of the 
two traits would yield further information of how these traits combine to effect outcomes 
after 
emotional disclosure about a life stressor. This should be examined in future studies. 
Further, our study included a very specific population of gynecological cancer patients which 
limits external validity of the findings. Previous studies, like our own, have not yielded 
significant main effects of emotional disclosure on psychological outcomes in cancer 
patients. Our data suggest that this may be explained by individual differences in responses 
to such interventions. Others have suggested other possible moderators of the effect such 
as alexithymia, coping style, and social constraints (e.g., Baikie, 2008; Kraft, Lumley, & 
D’Souza, 2008; Lumley, Tojek, & Macklem, 2002; Zakowski et al. 2004). Finally, we were 
unable to identify possible reasons for the moderating effects of neuroticism. While 
theoretical models point to mood and avoidance as mediators, this link did not bear out in 
our study. Thus, it is to date unclear why high N individuals displayed greater distress in 
response to the intervention. Assuming that this effect will be replicated in future studies, it 





‘It is possible that the combination of varying levels of the two traits would yield further 
information of how these traits combine to effect outcomes after emotional disclosure about 
a life stressor. This should be examined in future studies.’ 
 
 
Title Narrowing the gap: the effects of an expressive writing intervention on perceptions of 
actual and ideal emotional support in women who have completed treatment for early 
stage breast cancer. 
 






Aims To assess the effects of an expressive writing (EW) intervention on perceptions of 
emotional support in women completing treatment for early stage breast cancer. 
Design RCT, participants randomised to expressive writing or usual care. 
Sample (patient 
group) 
Women with breast cancer.  
Sample size 93 were randomised. 45 in EWI group, 48 in control group. 
Inclusion/exclus
ion criteria 
Patients were excluded from the study if: (1) they were unable to write for the duration of 20 
min; (2) they were unable to speak, read or write English or (3) they had a defined 
psychiatric disorder. 
Ethnicity Not reported. 
Age range EWI group 58.4 (10.8)  control group 57.5 (9.1) 
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Treatment type Women were recruited to the study during their final week of treatment. 
Stage of cancer Participants had been diagnosed with stage I and II breast cancer within the previous 12 
months. 
EWI description ‘Participants were asked to write, at home, for a period of 20 minutes on four consecutive 
days, to write continuously for the specified duration of the task, without focusing unduly on 
grammar or spelling. Participants were advised to write at roughly the same time each day. 
The confidentiality and anonymity of the written material were emphasised. As we 
specifically wanted women to explore their experience of breast cancer, we adapted the 
writing instructions to guide women’s writing over the 4 days. Based on previous research 
[27, 28], we anticipated that providing writing guidelines would result in similar benefits to 
the standard classic writing instructions [1]. Although participants were given writing 
guidelines for each of the 4 days, it was emphasised that it was crucial that participants 
should write about what was important to them.  The guidelines for each day had the 
following focus: Day 1: Emotional disclosure—exploring deepest thoughts and feelings 
about your experience of breast cancer. Day 2: Cognitive appraisal—making sense of your 
illness. What does having breast cancer mean to you? Day 3: Benefit finding—perceived 
benefits of your experience; challenges you have overcome; changed outlook on 
life/priorities? Day 4: Looking to the future—coping strategies; sharing experience with 
others. The researcher was not present during the completion of the writing tasks but 
telephoned participants on the final day to address any outstanding questions and/or 
concerns and to explore briefly participants’ immediate response to the writing task. 
Participants who reported distress following writing could be referred, with their permission, 
to a Macmillan Nurse Counsellor. Control groups in EW studies are typically instructed to 
write about unemotional neutral topics, often descriptions of daily events. Previous research 
has indicated that for some clinical groups the typical control condition may not in fact be 
completely neutral and engender distress in participants [29]. In order to avoid this, we did 
not ask the control group to engage in any type of writing task.’ 
Follow-up 
period 
baseline, 1 month, three months and 6 months. 
Measures used The Significant Others Scale 
Quality of life (QOL) was assessed using the 
Functional Assessment of Cancer Therapy—Breast 
Profile of Mood States 




‘Between group comparisons at baseline were made using independent samples t-tests for 
continuous variables and chi-square tests for categorical data. Repeated measures ANOVA 
were used to compare the intervention group with control group on measures of social 
support, QOL, negative affect and healthcare utilisation. Subsequent analyses involved 
ANCOVA for mixed designs with between subjects variables of condition (intervention 
or control) and within subjects variable of time of follow-up (1, 3 or 6 months) with baseline 
scores as the covariate. Partial correlations, controlling for baseline measures, were used to 
examine linear relationships between variables at 6 months post intervention.’ 
Findings ‘Eighty participants completed all follow-ups. There was a significant effect of group 
on women’s perceptions of social support with those in the intervention group being more 
satisfied with the emotional support they received (po0.05). Satisfaction with emotional 
support was negatively correlated with depression/dejection (po0.05) and anger/hostility 
(po0.05) and positively correlated with social and family well-being (po0.001) 6 months post 
intervention.There were no significant effects of the intervention on mood, QOL or 
healthcare utilisation. Most participants found writing valuable and did not report any long-
term negative effects. 
In interviews carried out 6 months after writing, several of the women indicated that writing 
gave them the opportunity to disclose feelings they found difficult to share with those closest 
to them because they did not want to cause them more worry. The effect of breast cancer 
on family members has previously been found to be one of the most important concerns of 
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women diagnosed with the disease [33]. Whether disclosing their deepest thoughts and 
emotions in their writing enabled women to be more open with others, or whether writing 
allowed them to gain a different perspective on things, thus changing how they interacted 





Conclusions ‘The results of this study revealed significant effects of an EW intervention on perceptions of 
social support in a cohort of women who had recently completed treatment for early stage 
breast cancer. Women who wrote about their experience of having breast cancer were more 
satisfied with the emotional support that they were receiving from significant people in their 
lives than those in the control group. More specifically, the support they reported receiving 
was more closely ‘matched’ to the support they would ideally like to have than those in the 
control group. In the sample as a whole, satisfaction with perceived emotional support was 
related to lower rates of depression/ dejection and anger/hostility and higher reported levels 
of social and family well-being 6 months post writing.’ 
Identified 
limitations 
‘There are some limitations to the study. The sample did not demonstrate cultural or ethnic 
diversity thus potentially limiting the extent to which these findings can be generalised. 
Furthermore, the sample consisted of women with early stage breast cancer and therefore 
no assumption can be made about the suitability of the writing paradigm to women with 
more advanced disease. Additionally, no provision was made to offer participants an 
alternative means of disclosure, such as the use of audiotapes, thus excluding women who 




‘The challenge is to identify the groups of people most likely to benefit from EW, the most 
effective methods of delivering the intervention and the protocol used.’ 
 
 
Title A Randomized Controlled Trial of Emotionally Expressive Writing for Women With 
Metastatic Breast Cancer 
Authors Carissa A. Low, Annette L. Stanton, Julienne E. Bower, Lauren Gyllenhammer 
Year 2010 




Aims ‘To test the effects of emotionally expressive writing in a randomized controlled trial of 
metastatic breast cancer patients and to determine whether effects of the intervention varied 
as a function of perceived social support or time since metastatic diagnosis.’ 
Design ‘Women (N = 62) living with Stage IV breast cancer were randomly assigned to write about 
cancer-related emotions (EMO; n = 31) or the facts of their diagnosis and treatment (CTL; n 
= 31). Participants wrote at home for four 20-min sessions within a 3-week interval. The 
randomization schedule was created by a biostatistician using a computerized random 
numbers generator. Sequentially numbered envelopes were used to conceal 
allocation. Instructions for the experimental conditions were adapted from Pennebaker and 
Beall (1986) and Stanton et al. (2002) and are available from the authors upon request.’ 
Sample (patient 
group) 
62 women living with Stage IV breast cancer. ‘On average, women had first been diagnosed 
with breast cancer 7.9 years ago (SD = 67 months) and had been living with their Stage IV 
diagnosis for 3.3 years (SD = 28.1 months). Most women had bone metastases (69%; 16% 
lung metastases, 44% liver metastases, 10% brain metastases).’ 
Sample size 62 






Ethnicity White (87%) 
Age range ‘Across the entire sample, the average age was 53.8 years (SD = 10.3, range = 29 to 78). 
Most women were college educated (74%), married or living as married (71%), and not 
working outside the home (78%). ‘ 
 
Treatment type ‘In addition, most participants had at least some experience with cancer support groups 
(72%), talking with a mental health professional about cancer (63%), or journaling about the 
cancer experience (63%).’ 
Stage of cancer IV 
EWI description ‘Instructions for the experimental conditions were adapted from Pennebaker and Beall 
(1986) and Stanton et al. (2002) and are available from the authors upon request. After 
women received materials for the writing exercises, they called the research office to 
schedule four 20-min sessions within a 3-week interval at their convenience. Following a 
procedure used in previous expressive writing research with cancer patients and loved ones 
(e.g., Bishop, Lee, Stanton, & Wingard, 2004; Zakowski et al. 2004), a trained research 
assistant telephoned women at the beginning of each session to read the instructions to the 
participant, then called again 20 min later to ask women to stop writing. Condition 
assignment was revealed to the assistant reading instructions during the first writing 




Measures used ‘The Center for Epidemiologic Studies– Depression Scale (CES–D; Radloff, 1977) contains 
20 items that assess the frequency of depressive symptoms in the past week. The 7-item 
Intrusions subscale of the Impact of Events Scale (IES; Horowitz, Wilner, & Alvarez, 1977) 
was administered to assess how distressing cancer-related intrusive thoughts (e.g., “I 
thought about it when I didn’t mean to.”) had been over the past week. Negative somatic 
symptoms were assessed using a measure developed by Pennebaker (1982), which has 
been shown to be responsive to the expressive writing intervention (Stanton et al. 2002). 
This scale asks participants to report the number of days in the past month on which they 
experienced each of nine somatic symptoms (e.g., headache, stomach ache, chest pain, 
runny/congested nose, faintness/ dizziness, shortness of breath, racing heart, stiff/sore 
muscles, coughing/sore throat). The Pittsburgh Sleep Quality Index (PSQI; Buysse et al. 
1989) assesses sleep quality over the past month and yields a total sleep disturbance scale, 
with scores of 5 or above on the PSQI indicative of clinically significant sleep disruptions 




‘Primary analyses were ANCOVAs, entering baseline value of the relevant dependent 
variable as a continuous independent variable (to control for nonsignificant chance variation 
between groups at baseline) and experimental condition as a categorical independent 
variable. In addition to main effect analyses, analyses were also conducted to determine 
whether intervention effects vary as a function of social support or time since metastatic 
diagnosis. Linear regression analyses were used to examine moderators, in which potential 
moderators were centered and included as continuous independent variables, along with 
baseline values of dependent variables, dummy-coded experimental condition (CTL = 0 and 
EMO = 1), and the condition × moderator interaction term. Significant condition × moderator 
interactions were interpreted following the recommendations of Aiken and West (1991); 
specifically, separate regression equations were calculated for high (1 SD) and low (−1 SD) 
levels of the moderator and the significance of the slopes of each regression line examined 
to determine whether the value of the simple slope differed from zero.’ 
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Findings ‘No significant main effects of experimental condition were observed. A significant condition 
× social support interaction emerged on intrusive thoughts; EMO writing was associated 
with reduced intrusive thoughts for women reporting low emotional support (η2 = .15). 
Significant condition × time since metastatic diagnosis interactions were also observed for 
somatic symptoms and sleep disturbances. Relative to CTL, EMO participants who were 
more recently diagnosed had fewer somatic symptoms (η2 = .10), whereas EMO 




‘An independent rater unaware of condition assignment read all transcribed essays in 
random order and recorded which condition instructions they most reflected. The rater 
correctly classified 94% of the essays, indicating excellent adherence to writing instructions. 
At three months, participants rated the extent to which they had thought about what they 
wrote, talked to others about what they wrote, felt the research project had positive or 
negative 
long-lasting effects, and how much the project increased their  understanding of their 
experience from 1 (not at all) to 7 (extremely). In contrast to previous trials, in which 
participants completed essay ratings immediately after each writing session (Stanton et al. 
2002; Zakowski et al. 2004), independent t tests revealed no significant group differences in 
these ratings at follow-up ( ps > .20), although mean ratings for “thought about what you 
wrote about” and “increased your understanding of your experience” were somewhat higher 
in the EMO than the CTL condition (3.35 vs. 2.74 and 3.29 vs. 2.84, respectively).’ 
Moderators ‘We also examined perceived emotional support as a moderator of intervention effects. This 
hypothesis was guided by social constraint theory, which suggests that the absence of 
social outlets for emotional expression and processing has a negative effect on adjustment 
to stressful situations. As hypothesized, women reporting low emotional support benefited 
from the opportunity to express and process cancer-related emotions, which was reflected 
in decreased intrusive thoughts at three months. These results are consistent with an earlier 
writing trial with cancer patients, and suggest that expressive writing may represent a useful 
intervention for individuals who lack opportunities for emotional expression in their social 
environments (Zakowski et al. 2004).’ 
Conclusions ‘Although there was no main effect of expressive writing on health among the current 
metastatic breast cancer sample, expressive writing may be beneficial for a subset of 
metastatic patients (including women with low levels of emotional support or who have been 
recently diagnosed) and contraindicated for others (i.e., those who have been living with the 
diagnosis for years).’ 
Identified 
limitations 
‘Although the sample of 31 women per condition at follow-up is larger than as those in 
previous expressive writing trials reporting main effects (de Moor et al. 2002; Stanton et al. 
2002), our study may have been underpowered to detect main effects, particularly for 





‘Future research should examine biological markers that might be clinically relevant for MBC 
patients. Larger sample sizes also needed. Future research may also benefit from 
exploration of alternative writing topics, such as the perceived benefits of the cancer 
experience (Stanton et al. 2002) or a noncancer related control topic.’ 
 
 
Title Emotional Disclosure Through Patient Narrative May Improve Pain and Wellbeing: 
Results of a Randomised Controlled Trial in Patients with Cancer Pain. 
Authors Cepeda 
Year 2008 
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Aims ‘To determine whether incorporating a structured narrative approach (writing about how the 
illness has affected the dimensions of life) in patients with advanced cancer decreases pain 
intensity and improves patients global assessment of their wellbeing.’ 
Design 234 patients were randomised into 3 groups: 1.) narrative (n = 79), in which patients wrote a 
story about how cancer affected their lives for at least 20 minutes once a week for three 
weeks; 2.) questionnaire (n = 77), in which patients filled out the McGill Pain Questionnaire, 
this was included as an attentional control.; and 3.) control (n = 78), in which patients came 
weekly to medical visits during which they received usual customary care.  
Sample (patient 
group) 
Recruited patients from the oncology, radiotherapy, and pain management services of the 
Javeriana University Oncology Centre and the Colombian National Institute of Cancer. 
Sample size 230 people were randomised. 
Inclusion/exclus
ion criteria 
‘To facilitate the generalisability of the results, the sample included adult patients with any 
type of cancer who reported average pain intensity levels of at least 5/10 on a 0-10 scale, 
were able to read and write, and scored 50% or higher on the Karnofsky scale.’ 
Ethnicity Not reported even though they say ethnicity is important with regards to narrative 
approaches in the discussion. 
Age range Narrative group mean = 50.2 
Questionnaire group mean = 49.1 
Control group mean = 46.2 
Treatment type Any. 
Stage of cancer Various. 
EWI description ‘We asked them to write about how cancer had affected their lives, calling upon their 
deepest thoughts, feelings and fears if present, and to do so about once a week for at least 
20 minutes. We asked them not to disclose any form of identification within the narrative, 
nor to concern themselves with polishing their grammar, spelling or style. Specific 
instructions not included in this article.’ 
Follow-up 
period 
‘Patients participated for eight weeks following randomisation. All patients were seen weekly 
for the first three weeks in the pain clinic or palliative care service, then called weekly for 
four more weeks, and then asked to come to the last session of this intervention at the 
eighth week.’ 
Measures used Patients rated their average pain intensity during the prior week using a verbal numerical 
rating scale in which 0 is no pain and 10 is the worst imaginable. As a secondary outcome, 
we evaluated each patient’s sense of general wellbeing on a seven point Likert scale that 




‘An analysis of repeated measures using generalised estimating equations (GEE). The GEE 
method adjusts standard errors because the multiple observations on the same subject are 
not independent. To analyse the effect of the treatment on patients sensation of wellbeing, 
we used a similar approach as described for pain intensity, despite assessing wellbeing with 
a Likert scale.’ 
Findings ‘Twenty patients had no emotional disclosure in one or more of the three written essays; in 
five patients, the emotional disclosure in at least one of the narratives was rated ‘‘very 
much.’’ These latter patients had significantly lower pain intensity than patients whose 
emotional disclosure in their narratives was never rated as great as ‘‘very much’’ (Fig. 3). 
The average difference in pain intensity between these two latter groups was 2.5 units (95% 
CI _4.2, _0.9). At subsequent follow up, patients whose narrative emotional disclosure rated 
highest also had higher well-being scores than patients whose narratives had lower 
emotional disclosure (1.37 difference, 95% CI 1, 1.7). These improved outcomes in patients 
with  a high degree of emotional disclosure cannot be explained by lower levels of pain 
intensity or higher senses of well-being at the start of the study. Baseline pain intensity 
scores in the patients whose narratives had the highest emotional disclosure were 8.7 _ 2. , 
vs. 7.5 _ 1.8 in patients with lesser emotional disclosure. In terms of well-being, baseline 
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scores were 3.8 _ 11 in the higher emotionally disclosing group and 3.75 _ 1.5 in individuals 
with less emotionally disclosing narratives. None of the other categorizations used to 
dichotomize the degree of emotional disclosure was associated with lower pain intensity 
levels or higher senses of well-being.’ 
Manipulation 
checks 
‘We assessed the emotional disclosure of the patients’ narratives using a six-point Likert 
scale that ranged from ‘‘none’’ to ‘‘very much.’’ Similar assessments of the magnitude of 
emotional disclosure have been performed in previous studies.20,32. Nonetheless, because 
of the subjectivity in rendering this assessment, two raters graded the degree of emotional 
disclosure in the patients’ narratives independently.’ 
Moderators None. 
Conclusions ‘Overall pain intensity and sense of well-being were similar in all three groups, suggesting 
that writing a narrative does not alter those outcomes. Other clinical trials have failed to 
show that writing has therapeutic benefit and an update of a systematic review on the effect 
of emotional disclosure concluded that writing did not produce any clear improvement in 
physical health or other health outcomes.’ 
Identified 
limitations 
‘We cannot rule out the possibility that our findings are subject to the additional confounding 
effect of our not having randomized patients to disclose narrative material of a neutral or 
emotional nature but instead relied upon patients to self-allocate within these categories. 
Nonetheless, confirmation of the present results would be worthwhile because, if our 
results are generalizable, the benefit of writing emotionally disclosing narrative may be 
clinically important. The 2.5-unit decrease in pain intensity observed in our study is typically 
considered by patients to be clinically meaningful.33 Despite efforts to assure adherence, 
only 50% of patients had the desired ‘‘exposure’’ writing three narratives and 25% of 
patients provided no emotional disclosure in one or more of the narratives. Patients may 
have not invested the time necessary to develop emotional themes in their stories; we did 
not measure how much time patients dedicated to writing these. This lack of ‘‘adherence’’ 
could explain the absence of a clear effect of composing versus not composing narratives 
upon pain and well-being. These findings may also be interpreted as showing that patients 
with advanced cancer and significant disease burden find it difficult to compose emotional 
narratives. Although previous studies that included patients with cancer17,20 have found 
that such patients were able to construct emotionally disclosing stories, these trials included 




‘Cultural differences, including beliefs and values, can shape how patients experience pain, 
how they form and express their narratives, their willingness to disclose narrative 
information, and the impact of the narrative on quality of life. Therefore, such issues should 




Title Expressive writing as a presurgical stress management intervention for breast 
cancer patients. 
Authors De Moor 
Year 2008 




Aims This study evaluated whether expressive writing (EW) was an effective stress management 
intervention for breast cancer patients. 
Design Women were recruited at the end of neoadjuvant chemotherapy and assigned to write about 
their cancer experience (EW group; n = 24) or neutral topics (neutral writing [NW] group; n = 
25).  





Women were recruited at the end of neoadjuvant chemotherapy 
Sample size EW group; n = 24) or neutral topics (neutral writing [NW] group; n = 25). 
Inclusion/exclus
ion criteria 
Inclusion criteria: Above 18 years of age, fluent in English, free from comorbidity, received 
over 2 months of neoadjuvant chemotherapy, and scored less than 30 on the Beck 
Depression Inventory. 
Ethnicity 58% white (EW group), 67% white (NW group) 
Age range 56 (EW) and 50 (NW) 
Treatment type Women were recruited at the end of neoadjuvant chemotherapy 
Stage of cancer 46% stage 2 (EW) and 48% stage 2 (NW). 54% stage 3 (EW) and 52% stage 3 (NW). 
EWI description Women were asked to write for 20 minutes a day for a total of four writing sessions that 
were completed over a 7-day period. 
Follow-up 
period 
Participants were reassessed approximately 3 days before and 2 weeks after surgery. 
Measures used Brief Symptom Inventory (BSI-18), Perceived Stress Scale (PSS), Pittsburgh Sleep Quality 
Index (PSQI), Social Constraints Scale (SCS) and the Brief Pain Inventory (BPI), Impact of 




‘A series of one-way analysis of variance tested whether the EW and NW groups differed in 
their word use. A general linear mixed model approach was conducted using the SAS 
system for Windows to test for group differences in the dependent variables and aspects of 
distress and sleep disturbance.’ 
Findings ‘The intervention did not significantly decrease women's distress, perceived stress, sleep 
disturbance, or pain. There was some evidence that the EW group used more sleep 
medication at the presurgical assessment than the NW group. Social constraints moderated 
the effect of the intervention. Among women with high social constraints, the EW group 
reported lower average daily pain than the NW group. Among women with low social 
constraints, the EW group reported higher average daily pain than the NW group. EW was 
not broadly effective as a stress management intervention for women with breast cancer. 
These data do not support the use of EW as a presurgical mind-body complementary 




Moderators Social constraints. Those with high levels of perceived social constraints reported lower 
average pain after surgery (t(1, 31) = 2.10, p = .05). 
Conclusions The authors do not recommend the use of EW as a complement to surgery for women with 
breast cancer.  
Identified 
limitations 





‘Additional research should assess whether changing the timing and the location of the 
intervention increases the effectiveness of writing for presurgical populations and determine 
whether writing is more effective on physical health outcomes of cancer patients.’ 
 
 
Title Expressive Writing in Patients Receiving Palliative Care: A Feasibility Study 
Authors Eduardo Bruera, Jie Willey, Marlene Cohen, & Lynn Palmer 








Aims The purpose of this study was to determine the feasibility of expressive writing in patients 
receiving palliative care and the most suitable outcomes of expressive writing in this patient 
population. 
Design Patients were randomly assigned to either the expressive writing group (EWI) or the neutral 
writing group (NW). Anxiety level before and after the writing session was compared 
between the two groups.  
Sample (patient 
group) 
24 patients were enrolled. Advanced cancer receiving palliative care. 
Sample size 24 but only 8% completed the two week study 
Inclusion/exclus
ion criteria 
Six patients not eligible for reasons such as high HADS score, treatment for depression and 
unable to write because of history of stroke. 
Ethnicity 92% Caucasian 
Age range Median age was similar at 55.4 and 54.3 respectively. 
Treatment type Palliative care. 
Stage of cancer Palliative. 
EWI description EWI group instructed to write about deepest thoughts and feelings regarding cancer 
experience. Neutral writing group wrote about diet, physical activity, and sleep habits. 
Sessions were conducted twice weekly for two weeks, lasting 20 mins each. 
Follow-up 
period 
STAI completed before and after each session. 
Measures used Brief Symptom Inventory 
Hospital Anxiety and Depression Scale 
Perceived Stress Scale 
Edmonton Symptom Assessment (ESAS) 
Functional Assessment  of Chronic Illness Therapy Fatigue (FACT-F) 




Simply looked at median and range of STAI scores before and after writing sessions. 
Findings There were no differences in STAI scores after writing sessions. All participants scores 
remained in the ‘somewhat anxious’ range. 
Manipulation 
checks 
Little of what was written in the EWI group was considered emotional content according to 
Pennebaker (1996). 
Moderators None. 
Conclusions EWI is not feasible in palliative care populations due to participants becoming too ill.  
Identified 
limitations 
Small sample size to begin with, and high drop out rate in palliative care population. 






Future research should address whether audio recorded statements or telephone interviews 
could be used as an alternative to writing for some patients. 
 
 
Title Does Self-Affirmation, Cognitive Processing, or Discovery of Meaning Explain Cancer-
Related Health Benefits of Expressive Writing? 
Authors Creswell, J. D., Lam, S., Stanton, A., Taylor, S. E., Bower, J. E. & Sherman, D. K.  
Year 2007 




Aims ‘The present study aimed to assess self-affirmation, cognitive processing, and discovery of 
meaning as potential mediators of the effects of expressive writing on physical health in 
early-stage breast cancer survivors.’ 
Design Further analysed data from Stanton et al (2002).  
Sample (patient 
group) 
Sixty-three early-stage (Stage I and II) female breast cancer patients who were within 20 
weeks after completing cancer treatment.  
Sample size 63. Numbers in each experimental group not reported. 
Inclusion/exclus
ion criteria 
‘Participants were excluded from the study if they had a diagnosis of recurrent or metastatic 
disease or were unable to write in English. Three participants dropped out of the study due 
to a cancer recurrence (n = 2) or lack of interest (n = 1).’ 
Ethnicity Caucasian (93%), African American (5%), and Asian American (2%). 
Age range Participants ranged in age from 21 to 76 years old (M = 49.5) 
Treatment type within 20 weeks after completing cancer treatment (e.g., chemotherapy, surgery, 
radiotherapy) 
 
Stage of cancer early-stage (Stage I and II) female breast cancer patients 
EWI description ‘Participants were randomly assigned to one of three conditions and instructed to write 
about their (a) deepest thoughts and feelings regarding their experience with breast cancer 
(Emotional Expression), (b) positive thoughts and feelings regarding their experience with 
breast cancer (Benefit-Finding), or (c) facts regarding their cancer and its treatment (Fact-
writing Control). For each writing session, participants were instructed to write continuously 
for 20 min. All procedures were IRB-approved. For a detailed description of the study, see 
Stanton et al. (2002).’ 
Follow-up 
period 
‘At 1 and three months after completing the last writing assignment, participants completed 
questionnaires assessing their physical symptoms, cancer-related doctor visits, general life 
satisfaction (as measured by the Satisfaction With Life Scale [SWLS]; Diener, Emmons, 
Larsen, & Griffin, 1985), and mood throughout the past week (as measured by the Profile of 
Mood States [POMS]; McNair et al. 1971).’’ 
Measures used ‘Heart rate was assessed continuously during the four writing sessions. Immediately before 
and after writing each essay, participants completed a measure of state distress using the 
state form of the Profile of Mood States (McNair, Lorr, & Droppelman, 1971). A state 
distress index was created by averaging the Anger, Depression, Tension, Fatigue, and 




‘The 240 essays (60 participants × 4 essays) were content analyzed by trained coders who 
were blind to the study hypotheses and the participants’ writing condition. Two groups of 
three judges coded the essays, with three judges coding for self-affirmation and three 
judges coding for cognitive processing and discovery of meaning. The judges were trained 
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to code the essays for examples of self-affirmation or cognitive processing and discovery of 
meaning, with a sentence being the smallest unit of text that could be coded to a category. 
Judges coded statements as “text units,” which was defined as a single sentence or multiple 
consecutive sentences describing a potential self-mediator. A series of multiple regression 
equations were conducted using an analytic approach specified by Baron and Kenny 
(1986).’ 
Findings ‘Preliminary analyses revealed no significant experimental condition differences at baseline 
for stage of breast cancer (p = .70), time since diagnosis (p = .65), or physical symptoms (p 
= .15), suggesting that randomization was effective in equalizing the health status of the 
groups at baseline. The three writing conditions yielded writing in each potential self-
mediator category across the four essays: self-affirmation statements (M = 8.98, SD = 8.53), 
cognitive processing statements (M = 5.32, SD = 5.50), and discovery of meaning 
statements (M =5.50, SD = 11.56). To assess the combined effects of cognitive processing 
and discovery of meaning on health, a pooled measure for cognitive processing and 
discovery of meaning was created by combining the composite measures of these two 
categories. The combined cognitive processing and discovery of meaning measure 
produced the highest frequency of coded statements across the potential self-mediator 




Moderators Life satisfaction and mood did not moderate outcomes of expressive writing. 
Conclusions ‘Contrary to study predictions, we did not find evidence that cognitive processing, discovery 
of meaning, or their combination mediated the association between expressive writing and 
physical health. The present study reveals that self-affirmation may act as a psychological 
mechanism for the benefits of expressive writing on aspects of health in early-stage breast 
cancer survivors. Using a content analysis methodological approach, the present findings 
show that self-affirmation writing was related to fewer physical symptoms at 3-month follow-
up. Moreover, self-affirmation writing fully mediated the relationships between emotional 
expression and benefit finding writing on physical symptoms at 3-month follow up. 
Consistent with predictions, self-affirmation writing fully mediated the relationship of both 
experimental writing conditions on reductions in physical symptoms at 3-month follow-up. 
A first plausible mechanism is that self-affirmation writing may have increased self-esteem 
and self-efficacy for coping with cancer. A second plausible, and in our judgment more 
likely, explanation is that self-affirmations buffered the stress associated with writing about 
difficult cancer-related thoughts and feelings.’ 
Identified 
limitations 
‘rather than manipulating self-affirmation, cognitive processing, or discovery of meaning 
writing directly, we assessed the naturalistic occurrence of these statements in the context 
of an expressive writing trial. Although this limitation restricts our ability to make causal 
statements about improving health in breast cancer, benefits of this approach include the 
opportunity to compare the naturalistic uses of self-affirmation, cognitive processing, and 
discovery of meaning as coping strategies during breast cancer recovery and the 
opportunity to test for underlying psychological mechanisms in a widely used, expressive 
writing intervention. A second potential limitation is that the present study did not define the 
potential mediators as mutually exclusive categories, making it difficult to interpret 
correlations among the mediators or assess their independent contributions as orthogonal 
constructs. However, this approach was necessary due to the fact that the essays revealed 
clear instances in which a single statement could be coded to more than one category. This 





‘The present findings suggest that writing about valued aspects of the self reduces stress 
and promotes health and well-being, and it is hoped that these findings provide an impetus 
for considering the protective role of the self in future studies and interventions.’ 
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Title Expressive Disclosure and Benefit Finding Among Breast Cancer Patients: 
Mechanisms for Positive Health Effects 
Authors Carissa A. Low and Annette L. Stanton & Sharon Danoff-Burg 
Year 2006 
Journal Health Psychology 
Country of origin USA 
Aims ‘A randomized trial (n _ 60; A. L. Stanton, S. Danoff-Burg, L. A. Sworowski, et al. 2002) 
revealed that 4 sessions of written expressive disclosure or benefit finding produced 
lower physical symptom reports and medical appointments for cancer-related morbidities 
at 3-month follow-up among breast cancer patients relative to a fact-control condition. 
The goal of this article is to investigate mechanisms underlying these effects. Hypothesis 
1. Objective (i.e., heart rate [HR]) physiological activation and habituation within and 
across writing sessions will account for the health benefits in the EMO condition.2 
Hypothesis 2. Subjective positive emotion and essay words indicating positive emotion 
will account for health benefits in the POS condition (we also explore the role of negative 
emotion as a mediator). Hypothesis 3. Essay words indicative of cognitive processing will 
mediate the health effects of both interventions.’ 




Sample size 63 
Inclusion/exclusion 
criteria 
Participants were excluded from the study if they had a diagnosis of recurrent or 
metastatic disease or were unable to write in English. Three participants dropped out of 
the study due to a cancer recurrence (n = 2) or lack of interest (n = 1). 
Ethnicity Caucasian (93%), African American (5%), and Asian 
American (2%). 
Age range Participants ranged in age from 21 to 76 years old (M = 49.5) 
Treatment type within 20 weeks after completing cancer treatment (e.g., chemotherapy, surgery, 
radiotherapy) 
Stage of cancer early-stage (Stage I and II) female breast cancer patients 
EWI description ‘Participants were randomly assigned to one of three conditions and instructed to write 
about their (a) deepest thoughts and feelings regarding their experience with breast 
cancer (Emotional Expression), (b) positive thoughts and feelings regarding their 
experience with breast cancer (Benefit-Finding), or (c) facts regarding their cancer and its 
treatment (Fact-writing Control). For each writing session, participants were instructed to 
write continuously for 20 min. All procedures were IRB-approved. For a detailed 
description of the study, see Stanton et al. (2002).’ 
Follow-up period ‘At 1 and three months after completing the last writing assignment, participants 
completed questionnaires assessing their physical symptoms, cancer-related doctor 
visits, general life satisfaction (as measured by the Satisfaction With Life Scale [SWLS]; 
Diener, Emmons, Larsen, & Griffin, 1985), and mood throughout the past week (as 
measured by the Profile of Mood States [POMS]; McNair et al. 1971).’ 
Measures used ‘Physical health variables. At the final writing session, participants were given a form on 
which to record prospectively any medical visits over the subsequent three months. At 
the 3-month follow-up, these reports were confirmed through medical records for 20% of 
patients (n _ 12), with patients’ consent, demonstrating 92% agreement (23 patient-
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reported appointments/ 25 medical records appointments). At baseline and three months 
after the final writing session, participants also completed a 9-item measure adapted from 
King and Emmons (1990) and Pennebaker (1982) to assess physical symptoms. Heart 
rate was assessed continuously during the four writing sessions. Immediately before and 
after writing each essay, participants completed a measure of state distress using the 
state form of the Profile of Mood States (McNair, Lorr, & Droppelman, 1971). A state 
distress index was created by averaging the Anger, Depression, Tension, Fatigue, and 




‘A series of multiple regression equations were conducted using an analytic approach 
specified by Baron and Kenny (1986).’ 
Findings ‘Within-session heart rate habituation mediated effects of expressive disclosure on 
physical symptoms, and greater use of negative emotion words in essays predicted a 
decline in physical symptoms. Postwriting mood and use of positive emotion and 
cognitive mechanism words in essays were not significant mediators, although greater 
cognitive mechanism word use was related to greater heart rate habituation and negative 





Conclusions ‘Taken together, findings suggest that the positive health outcomes observed in the 
expressive disclosure group may be related to the decreasing autonomic arousal that 
occurs as participants engage in emotional processing of negative memories (Bootzin, 
1997; Jaycox et al. 1998). This prolonged and repeated exposure and concomitant 
processing might contribute to improved regulation of physiological responses, 




‘First, the relatively small sample size limited the power of our analyses to detect 
significant mediators of the effects. A second limitation regards generalizability of results. 
Because our sample was limited to women with early stage breast cancers, the findings 
may not extend to patients with more advanced disease or men, for example. Finally, the 
reliance on participant self-report for assessment of physical health outcomes may have 
compromised validity, and it should be noted that evidence of mediation occurred only for 






‘There is much still to investigate with regard to the role of habituation in expressive writing. 
Because all women were writing about their cancer experience and thus the same general 
stimulus, our data do not allow a conclusion regarding whether stimulus-specific habituation 
or response-specific habituation is more important. Important goals of future research should 
be replication of these findings in a larger sample as well as exploration of alternative 
mediators of the interventions. Further, investigation of additional, more refined biological 
mediators, such as cytokine, endocrine, or parasympathetic nervous system activity, would 
also help to clarify the processes underlying the physical health effects of writing about 
emotional experiences.’ 
 
Title Written Emotional Disclosure Buffers the Effects of Social Constraints on Distress 
Among Cancer Patients 
 
Authors Sandra G. Zakowski, Alona Ramati, and Carla Morton, Peter Johnson & Robert Flanagan 
 
Year 2004 
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Journal Health Psychology 
Country USA 
Aims ‘To examine whether written emotional disclosure would reduce distress among cancer 
patients and whether it would buffer the effects of high levels of social constraint (negative 
social responses to patients’ expressions of emotion regarding their cancer) on distress.’ 
Design RCT. Participants were randomly assigned to one of two experimental conditions, 





‘Patients who had been diagnosed with prostate or gynecological cancer within the past 5 
years were recruited through clinics in the Chicago and Milwaukee metropolitan areas for a 
broader ongoing longitudinal study examining the psychosocial effects of emotional 
disclosure. Treating physicians referred eligible patients to the study.’ 
Sample size ‘The final sample of 104 patients who completed all of the assessments necessary for the 
present analyses had been recruited over the course of 2 years.’ 
Inclusion/exclu
sion criteria 
‘Eligibility requirements included a first-time diagnosis of prostate or gynaecological cancer, 
completion of active cancer treatment, no evidence of psychiatric problems or any current 
life-threatening disease other than cancer, and ability to fluently read and write in English.’ 
Ethnicity 95.2% were Caucasian, 79.8% were married, 51% were employed, and 46.2% had at least a 
college education.  
Age range Patients were between 25 and 84 years of age (M = 59.75, SD = 11.09); 51.9% were female. 
Treatment type 85.6% of patients had undergone surgery to treat their cancer. 
Stage of cancer ‘Types of cancer included prostate carcinoma (48.1%), uterine (18.3%), ovarian 
(13.5%), cervical (11.5), and other (4.9%); 3.8% of the patients had more than one type of 
cancer. Gleason scores, available for 40 of the prostate cancer patients, ranged from 3 to 8; 
the majority of these patients presented at Gleason Stage 6 (44%). Stages were available for 
41 gynaecological cancer patients; these patients ranged from Stage I to Stage IV, with the 
majority presenting at Stage I (43%). Time since cancer diagnosis ranged from 0.14 to 4.96 
years (M _ 1.43, SD _ 1.21).’ 
EWI 
description 
‘On completion of Assessment 1, participants were scheduled for 3 consecutive 
days on which they completed the writing task (“writing days”). In the rare event that a patient 
was unable to schedule 3 consecutive days, 3 days were scheduled as close to each other 
as possible and within the same 1-week period (10 participants completed the writing in 4 
days, and 1 participant did so in 7 days). Instructions based on Pennebaker et al (1990). 
Participants in the emotional disclosure condition were told to write continuously for 20 min 
about their deepest thoughts and feelings regarding their cancer experience. Participants 
assigned to the control condition were asked to describe in detail their daily activities in a 




Baseline and six months. 
Measures used Social Constraints Scale (SCS) 
Brief Symptoms Inventory (BSI) 
Impact of Events Scale (IES)  
Data analysis 
 
‘To examine whether emotional disclosure affected distress and buffered the effects of social 
constraints on distress at follow-up, we conducted a multiple regression analysis in which 
baseline distress (GSI score) was entered in Step 1, social constraints and experimental 
condition were entered in Steps 2 and 3, and their cross product was entered in Step 4.’ 
Findings ‘As compared with participants in the control condition, participants in the disclosure condition 
rated their essays as significantly more personal, as shown by a significant condition main 
effect, F(1, 102) _ 20.25, p _ .001, and a Condition _ Writing Day interaction, F(2, 204) _ 
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3.58, p _ .04. Analyses (t tests) conducted for each writing day revealed significantly higher 
scores in the disclosure condition on all days, with the effects being strongest on  Days 2 and 
3. Similar results were found for the extent to which participants reported revealing their 
emotions in the essay, F(1, 102) _ 28.40, p _ .001, and there was a significant writing day 
main effect, F(2, 204) _ 5.23, p _ .01, suggesting an increase in emotionality across writing 
days. Thus, participant self-reports indicated that our emotional disclosure manipulation was 
successful. There was a significant main effect for baseline GSI score, but main effects for 
experimental condition and social constraints were nonsignificant. As expected, there was a 
significant Social Constraints _ Condition interaction (see Table 3). Regression lines plotted 
according to the criteria of Aiken and West (1991) revealed that participants in the control 
condition who reported high levels of social constraint exhibited the highest levels of distress 
at follow-up, whereas participants in the experimental group exhibited relatively low levels 




‘After each writing session, participants were asked specific questions regarding how 
personal they felt their essays were and the extent to which they felt they had revealed their 
emotions in the essays (Pennebaker, Kiecolt-Glaser, & Glaser, 1988). Each of these 
questions was rated on a 7-point scale.’ 
Moderators ‘Entering avoidance at baseline and follow-up in the first and second steps of the regression 
equation rendered the Social Constraints _ Condition interaction nonsignificant 
(see Table 4). This suggests that changes in avoidance partly accounted for the buffering 






‘The first hypothesis regarding the effects of expressive writing on distress was not 
supported. The nonsignificant main effect of experimental condition on distress suggests that 
written emotional expression was not effective for all cancer patients in this study. These 
findings are comparable to those of recent studies conducted with breast cancer patients that 
reported no significant differences in self-reported distress at follow-up (Stanton & Danoff-
Burg, 2002; Walker et al. 1999). It has, however, been suggested that the benefits of writing 
for cancer patients may reside in more objective measures of health rather than selfreported 
distress (Stanton & Danoff-Burg, 2002), given that many cancer patients are quite well 
adjusted emotionally. The second hypothesis was supported by the results showing 
that written disclosure buffered the effects of social constraints on distress such that patients 
with high levels of constraint at study intake exhibited distress levels comparable to patients 
with low levels of constraint if they were given the opportunity to express their emotions in 
writing. Those at high constraint levels who were not given that opportunity (control condition) 
continued to exhibit heightened levels of distress at follow-up. These findings suggest 
that patients whose social environment precludes successful expression of emotion may be 
able to use other tools of emotional expression, specifically written emotional disclosure, to 
compensate for this deficit.’ 
Identified 
limitations 
‘It is possible that in-person contact was a beneficial element of the intervention the 
contribution of which has not previously been explored. In addition, asking patients to write 
about their cancer experience, a procedure used in both of the previous studies in this area 
conducted with cancer patients, may have been too constraining, and some of the patients 
might have benefited more from writing about other experiences that may have been more 
stressful to them. Although statistically significant, the clinical significance of the changes 
observed in the present study is unclear. Effect sizes were relatively small, and examination 
of patients’ distress scores at baseline and follow-up using a cutoff score of one standard 
deviation above the mean of standard t-score norms revealed no significant Condition _ 
Social Constraints interaction. This suggests that, despite the fact that expressive writing 
buffered the effects of social constraints on distress, it did not alter distress levels from 
clinical to nonclinical categories. However, these results are limited by the fact that only a 
small proportion of patients were within the clinical range at study initiation (n _ 22). This 
does not minimize the importance of our findings. Given that many cancer patients exhibit 
subclinical levels of distress that may have a significant impact on other aspects of their lives, 
finding means of reducing their distress remains an important endeavor in health psychology. 
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As in many previously published emotional disclosure studies (most of which were conducted 
with college students), the participants in this study were relatively well educated (almost half 
had a college degree). However, we did note a range from partial high school education to 
graduate professional training, and our results revealed no significant relations between 
education and any of the major study variables, suggesting that our results may be 
generalizable to individuals at various educational levels. This, however, should be 
addressed more systematically in future research.’ 
Future 
research 
‘Finally, it is conceivable that a third variable accounted for the buffering effect of written 
disclosure. For example, a certain personality style or situational characteristic may be 
responsible for perceptions of social constraints and th e benefits drawn from written 
disclosure. For example, patients who have a greater need for emotional expression or 
greater interpersonal sensitivity may consider any amount of emotional support insufficient 
and may thus perceive heightened social constraints. These same individuals may benefit 
more from writing because it allows a relatively unlimited amount of emotional expression 
within the time limit of the experimental procedure. The SCS is unable to address this issue 
because it focuses on patients’ subjective perceptions. Although this was our measure of 
choice because of the theoretical importance of perceived over objective experiences of 
events (e.g., Lazarus & Folkman, 1984), future studies could examine this alternative 
explanation by supplementing self-report measures of social constraints with reports from 




Title Expressive disclosure and health outcomes in a prostate cancer population 
Authors Rosenberg, H. J., Rosenberg, S. D., Ernstoff, M. S., Wolford, G. L., Amdur, R. J, Elshamy, M. 
R., Buar-Wu, S. M., Ahles, T. A., & Pennebacker, J. L. 
Year 2002 




Aims ‘Explored the feasibility and efficacy of a brief, well-defined psychosocial intervention 
(expressive disclosure) in improving behavioural, medical, immunological and emotional 
health outcomes in men with prostate cancer.’ 
Design ‘Thirty prostate cancer patients receiving outpatient oncology care were randomised into 
experimental (disclosure) and control (non-disclosure) groups.’ 
Sample 
(patient group) 
Thirty prostate cancer patients 
Sample size 30. 16 experimentals and 14 controls 
Inclusion/exclu
sion criteria 
‘Inclusion criteria: over 18 years, histologic diagnosis of adenocarcinoma of the prostate being 
followed with serial PSAs; definitive local treatment (radiation or prostatectomy) within the last 
4 years; routine monitoring of PSA levels prior to study enrolment; able to speak, read, and 
write in English; able to sign an informed consent form.’ 
Ethnicity 29 Caucasians and 1 native american 
Age range Mean age was 70.43 (SD = 5.42). 
Treatment type ‘All had been previously treated by surgery or radiation within the last 4 years and were being 
monitored without further intervention for change in PSA levels.’ 
 
Stage of Not reported. 






‘Writing instructions were as follows: During each of the four writing days, write about your 
experience with prostate cancer and its treatment. You may also write about other traumatic 
and upsetting experiences in your life. You can write on different topics each day or on the 
same topic each of the four days. It is very important that you write continuously for at least 
20 minutes but not for longer than 30 minutes. Don’t worry about grammar, sentence 
structure, form, spelling or any of that. Remember, please write continuously. Even if you 
have to repeat yourself, keep on writing. We’d appreciate it if you would not talk about your 
writing assignments with others until the 4 writing assignments have been completed.’ 
Follow-up 
period 
3 and 6 months 
Measures used N abbreviated version of the questionnaire used in the National Medical Care Utilization and 
Expenditure Survey (assesses multiple forms of health care utilisation and behaviours over a 
specified time period). PSA values were obtained from medical chart review one year pre and 
post intervention. Peripheral blood T-cell proliferation to specified antigens was assessed by 
the cell census proliferation assay method.  
The Brief Pain Inventory (BPI) 
The Medical Outcomes Study – Short Form 
The Functional Assessment of Cancer Therapy Scale – Prostate (FACT) 
The Symptom Checklist 90 – revised 
The Brief Profile of Mood States (Brief POMS) 
Rumination Scale 




‘Multivariate analysis (repeated measures MANOVA) with particular emphasis on group/time 
interactions were used to examine how expressive disclosure impacted the hypothesised 
domains of functioning: physical and psychological symptims; health care utilisation; and 
immunocompetence.’ 
Findings ‘Compared to controls patients in the expressive disclosure condition showed improvements 
in the domains of physical symptoms and health care utilisation, but not in psychological 
variables nor In disease relevant aspects of immnocompetence. PSA specific and tetanux 
toxoid specific T-lymphocyte precursor frequencies were measurwed from peripheral blood 
samples at 3 time points. We did not find an effect of expressive disclosure on PSA- specific 
CD4 and CD8 T cell precursors. Comparing the experimental and control groups on the BPI 
pain severity factor scale, there was a statistically significant difference (F=3.98, df=2.0, 
p=.03) over time. Participants assigned to the disclosure intervention exhibited a trend 
towards a lower frequency of health care contacst (F = 2.65, df = 2.0, p = .09) and lower 





Moderators None measured. 
Conclusions ‘Study results support the feasibility of an expressive disclosure intervention for men with 
prostate cancer. The intervention was well accepted and adherence was high. Results 
provide only limited support for the hypothesis that a written emotional disclosure task can 
positively impact health outcomes in a cancer population. However this pilot study may have 
lacked adequate power to detect possible intervention benefits.’ 
Identified 
limitations 
‘It is possible that positive immunologic response to expressive disclosure is more feasible in 
a physically well sample, and is more difficult to demonstrate in a population where immune 
function may already be stressed or compromised. In addition to beung ill, the prostate cancer 
patients we studied were also considerably older, on average, than most other populations 
who have participated in these disclosure studies. A more comprehensive health evaluation, 
including information on specific prescription medicines, lifetime alcohol and nicotine use, 
would have given us information on important variables known to affect immune function. A 
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larger sample size, beyond the scope of this pilot study, would have provided a more robust 







‘Further studies with larger samples are needed to better assess the interventions impact on 
psychological wellbeing and immunocompetence. Pain is an important quality of life and 
illness management issue for patients with prostate cancer. If our finding that expressive 
disclosure can impact reported level of pain severity is replicated in larger and more diverse 
samples, expressive disclosure might be seen as a worthwhile intervention for this population 
based on the pain outcome alone. Similarly our findings of reduced use of medications and 
reduced health care contacts would be important benefits for both patients and the health 
care system if they were to be replicated.’ 
 
 
Title A Pilot Study of the Effects of Expressive Writing on Psychological and Behavioural 
Adjustment in Patients Enrolled in a Phase II Trial of Vaccine Therapy for Metastatic 
Renal Cell Carcinoma 
Authors De Moor 
Year 2002 




Aims To evaluate the potential health benefits of EW in patients with metastatic renal cell 
carcinoma (RCC) who were participating in a Phase II clinical trial of vaccine therapy. 
Design RCT with EWI and NW groups 
Sample (patient 
group) 
Patients with newly diagnosed Stage IV RCC receiving an experimental tumor vaccine 
prepared from their own tumor specimen. 
Sample size 42 total 
Inclusion/exclu
sion criteria 
Life expectancy greater than 4 months, a Zubrod performance status of 2, no serious 
intercurrent illnesses, and no brain metastases. Prior to enrolment in the Phase II trial, 
patients could not have had any chemotherapy or immunotherapy. 
Ethnicity Not reported. 
Age range Mean 56.4 years, 85.7% male 
Treatment type receiving an experimental tumor vaccine prepared from their own tumor specimen. 
Stage of cancer Stage IV 
EWI description EWI group were instructed to write about their deepest thoughts and feelings about their 
cancer. The instructions included specific writing prompts that varied slightly from one 
session to the nextbut remained essentially the same for each assignment. The NW group 
were instructed to write about a different health behaviour per session. (Diet, physical 
activity, substance use, sleep). 
Follow-up 
period 
4, 6, 8, 20 weeks 
Measures used Impact of Events Scale (IES) 
Perceived Stress Scale (PSS) 
Profile of Mood States (POMS) 
Pittsburgh Sleep Quality Index (PSQI) 






Group comparisons of the psychological and behavioural adjustment measures were 
performed by regressing the follow-up assessments for each adjustment measure on time, 
group assignment, and the respective baseline assessment using mixed-model regression. 
Correlations among observations from the same individual were modelled by selecting the 
best-fitting variance-covariance matrix using the approach  described by Wolfinger (1993). 
Findings No statistically significant differences were found between the groups in the IES total, IES 
subscales, the PSS, the POMS total, or POMS subscales, with the exception of the POMS 
Vigor subscale (ES = 0.82, p = .03). Statistically significant differences were found for four of 
the sleep disturbance measures: the PSQI total score (ES = -.73, p = .04) and three of the 
PSQI subscales scores, Sleep Quality (ES = -.99, p = .01), Sleep Duration (ES = -.87, p = 
.04) and Daytime Dysfunction (ES = 1.03, p = .04), with patients in the EW group reporting 





Conclusions EW is beneficial for sleep but not other psychological variables. 
Identified 
limitations 
Small sample size, especially given the number of variables tested. 
Future research Larger sample sizes needed. 
 
 
Title Randomized, Controlled Trial of Written Emotional Expression and Benefit Finding in 
Breast Cancer Patients 
 
Authors Annette L. Stanton, Sharon Danoff-Burg, Lisa A. Sworowski, Charlotte A. Collins, Ann D. 
Branstetter, Alicia Rodriguez-Hanley, Sarah B. Kirk, and Jennifer L. Austenfeld 
 
Year 2002 




Aims ‘A randomized trial was performed to compare effects of experimentally induced written 
emotional disclosure and benefit finding with a control condition on physical and 
psychological adjustment to breast cancer and to test whether outcomes varied as a function 
of participants’ cancer-related avoidance.’ 
Design ‘assigned randomly to write over four sessions about (1) their deepest thoughts and feelings 
regarding breast cancer (EMO group; n 21), (2) positive thoughts and feelings regard- 
ing their experience with breast cancer (POS group; n 21), or (3) facts of their breast cancer 
experience (CTL group; n 18).  
Sample (patient 
group) 
Early-stage breast cancer patients completing medical treatment  
 
Sample size 60 
Inclusion/exclu
sion criteria 
‘inclusion criteria of having a first diagnosis of stage I or II breast cancer and being within 20 
weeks after completion of medical treatments (ie, surgery, radiotherapy, or 
chemotherapy). Exclusion criteria were diagnosis of recurrent or metastatic disease and 
inability to read or write English. ‘ 
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Ethnicity Most (93%) were white (5% African American; 2% Asian American),  
 
Age range mean age of 49.53 years (SD, 12.16 years; range, 21 to 76 years) 
 
Treatment type ‘Average diagnosis duration was 28.37 weeks (SD, 9.95 weeks; range, 12 to 52 weeks). 
Mastectomy was received by 30%, breast conservation by 62%, and both surgical 
procedures by 8%. Most (75%) had received chemotherapy, 67% had received 
radiotherapy, 17% had undergone reconstructive surgery, and 52% were taking a selective 
estrogen receptor modula- tor (eg, tamoxifen) at the time of the study.’ 
 
Stage of cancer I or II breast cancer 
EWI description “What I would like you to write about for these four sessions are your deepest thoughts and 
feelings about your experience with breast cancer. I realize that women with breast cancer 
experience a full range of emotions, and I want you to focus on any and all of them. In your 
writing, I want you to really let go and explore your very deepest emotions and thoughts. You 
might think about all the various feelings and changes that you experienced before being 
diagnosed, after diagnosis, during treatment, and now. Whatever you choose to write, it is 
critical that you really focus on your deepest thoughts and feelings. Ideally, I would like you to 
focus on feelings, thoughts, or changes that you have not discussed in great detail with 
others. You might also tie your thoughts and feelings about your experiences with cancer to 
other parts of your life, ie, your childhood, people you love, who you are, or 
who you want to be. Again, the most important part of your writing is that you really focus on 
your deepest emotions and thoughts. The only rule we have is that you write continuously for 
the entire time. If you run out of things to say, just repeat what you have already written. 
Don’t worry about grammar, spelling, or sentence structure. Don’t worry about erasing or 
crossing things out. Just write.’’ 
Follow-up 
period 
Baseline, 1 month, three months 




‘Primary statistical procedures were multivariate analyses of covariance (MANCOVA), 
controlling for baseline values, on two conceptually related groups of variables, which are 
physical health-related outcomes (ie, somatic symptoms and medical care use) and 
psychological adjustment (ie, quality of life and positive and negative affect).’ 
Findings ‘Although analyses revealed no signifcant main effects for condition or cancer-related 
avoidance, a significant multivariate effect emerged for the condition avoidance interaction at 
1 month (F[6,88] 5.14;P.0001) and at three months (F[6,92] 2.92; P .0118). In both cases, 
these were accompanied by a significant univariate interaction on POMS distress (F[2,48] 
7.37; P.0016) at 1 month and three months (F[2,50] 4.80; P .0124). At three months, the 
multivariate condition effect on health-related outcomes was significant (F[4,100] 3.18; P 
.0166). Both self-reported physical symptoms and prospectively recorded medical 
appointments for cancer-related morbidities yielded a significant effect of Experimental 
conditions at three months. The EMO group evidenced a significant decrease in physical 
symptoms compared with the CTL group, and the POS group participants’  symptom scores 
fell between the other groups.’ 
Manipulation 
checks 
‘The independent judge’s determination of the experimental condition assignment 
corresponding to each essay was correct for 95% of the 240 individual essays, indicating 
excellent adherence to experimental instructions by participants.’ 
Moderators None. 
Conclusions ‘Findings support the hypothesis that promoting expression of the full range of thoughts and 
feelings in breast cancer patients produces benefit with regard to the primary 
dependent variable of physical health-related outcomes. At three months, women who 
expressed their emotions through writing reported significantly fewer negative physical 
EMOTIONAL EXPRESSION IN CANCER SURVIVORS 
127 
 




‘A first potential limitation includes a primary reliance on participant self report. However, 
questionnaire measures were psychometrically sound and empirically validated. Further, that 
medical appointments for cancer-related morbidities and self reported physical symptoms 
comprised valid indicators of physical health outcomes is supported by: (1) the 
Finding that a subset of self-reported medical appointments corresponded closely with 
medical records, (2) the positive association of the two indicators of health outcomes, and (3) 
their positive relations with psychological distress and poorer quality of life. It also should be 
noted that selfreported physical symptoms (and psychological distress) declined from study 
entry to the 3-month follow-up for all groups, indicating that the intervention effects resulted 
from a greater decline in symptoms in the experimental conditions than in the CTL condition 
rather than from amplification of symptoms in the CTL group. A second limitation regards 
generalizability of the findings. Participants evidenced somewhat more positive psy- 
chological adjustment than other samples, 7,18-20 and generalizability to very distressed or 
less motivated women requires study. Further, applicability of the findings to men, 
individuals with metastasized disease, and cancer patients at other points in the treatment 





‘Clearly, the most appropriate format and timing of interventions to allow women to consider 
positive consequences of what typically is viewed as a stressful or traumatic experience 
require study. Extension of the findings to longer-term psychological adjustment and cancer 




Title Does Emotional Expression Make a Difference in Reactions to Breast Cancer? 
Authors Walker, B, L., Nail, L. M., & Croyle, R. T.  
Year 1999 




Aims ‘To examine the feasibility of using an emotional expression intervention with patients with 
cancer and test the hypothesis that emotional expression improves psychosocial adjustment.’ 
Design Sequentially randomised pretest/post-test design with repeated measures. 
Sample 
(patient group) 
‘Women completing RT for stage I or II breast cancer, who spoke and read English, were 
independent in self care, and provided written consent.’ 
Sample size 44 
Inclusion/exclu
sion criteria 
‘Women who were 18 years or above, had a Karnofsky performance status of 70% or higher, 
were independent in self-care; were oriented to time, place and person; spoke and read 
English; and were completing RT for stage I or II breast cancer. The Karnofsky performance 
cut-off was chosen to avoid burdening patients who had multiple illnesses.’ 
Ethnicity 95% Caucasian 
Age range M = 53.6 years 
Treatment type Radiotherapy 
Stage of 
cancer 
I or II 





‘Participants were assigned sequentially to one of the treatment groups or a usual care 
control group. Usual care, in this setting, consists of preparing clients to begin treatment and 
providing written information and advice on managing specific side effects. The researchers 
used an adaptation of Pennebaker’s intervention that directed participants in each of the 
emotional expression groups to write specifically about their deepest thoughts and feelings 
about their cancer experience. Initially, all participants in the emotional expression groups 
completed the first writing in a quiet room at the clinic immediately following the last day of 
RT, and the researcher collected the writings. Participants who were assigned to write for 30 
minutes on three separate days then completed the second and third writings at home during 
the next two to three days and returned them in a stamped, self-addressed envelope provided 
by the researchers.’ 
Follow-up 
period 
1, 4-6, 16 and 28 weeks 
Measures used Impact of Events Scale 
Positive and Negative Affect Scale 




‘Separate repeated measures analysis of covariance were computed for each of the four 
outcomes. Trait negative affectivity and side effect severity were used as covariates, and 
group assignment was the between-groups factor in all of the analyses. A Bonferroni 
correction was applied to correct for the multiple statistical tests, setting the alpha at 0.0125 
for main effects and interactions. No main effect of group or group-by-time interaction existed. 
‘ 
Findings ‘No main effect of group or group-by-time interaction existed. Although analysis of covariance, 
using trait negative affectivity and side effect severity as covariates, indicated no effect from 
the intervention on any of the psychosocial adjustment measures, content analysis of the 
written essays revealed themes consistent with Pennebaker’s framework, such as end-of-
treatment concerns, inhibition, and integration. Some women reported that the writing 
provided them a forum for expressing emotions they felt might be burdensome for family 
members or other confidants. Others indicated that the writing helped them to identify 
priorities or focus their concerns more specifically. Several of the women commented on the 
writing task itself, indicating that it was helpful or expressing surprise at the issues that came 





Conclusions ‘The results of this pilot study demonstrate the feasibility of the emotional expression 
intervention. Although the emotional expression group experienced no benefit on measures of 
adjustment, comments on the value of writing as a way to help integrate the breast cancer 
experience and it identify future priorities expressed in both the written essays and at the 




‘Generalizability of results is limited by the small sample and corresponding low statistical 







‘Although many of the women expressed their belief that the writing exercise was helpful, a 
more extensive test of the emotional expression intervention is needed. The possibility of a 
subgroup of patients who benefit from writing should also be explored. Instruments for writing 
may need to be more targeted at encouraging subjects to respond to their previous writing 
and focus on integration tasks.’ 
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Methodological quality according to  
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Reporting analysis using the Downs and Black tool for assessing methodological quality  
 
Author 1 2 3 4 5 6 7 8 9 10 
 
Arden-Close et al. 
(2013) 
1 1 1 1 1 1 1 UTD 1 1 
Craft et al. (2013) 1 1 1 1 1 1 0 UTD 1 1 
Jensen-Johansen et 
al. (2012) 
1 1 1 1 1 1 0 UTD 0 0 
Mosher et al. (2012) 1 1 1 1 1 1 1 UTD 0 1 
Zakowski et al. (2011) 1 1 1 0 1 1 1 UTD 1 0 
Gellaitry et al. (2010) 1 1 1 1 1 1 1 UTD 1 0 
Low et al. (2010) 1 1 1 1 1 1 1 UTD 1 1 
Cepeda et al. (2008) 1 1 1 1 1 1 0 UTD 1 1 
De Moor et al. (2008) 1 1 1 1 1 1 1 UTD 1 1 
Bruera et al. (2008) 1 1 1 1 1 1 1 UTD 0 0 
Creswell et al. (2007) 1 1 1 1 1 1 1 UTD 0 1 
Low et al. (2006) 1 1 1 1 1 1 1 UTD 1 0 
Zakowski et al. (2004) 1 1 1 1 1 1 1 UTD 0 0 
Rosenburg et al. 
(2002) 
1 1 1 1 1 1 0 UTD 1 1 
De Moor et al. (2002) 1 1 1 0 1 1 1 UTD 0 1 
Stanton et al. (2002) 1 1 1 1 1 1 1 UTD 1 1 
Walker, Nail & Croyle 
(1999) 
1 1 1 1 1 1 1 UTD 1 1 
1. Is the hypothesis/aim/objective of the study clearly described?                                                                                     
2. Are the main outcomes to be measured clearly described in the Introduction or Methods section?                                    
3. Are the characteristics of the patients included in the study clearly described?                                                
4. Are the interventions of interest clearly described?                                                                                                              
5. Are the distributions of principal confounders in each group of subjects to be compared clearly described? 
6. Are the main findings of the study clearly described? 
7. Does the study provide estimates of the random variability in the data for the main outcomes? 
8. Have all important adverse events that may be a consequence of the intervention been reported? 
9. Have the characteristics of patients lost to follow-up been described? 
10. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the main outcomes except where the probability value 
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External validity and power analysis using the Downs and Black tool for assessing 
methodological quality  
 
 
Author 11 12 13 14 
 
Arden-Close et al (2013) 1 1 1 1 
Craft et al (2013) 1 1 1 1 
Jensen-Johansen et al (2012) 1 1 1 1 
Mosher et al (2012) 1 1 1 1 
Zakowski et al (2011) 1 1 1 1 
Gellaitry et al (2010) 1 1 1 0 
Low et al (2010) 1 1 1 1 
Cepeda et al (2008) 1 1 1 1 
De Moor et al (2008) 1 1 1 0 
Bruera et al (2008) 1 1 1 0 
Creswell et al (2007) 1 1 1 1 
Low et al (2006) 1 1 1 1 
Zakowski et al (2004) 1 1 1 0 
Rosenburg et al (2002) 1 1 1 0 
De Moor et al (2002) 1 1 1 0 
Stanton et al (2002) 1 1 1 1 
Walker, Nail & Croyle (1999) 1 1 1 0  
11. Were the subjects asked to participate in the study representative of the entire population from which they were recruited? 
12. Were those subjects who were prepared to participate representative of the entire population from which they were recruited? 
13. Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? 
14. Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to 
chance is less than 5%? 
 
 
Internal validity (bias) using the Downs and Black tool for assessing methodological quality 
 
Author 15 16 17 18 
 
19 20 21 
Arden-Close et al (2013) 1 1 1 1 1 1 1 
Craft et al (2013) 1 UTD 1 1 1 0 1 
Jensen-Johansen et al (2012) UTD UTD 1 1 1 1 1 
Mosher et al (2012) 1 UTD 1 1 1 1 1 
Zakowski et al (2011) 1 UTD 1 1 1 1 1 
Low et al (2010) 1 1 1 UTD 1 0 1 
Cepeda et al (2008) 1 1 1 1 1 1 1 
De Moor et al (2008) UTD UTD 1 1 1 0 1 
Bruera et al (2008) UTD UTD 1 1 1 0 1 
Creswell et al (2007) UTD 1 1 1 1 1 1 
Gellaitry et al (2010) UTD UTD 1 1 1 1 1 
Low et al (2006) 1 UTD 1 1 1 1 1 
Zakowski et al (2004) UTD UTD 1 1 1 1 1 
Rosenburg et al (2002) UTD UTD 1 1 1 1 1 
De Moor et al (2002) UTD UTD 1 1 1 1 1 
Stanton et al (2002) 1 1 1 1 1 1 1 
Walker, Nail & Croyle (1999) 0 1 1 0 1 1 1 
15. Was an attempt made to blind study subjects to the intervention they have received? 
16. Was an attempt made to blind those measuring the main outcomes of the intervention? 
17. If any of the results of the study were based on “data dredging”, was this made clear? 
18. Do the analyses adjust for different lengths of follow-up of patients? 
19. Were the statistical tests used to assess the main outcomes appropriate? 
20. Was compliance with the intervention/s reliable? 
21. Were the main outcome measures used accurate (valid and reliable)? 
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Internal validity (confounding) using the Downs and Black tool for assessing methodological 
quality 
 
Author 22 23 24 25 
 
26 27 Total 
score 
Arden-Close et al (2013) 1 1 1 1 1 1 26 
Craft et al (2013) 1 1 1 UTD 0 1 21 
Jensen-Johansen et al (2012) 1 1 1 UTD 1 1 20 
Mosher et al (2012) 1 1 1 UTD 1 1 23 
Zakowski et al (2011) 1 1 1 UTD 0 1 21 
Gellaitry et al (2010) 1 1 1 UTD 1 1 21 
Low et al (2010) 1 1 1 1 1 1 24 
Cepeda et al (2008) 1 1 1 1 1 1 25 
De Moor et al (2008) 1 1 1 UTD 1 1 21 
Bruera et al (2008) 1 1 1 UTD 0 1 18 
Creswell et al (2007) 1 1 1 UTD 1 1 23 
Low et al (2006) 1 1 1 UTD 1 1 23 
Zakowski et al (2004) 1 1 1 UTD 1 1 20 
Rosenburg et al (2002) 1 1 1 UTD 0 1 20 
De Moor et al (2002) 1 1 1 UTD 1 1 20 
Stanton et al (2002) 1 1 1 1 1 1 26 
Walker, Nail & Croyle (1999) 1 UTD 1 1 0 1 21 
22. Were the patients in different intervention groups recruited from the same population? 
23. Were study subjects in different intervention groups recruited over the same period of time? 
24. Were study subjects randomised to intervention groups? 
25. Was the randomised intervention assignment concealed from both patients and health care staff until recruitment was complete and 
irrevocable? 
26. Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? 






















































Risk of bias with supporting  
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Support for judgement 
Random sequence 
allocation (selection bias) 
- Quote: ‘Randomisation was conducted before study 
commencement, in blocks of 10, using 
www.randomization.com, matching for recurrence since 
initial diagnosis, to increase the probability of obtaining 
equivalent groups regarding prognosis.’ 
Allocation concealment 
(selection bias) 
- Quote: ‘Opaque envelopes were numbered, and the 
appropriate condition was written inside each envelope 
according to the randomisation table, which was then 
destroyed. The envelopes were locked in a cabinet and 
inaccessible to anyone involved in the project. An 
independent administrator opened the cabinet and the 
appropriate envelope and informed the first author of 
group assignment, after which the appropriate task was 
posted out.’ 
Blinding of participants and 
researchers (performance 
bias) 
- Quote: ‘As a single researcher carried out this study, 
double blinding was not possible. Participants were 
informed that writing had improved health across a variety 
of illnesses, and they would be asked to write about 
events in either an emotional or a non-emotional way, to 
ensure expectations did not differ by group.’ 
Blinding of outcome 
assessment (detection bias) 
- Quote: ‘To reduce risk of measurement bias, 
questionnaires were returned to a researcher who had no 
contact with the participants and was unaware of group 
allocation.’ 
Incomplete outcome data 
(attrition bias) 
- Quote: ‘Analyses controlled for baseline demographic and 
illness differences between groups and were intention-to-
treat, by carrying the last observation forward.’ 
Selective reporting - All prespecified outcomes were reported. 
 




Support for judgement 
Random sequence 
allocation (selection bias) 
U States participants were ‘sequentially randomised’ but 
no further information given. 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Participants instructions did not mention allocation or 
expected benefits. Researcher blinding not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Quote: ‘A decision to report the findings of the sample of 
97, rather than the 70 who completed all three testings, 
was based on the fact that the ITT analysis revealed 
essentially the same results.’ 
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Support for judgement 
Random sequence 
allocation (selection bias) 
- Quote: ‘Computerized random assignment to the 
expressive writing or neutral writing group then occurred 
using the method of random permuted block.’ 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
U No mention of intention-to-treat analysis. 
Selective reporting - All prespecified outcomes were reported. 
 
 




Support for judgement 
Random sequence 
allocation (selection bias) 
- Quote: ‘The randomization was conducted independently 
by the 
Research Unit for Clinical Cancer Research, Aarhus 
University Hospital, using a stratified sampling method 
with four mutually exclusive strata reflecting the four 
standard adjuvant cancer treatment protocols 
(chemotherapy, radiotherapy, both, or none), and was 
concealed until intervention assignment.’ 
Allocation concealment 
(selection bias) 
- As above. 
Blinding of participants and 
researchers (performance 
bias) 
- Quote: ‘The trial hypotheses were masked by officially 
naming the 
project the ‘Stress-Management & Quality-of-Life Brief 
Writing Exercise Program’. Furthermore, participants were 
told that they were randomized to one of several groups 
and that the writing tasks of the other participants would 
not be revealed.’ 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Losses to follow up were disclosed and no differences 
were found between completers and non-completers, 
however intention to treat analysis was not conducted. 
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Support for judgement 
Random sequence 
allocation (selection bias) 




U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Participants blinding not reported. Quote: ‘Because the 
experimenters also administered the writing instructions 
they were not blind to condition, however, given that 
contact was minimal at follow-up assessments (except for 
mailing the questionnaires and placing a reminder phone 
call) we consider the possibility of experimenter bias to be 
minimal.’ 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Describes characteristics of noncompleters, and found 
those 
who discontinued the study were more likely to have other 
chronic illnesses, p < .05. An intention-to-treat analysis 
was not used. 
 
Selective reporting - All prespecified outcomes were reported. 
 




Support for judgement 
Random sequence 
allocation (selection bias) 
- Quote: ‘Participants were aware that they would be 
randomised, using computer-generated random number 
tables, to either a writing or 
non-writing group on return of baseline questionnaires.’ 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Quote: ‘Participants who completed the study did not 
significantly differ from those who did not on age, clinical 
or psychological measures taken at baseline.’ 
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Support for judgement 
Random sequence 
allocation (selection bias) 
- Quote: ‘The randomization schedule was created by a 




- Quote: ‘Sequentially numbered envelopes were used to 
conceal allocation.’ 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Describes characteristics of noncompleters, and found no 
differences between completers and noncompleters. An 
intention-to-treat analysis was not used. 
 
Selective reporting - All prespecified outcomes were reported. 
 
 




Support for judgement 
Random sequence 
allocation (selection bias) 
- Quote: ‘For the randomization, we used a computer- 





- Quote: ‘We concealed the randomization schedule using 
serially numbered, sealed, opaque envelopes.’ 
Blinding of participants and 
researchers (performance 
bias) 
- Participants blinding not reported. Quote: ‘A second 
research nurse who was unaware of patients’ group 
assignments then collected information for the study. 
Weekly follow-up phone calls were made by research 
personnel unaware of patient allocation.’ 
Blinding of outcome 
assessment (detection bias) 
- Quote: ‘A second research nurse who was unaware of 
patients’ group assignments then collected information for 
the study. Weekly follow-up phone calls were made by 
research personnel unaware of patient allocation.’ 
Incomplete outcome data 
(attrition bias) 
- Intention-to-treat analysis was used. 
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Support for judgement 
Random sequence allocation 
(selection bias) 
- ‘Patients were then assigned to the EW or neutral writing 
(NW) group using adaptive randomisation to achieve 




U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- 62% completion rate. No differences between completers 
and noncompleters in demographic or clinical 
characteristics. 
Selective reporting - All prespecified outcomes were reported. 
 




Support for judgement 
Random sequence allocation 
(selection bias) 
U Simply states they were randomly assigned. 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
+ Only 8% completion rate. 
Selective reporting  All prespecified outcomes were reported. 
 




Support for judgement 
Random sequence allocation 
(selection bias) 
U Simply states that they were randomised. 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Blinding of participants not reported.  
Blinding of outcome 
assessment (detection bias) 
- Quote: ‘The 240 essays (60 participants × 4 essays) were 
content analyzed by trained coders who were blind to the 
study hypotheses and the participants’ writing condition.’ 
Incomplete outcome data 
(attrition bias) 
U States that 3 people dropped out and why, but does not 
describe characteristics of noncompleters. Analysis did 
not include noncompleters. 
Selective reporting - All prespecified outcomes were reported. 
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Support for judgement 
Random sequence allocation 
(selection bias) 
U Simply states that they were randomised. 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
- Participants were blinded. Quote: ‘They were informed 
by research staff or medical personnel that the purpose 
of the study was “to learn more about how women adjust 
to having breast cancer” and were told that they would 
be asked to write about their experiences with breast 
cancer.’ Researchers who gave writing instructions were 
blind to hypotheses. 
Blinding of outcome 
assessment (detection bias) 
U Not reported.  
Incomplete outcome data 
(attrition bias) 
- All participants who completed the baseline assessment 
completed the study. 
Selective reporting - All prespecified outcomes were reported. 
 




Support for judgement 
Random sequence allocation 
(selection bias) 
U Simply says that participants were randomised. 
Allocation concealment 
(selection bias) 
U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Blinding of participants not reported. Quote: ‘Because 
experimenters also administered the writing instructions, 
they were aware of condition assignments; however, 
given that contact was minimal at the follow-up 
assessments (except for mailing of the questionnaires 
and placing of a reminder phone call), we consider the 
possibility of experimenter bias to be minimal.’ 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Losses to follow up were disclosed and no differences 
were found between completers and non-completers, 
however intention to treat analysis was not conducted. 
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Support for judgement 
Random sequence allocation 
(selection bias) 




U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Researchers blind to condition prior to baseline 
assessment. Participant blinding not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- All participants who completed the baseline assessment 
completed the study. 
Selective reporting - All prespecified outcomes were reported. 
 




Support for judgement 
Random sequence allocation 
(selection bias) 
- Quote: ‘Participants were randomised using 
minimisation, a form of adaptive randomisation that 
results in better group balance than stratification. Patient 
characteristics used for assignment in this study were 




U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Losses to follow up were disclosed, however differences 
between completers and noncompleters were not 
explored, and intention-to-treat analysis was not used. 
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Support for judgement 
Random sequence allocation 
(selection bias) 
- Quote: ‘The randomization schedule was created by the 




- Quote: ‘Sequentially numbered envelopes were used to 
conceal allocation’ 
Blinding of participants and 
researchers (performance 
bias) 
- Quote: ‘The study coordinator did not have access to the 
randomization schedule, which was kept in a separate 
office throughout the study. The informed consent form 
included no mention of expected benefits from the 
writing conditions.’ 
Blinding of outcome 
assessment (detection bias) 
- Quote: ‘The study coordinator did not have access to the 
randomization schedule, which was kept in a separate 
office throughout the study.’ 
Incomplete outcome data 
(attrition bias) 
- Quote: ‘In addition to the 60 participants that composed 
the sample for analyses, 14 women were recruited for 
the study but did not complete it for reasons as follows 
(Table 1): two women declined on study recruitment, 
four consented to the study but did not complete the 
baseline questionnaire, five completed the baseline 
questionnaire but then terminated participation before 
randomization, two were diagnosed with cancer 
recurrence and terminated participation after completing 
the baseline questionnaire but before attending the 
writing 
sessions (thus, they were not aware of condition 
assignment), and one 
declined further participation after completing one 
control condition writing session. Thus, 81% of the 
women introduced to the research completed it, and only 
one who terminated participation was aware of her 
condition assignment.’ 
Selective reporting - All data reported 
 
 




Support for judgement 
Random sequence allocation 
(selection bias) 




U Not reported. 
Blinding of participants and 
researchers (performance 
bias) 
U Not reported. 
Blinding of outcome 
assessment (detection bias) 
U Not reported. 
Incomplete outcome data 
(attrition bias) 
- Losses to follow up were disclosed, however differences 
between completers and noncompleters were not 
explored, and intention-to-treat analysis was not used. 
Selective reporting - All data reported. 
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Participant Information Sheet 
 
Resilience, Emotional Expression and Illness Beliefs in 
Cancer Survivors 
 
Information about the research 
We would like to invite you to take part in a research study. Before you decide, you need to 
understand why the research is being done and what it would involve for you. 
Please take time to read the following information carefully. Talk to others about the study if 
you wish.  
The study explores the way in which the thoughts and feelings that you have impact on the 
way you cope and adapt following illness.  
Ask us if there is anything that’s not clear, or if you would like more information before 
deciding. Take time to decide whether or not you wish to take part.  
What is the purpose of the study? 
The concept of resilience can be helpful in providing some explanation of how individuals 
“bounce back” in the face of adversity. There appears to be a ‘knowledge gap’ in the 
research around the relationship between resilience, emotional expression and illness 
beliefs. We are interested in finding out why some cancer survivors are more vulnerable to 
distress than others. 
We hope that this study will help us produce useful information for people in the future so 
that we can help identify cancer survivors that may be more vulnerable to anxiety and 
depression. Furthermore, this research may help develop interventions that may improve 
cancer patients’ resilience through considering their attitude towards emotional expression 
and perceptions about their illness. 
Why have I been invited?  
You’re being asked to take part in this study because you have had a diagnosis of cancer 
in the past. We are sending a questionnaire to people to find out about their views on their 
resilience, emotional expression, illness beliefs, psychological wellbeing and quality of life. 
We have used the cancer centre’s patient database in order to identify those who have 
completed cancer treatment in the last eight months. These individuals have been invited to 
take part. Although we do our very best to ensure that our records are correct and up to 
date, on occasion there may be an error in our system. If you think that you have been 
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contacted by mistake, please accept our sincere apologies and feel free to contact us 
regarding this. We understand and appreciate that this could be a difficult time for you. We 
apologise if you have been sent this questionnaire at an inappropriate time. 
What happens if I take part? 
If you decide to take part we would like you to complete the questionnaire provided. It will 
take around 50 minutes to complete the questionnaire, however it could take up to 90 
minutes if you take your time and take a break. You are only required to complete the 
questionnaire once. 
We may wish to access your medical records to gain further information regarding your 
diagnosis and treatment for cancer. All information accessed will be treated confidentially 
and anonymised.  
Do I have to take part? 
It’s entirely up to you whether to take part or not. If you wish to complete the questionnaire 
we would be grateful if you could then return it in the FREEPOST envelope provided. If you 
do not wish to take part in the study please return the uncompleted questionnaire in the 
FREEPOST envelope provided. 
What are the possible disadvantages and risks of taking part? 
This study doesn’t involve any treatment or tests, so there is no physical risk involved.  
Some people may find it distressing being asked about their cancer experience. 
What are the possible benefits of taking part? 
You’ll have the satisfaction of knowing that others may be helped by this research in the 
future, but there are no direct benefits to you personally.  
If you do decide to take part then we will donate £1 to Macmillan Cancer Support on your 
behalf. 
What happens when the research study stops? 
When all the questionnaires have been returned, a report will be prepared and the findings 
will be published in medical journals and at conferences.  It will be several months before 
this happens.  Once published, a summary of the report will be available to all participants 
who would like one, and will be published on the University of Birmingham’s website.  All 
reports and publications will use the information collected in a way that makes sure that you 
cannot be identified. 
What if there’s a problem? 
It is possible that you may find the completion of the questionnaire distressing. If this is the 
case, and you realise that you are experiencing more distress than you were initially aware 
of, please feel free to contact the Cancer Psychology Service on 0121 3713617. If you find 
that you are upset, and it is during out of hours, you could contact a charity such as the 
Samaritans on 08457 909090. 
If you have any complaint about the way you are dealt with during the study, please contact 
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What will happen if I don’t want to carry on with the study? 
You can decide to leave the study at any time. This will have no effect on your care. 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all the information about you will be 
handled in confidence. No-one except the researchers will be able to identify you. 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people called a Research 
Ethics Committee, to protect your safety, rights, well-being and dignity. This study has been 
reviewed and given a favourable opinion by Solihull Research Ethics Committee. 
How can I find out more? 
 




























































































This questionnaire is divided into a number of sections with questions examining your beliefs 
about cancer, your attitudes towards your health and expressing emotions, your resilience and 
well-being. 
 
Example questions  
Please read each section carefully for section specific instructions.  Examples of common 
formats are below: 
Example 1 
 
Questions in this table format require you to circle the number that represents how you feel 
about each particular statement.  So if you felt that you disagreed with this question you would 
circle number 2. 
Example 2 

















Responses to this question require you to circle the number that represents your overall 
health over the last week. For example if you feel that your health has been very poor over the 
last week you would circle 1, 2, or 3; if you fell that your health has been good or excellent over 
the last week you would circle 5, 6 or 7. The specific number you select depends on how you 
rate your health.  
 
PLEASE TRY TO ANSWER ALL OF THE QUESTIONS 
 
 
Please state date completed questionnaire _ _ / _ _ / _ _ 
 
Views about cancer  
Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
1 My treatment will be effective in 
curing my cancer 
1  3 4 5 
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SECTION 1. Views about cancer – There are no “right” or “wrong” answers to the questions 
below, we are interested in your own views about cancer rather than what others have 
suggested to you  
 
Views about cancer  
Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
1. From my experience cancer is a 
serious condition 
1 2 3 4 5 
2. From my experience cancer has 
major consequences on life 
1 2 3 4 5 
3. Cancer makes me feel afraid  1 2 3 4 5 
4. From my experience even if you have 
no more symptoms after treatment, 
cancer never really goes away   
1 2 3 4 5 
5. From my experience there is nothing 
which can help cancer 
1 2 3 4 5 
6. I have a clear understanding about 
the cancer I experienced 
1 2 3 4 5 
7. From my experience there is a lot 
which can be done to control 
symptoms 
1 2 3 4 5 
8. From my experience cancer does not 
have much effect on life 
1 2 3 4 5 
9. From my experience cancer strongly 
affects the way some people see you 
1 2 3 4 5 
10. From my experience cancer has 
serious financial consequences 
1 2 3 4 5 
11. From my experience cancer causes 
difficulties for those who are close to 
you 
1 2 3 4 5 
12. I don’t understand the cancer I’ve 
experienced 
1 2 3 4 5 
13. From my experience you get 
depressed when you think about 
cancer 
1 2 3 4 5 
14. From my experience the course of the 
cancer depends on the individual  
1 2 3 4 5 
15. From my experience nothing a person 
does will affect cancer  
1 2 3 4 5 
16. The cancer I’ve experienced is a 
mystery    
1 2 3 4 5 
17. From my experience a person’s 
actions will have little affect on the 
outcome of cancer 
1 2 3 4 5 
18. From my experience cancer will 
improve in time 
1 2 3 4 5 
19. From my experience cancer is very 
unpredictable 
1 2 3 4 5 





SECTION 2. Possible causes of my cancer 
There are no “right” or “wrong” answers to the questions below, we are interested in your own 
views about what could have contributed to causing your cancer rather than what others have 
suggested to you (including doctors and family) 
20. From my experience treatment is 
effective in curing cancer 
1 2 3 4 5 
21. From my experience the negative 
effects of cancer can be prevented 
(avoided) by treatment   
1 2 3 4 5 
22. From my experience treatment can 
control cancer 
1 2 3 4 5 
23. From my experience a person could 
expect to have cancer for the rest of 
their life 
1 2 3 4 5 
24. The cancer I’ve experienced does not 
worry me  
1 2 3 4 5 
25. The cancer I’ve experienced doesn’t 
make any sense to me 
1 2 3 4 5 
26. Cancer is likely to be permanent 
rather than temporary 
1 2 3 4 5 
27. From my experience what a person 
does can determine whether cancer 
gets better or worse 
1 2 3 4 5 
28. From my experience you have the 
power to influence cancer 
1 2 3 4 5 
29. From my experience when I think 
about cancer I get upset 
1 2 3 4 5 
30. From my experience cancer makes 
you feel angry  
1 2 3 4 5 
31. From my experience treatment for 
cancer will remove the disease 
forever 
1 2 3 4 5 
32. From my experience cancer makes 
me feel anxious 
1 2 3 4 5 
33. From my experience there is very 
little that can be done to improve 
cancer 
1 2 3 4 5 
34. Even if cancer is treated it will always 
come back 
1 2 3 4 5 
35. From my experience the symptoms of 
cancer are puzzling  
1 2 3 4 5 
 
Contributing causes  
No Yes 
1. My cancer was caused by stress or worry 0 1 




Please list in rank-order the three most important factors that you now believe caused your 
cancer. You may use any of the items from the box above or you may have additional ideas of 
your own.  
 
1. ……………..  
 




2. My cancer is hereditary – it runs in my family 0 1 
3. My cancer was caused by a germ or virus 0 1 
4. My cancer was caused by diet or eating habits 0 1 
5. My cancer was due to chance or bad luck 0 1 
6. My cancer was caused by poor medical care in the past 0 1 
7. My cancer was caused by pollution in the environment 0 1 
8. My cancer was caused by my mental attitude e.g. Thinking about life negatively 0 1 
9. Family problems or worries caused my cancer 0 1 
10. My cancer was caused by overworking 0 1 
11. My cancer was caused by my emotional state e.g. feeling down, lonely, anxious, 
empty 
0 1 
12. My cancer was caused my ageing  0 1 
13. My cancer was caused by alcohol 0 1 
14. My cancer was caused by smoking 0 1 
15. My cancer was caused by my personality  0 1 
16. My cancer was caused by altered immunity  0 1 
17. My cancer was caused by pressure at work  0 1 
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SECTION 3. Concern about cancer in the future   
In thinking about the past week, please indicate how much you agree or disagree with each 










1. Because cancer is 
unpredictable, I feel I cannot 
plan for the future 
1 2 3 4 5 
2. I will probably have a relapse 
in the next 5 years  
1 2 3 4 5 
3. My fear of having my cancer 
coming back gets in the way 
of my enjoying life 
1 2 3 4 5 
4. I am afraid of my cancer 
coming back  
1 2 3 4 5 
5. I am certain that I have been 
cured of cancer  
1 2 3 4 5 
SECTION 4.  Your health   
Please answer all of the questions.  There are no “right” or “wrong” answers. 
 Not at 
all 




1. Do you have any trouble doing strenuous activities, like 
carrying a heavy shopping bag or a suitcase? 
1 2 3 4 
2. Do you have any trouble taking a long walk? 1 2 3 4 
3. Do you have any trouble taking a short walk outside of the 
house? 
1 2 3 4 
4. Do you need to stay in bed or a chair during the day? 1 2 3 4 
5. Do you need help with eating, dressing, washing yourself or 
using the toilet? 
1 2 3 4 
During the past week:     
6. Were you limited in doing either your work or other daily 
activities? 
1 2 3 4 
7. Were you limited in pursuing your hobbies or other leisure 
time activities? 
1 2 3 4 
8. Were you short of breath? 1 2 3 4 





For the following questions please circle the number between 1 and 7 that best applies to you  
 
1. How would you rate your overall health during the last week? 
9. Have you had pain? 1 2 3 4 
10. Did you need to rest? 1 2 3 4 
11. Have you lacked appetite? 1 2 3 4 
12. Have you felt nauseated? 1 2 3 4 
13. Have you vomited? 1 2 3 4 
14. Have you been constipated? 1 2 3 4 
15. Have you had diarrhoea? 1 2 3 4 
16. Have you had trouble sleeping? 1 2 3 4 
17. Have you felt weak? 1 2 3 4 
18. Were you tired? 1 2 3 4 
19. Did pain interfere with your daily activities? 1 2 3 4 
20. Have you had difficulty in concentrating on things, like 
reading a newspaper or watching television? 
1 2 3 4 
21. Did you feel tense? 1 2 3 4 
22. Did you worry? 1 2 3 4 
23. Did you feel irritable? 1 2 3 4 
24. Did you feel depressed? 1 2 3 4 
25. Have you had difficulty remembering things? 1 2 3 4 
26. Has your physical condition or medical treatment interfered 
with your family life? 
1 2 3 4 
27. Has your physical condition or medical treatment interfered 
with your social activities 
1 2 3 4 
28. Has your physical condition or medical treatment caused 
you financial difficulties  
1 2 3 4 



































SECTION 5. Emotional expression 
This section contains questions asking about how you express emotions.  
Please read each of the following statements carefully and indicate how much you agree or 










1. I think getting emotional is a sign 
of weakness. 
1 2 3 4 5 
2. Turning to someone else for advice 
or help is an admission of weakness. 
1 2 3 4 5 
3. It is shameful for a person to 
display his or her weaknesses. 
1 2 3 4 5 
4. People will reject you if they know 
your weaknesses. 
1 2 3 4 5 
5. If a person asks for help it is a sign 
of weakness. 
1 2 3 4 5 
6. When I am upset I bottle up my 
feelings. 
1 2 3 4 5 
7. When I am upset I usually try to 
hide how I feel. 
1 2 3 4 5 
8. I seldom show how I feel about 
things. 
1 2 3 4 5 
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9. When I get upset I usually show 
how I feel. 
1 2 3 4 5 
10. I do not feel comfortable showing 
my emotions. 
1 2 3 4 5 
11. I think you should always keep 
your feelings under control. 
1 2 3 4 5 
12. I think you ought not to burden 
other people with your problems. 
1 2 3 4 5 
13. You should always keep your 
feelings to yourself. 
1 2 3 4 5 
14. You should always hide your 
feelings. 
1 2 3 4 5 
15. I should always have complete 
control over my feelings. 
1 2 3 4 5 
16. I think other people do not 
understand your feelings. 
1 2 3 4 5 
17. Other people will reject you if you 
upset them. 
1 2 3 4 5 
18. My bad feelings will harm other 
people if I express them. 
1 2 3 4 5 
19. If I express my feelings I am 
vulnerable to attack. 
1 2 3 4 5 
20. If other people know what you 
are really like, they will think less of 
you. 
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SECTION 6. Resilience 
Please indicate how much you agree with the following statements as they apply to you over 
the last month. If a particular situation has not occurred recently, answer according to how you 
think you would have felt. 
 











1. I am able to adapt when changes 
occur.  
0 1 2 3 4 
2. I have at least one close and 
secure relationship that helps me 
when I am stressed 
0 1 2 3 4 
3. When there are no clear 
solutions to my problems, 
sometimes fate or God can help. 
0 1 2 3 4 
4. I can deal with whatever comes 
my way. 
0 1 2 3 4 
5. Past successes give me 
confidence in dealing with new 
challenges and difficulties. 
0 1 2 3 4 
6. I try to see the humorous side of 
things when I am faced with 
problems. 
0 1 2 3 4 
7. Having to cope with stress can 
make me stronger. 
0 1 2 3 4 
8. I tend to bounce back after 
illness, injury, or other hardships. 
0 1 2 3 4 
9. Good or bad, I believe that most 
things happen for a reason. 
0 1 2 3 4 
10. I give my best effort no matter 
what the outcome may be. 
0 1 2 3 4 
11. I believe I can achieve my goals, 
even if there are obstacles. 
0 1 2 3 4 
12. Even when things look 0 1 2 3 4 
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hopeless, I don’t give up. 
13. During times of stress/crisis, I 
know where to turn for help. 
0 1 2 3 4 
14. Under pressure, I stay focused 
and think clearly. 
0 1 2 3 4 
15. I prefer to take the lead in 
solving problems rather than 
letting others make all the 
decisions. 
0 1 2 3 4 
16. I am not easily discouraged by 
failure. 
0 1 2 3 4 
17. I think of myself as a strong 
person when dealing with life’s 
challenges and difficulties. 
0 1 2 3 4 
18. I can make unpopular or 
difficult decisions that affect other 
people, if it is necessary. 
0 1 2 3 4 
19. I am able to handle unpleasant 
or painful feelings like sadness, 
fear, and anger. 
0 1 2 3 4 
20. In dealing with life’s problems, 
sometimes you have to act on a 
hunch without knowing why. 
0 1 2 3 4 
21. I have a strong sense of 
purpose in life. 
0 1 2 3 4 
22. I feel in control of my life. 0 1 2 3 4 
23. I like challenges. 0 1 2 3 4 
24. I work to attain my goals no 
matter what roadblocks I 
encounter along the way. 
0 1 2 3 4 
25. I take pride in my 
achievements. 
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SECTION 7.  
In the last 7 days, how distressed have you been by the following symptoms? 
 
In the last 7 days, how 
distressed have you been by 














1. Headaches  0 1 2 3 4 
2. Nervousness or shakiness 
inside 
0 1 2 3 4 
3. Repeated unpleasant 
thoughts that won't leave your 
mind   
0 1 2 3 4 
4. Faintness or dizziness   0 1 2 3 4 
5. Loss of sexual interest or 
pleasure  
0 1 2 3 4 
6. Feeling critical of others  0 1 2 3 4 
7. The idea that someone else 
can control your thoughts  
0 1 2 3 4 
8. Feeling others are to blame 
for most of your troubles  
0 1 2 3 4 
9. Trouble remembering things  0 1 2 3 4 
10.Worried about sloppiness or 
carelessness  
0 1 2 3 4 
11. Feeling easily annoyed or 
irritated  
0 1 2 3 4 
12. Pains in heart or chest  0 1 2 3 4 
13. Feeling afraid in open 
spaces or on the streets  
0 1 2 3 4 
14. Feeling low in energy or 
slowed down  
0 1 2 3 4 
15. Thoughts of ending your life  0 1 2 3 4 
16. Hearing voices that other 0 1 2 3 4 
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people do not hear  
17. Trembling  0 1 2 3 4 
18. Feeling that most people 
cannot be trusted  
0 1 2 3 4 
19. Poor appetite  0 1 2 3 4 
20. Crying easily  0 1 2 3 4 
21. Feeling shy or uneasy with 
the opposite sex  
0 1 2 3 4 
22. Feelings of being trapped or 
caught  
0 1 2 3 4 
23. Suddenly scared for no 
reason  
0 1 2 3 4 
24. Temper outbursts that you 
could not control  
0 1 2 3 4 
25. Feeling afraid to go out of 
your house alone  
0 1 2 3 4 
26. Blaming yourself for things  0 1 2 3 4 
27. Pains in lower back  0 1 2 3 4 
28. Feeling blocked in getting 
things done  
0 1 2 3 4 
29. Feeling lonely  0 1 2 3 4 
30. Feeling blue  0 1 2 3 4 
31. Worrying too much about 
things  
0 1 2 3 4 
32. Feeling no interest in things  0 1 2 3 4 
33. Feeling fearful  0 1 2 3 4 
34. Your feelings being easily 
hurt  
0 1 2 3 4 
35. Other people being aware 
of your private thoughts  
0 1 2 3 4 
36. Feeling others do not 
understand you or are 
0 1 2 3 4 




37. Feeling that people are 
unfriendly or dislike you  
0 1 2 3 4 
38. Having to do things very 
slowly to insure correctness 
0 1 2 3 4 
39. Heart pounding or racing  0 1 2 3 4 
40. Nausea or upset stomach  0 1 2 3 4 
41. Feeling inferior to others                              0 1 2 3 4 
42. Soreness of your muscles  0 1 2 3 4 
43. Feeling that you are watched 
or talked about by others  
0 1 2 3 4 
44. Trouble falling asleep  0 1 2 3 4 
45. Having to check and double-
check what you do  
0 1 2 3 4 
46. Difficulty making decisions  0 1 2 3 4 
47. Feeling afraid to travel on 
buses, subways, or trains  
0 1 2 3 4 
48. Trouble getting your breath  0 1 2 3 4 
49. Hot or cold spells  0 1 2 3 4 
50. Having to avoid certain 
things, places, or activities 
because they frighten you  
0 1 2 3 4 
51. Your mind going blank  0 1 2 3 4 
52. Numbness or tingling in 
parts of your body  
0 1 2 3 4 
53. A lump in your throat                                                                         0 1 2 3 4 
54. Feeling hopeless about the 
future  
0 1 2 3 4 
55. Trouble concentrating  0 1 2 3 4 
56. Feeling weak in parts of your 
body  
0 1 2 3 4 
EMOTIONAL EXPRESSION IN CANCER SURVIVORS 
171 
 
57. Feeling tense or keyed up  0 1 2 3 4 
58. Heavy feelings in your arms 
or legs  
0 1 2 3 4 
59. Thoughts of death or dying  0 1 2 3 4 
60. Overeating  0 1 2 3 4 
61. Feeling uneasy when people 
are watching or talking about 
you  
0 1 2 3 4 
62. Having thoughts that are not 
your own  
0 1 2 3 4 
63. Having urges to beat, injure, 
or harm someone  
0 1 2 3 4 
64. Awakening in the early 
morning                                                           
0 1 2 3 4 
65. Having to repeat the same 
actions such as touching, 
counting, or washing  
0 1 2 3 4 
66. Sleep that is restless or 
disturbed  
0 1 2 3 4 
67. Having urges to break or 
smash things  
0 1 2 3 4 
68. Having ideas or beliefs that 
others do not share  
0 1 2 3 4 
69. Feeling very self-conscious 
with others  
0 1 2 3 4 
70. Feeling uneasy in crowds, 
such as shopping or at a movie  
0 1 2 3 4 
71. Feeling everything is an 
effort  
0 1 2 3 4 
72. Spells of terror or panic  0 1 2 3 4 
73. Feeling uncomfortable about 
eating or drinking in public  
0 1 2 3 4 
74. Getting into frequent 
arguments  
0 1 2 3 4 
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75. Feeling nervous when you 
are left alone  
0 1 2 3 4 
76. Others not giving you proper 
credit for your achievements  
0 1 2 3 4 
77. Feeling lonely even when you 
are with people  
0 1 2 3 4 
78. Feeling so restless you 
couldn't sit still                              
     
0 1 2 3 4 
79. Feelings of worthlessness  0 1 2 3 4 
80. The feeling that something 
bad is going to happen to you  
0 1 2 3 4 
81. Shouting or throwing things  0 1 2 3 4 
82. Feeling afraid you will faint in 
public  
0 1 2 3 4 
83. Feeling that people will take 
advantage of you if you let them  
0 1 2 3 4 
84. Having thoughts about sex 
that bother you a lot  
0 1 2 3 4 
85. The idea that you should be 
punished for your sins  
0 1 2 3 4 
86. Thoughts and images of a 
frightening nature  
0 1 2 3 4 
87. The idea that something 
serious is wrong with your body  
0 1 2 3 4 
88. Never feeling close to 
another person  
0 1 2 3 4 
89. Feelings of guilt  0 1 2 3 4 
90. The idea that something is 
wrong with your mind  
0 1 2 3 4 
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SECTION 8. Information about you  
1. Are you currently? 
Single □        Married/living with a partner □       Divorced/Separated □        Widowed □ 
2a. Are you currently working? 
Full time        □        Part time        □        Retired        □        Homemaker       □       Student       □ 
 
Other (please specify) ………………………………………………….. 
2b. Occupation…………….. …………………………….... 
- Hours worked before the diagnosis: ……..……………. 
- Hours worked after the diagnosis: ……..……………. 
3. What is your highest level of education?  
No academic 
qualifications                           □ 
GCSE/O-Level/Equivalent □ 
A-Level/Equivalent                                        □ Degree Level or Higher □ 
 
Other (please specify) ………………………………………………….. 
 
4. Do you… 
Live alone □         Live with a partner □       Live with a partner and children □         Live with 
children □        
Other (please state) □……... 
5. Would you describe yourself as….       
Black-Caribbean □ Indian  □ Bangladeshi □ 
Black-African □ White □ Chinese □ 
Black-Other □ Pakistani  □ Other  (please specify):…….. 
6. Religion: ……………………………….  
7. Date of birth: ……………………………… 
8. Gender:    Male         □        Female       □ 
 
9. Country of birth: ……………………………… 
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